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Summary 
 
SeV genome is characterized by a non-segmented negative stranded RNA of negative 
polarity, which is tightly associated with the viral nucleoprotein N, forming a very stable 
helicoïdal structure called the nucleocapsid (NC). This genome is replicated via an 
intermediate RNA of positive polarity, the antigenome, representing the full copy of the 
genome. SeV is composed of 6 genes, which are flanked by control regions essential for 
transcription and replication, namely the leader and the trailer. The leader and the trailer are 
part of the genomic promoter (G/Pr) and the antigenomic promoter (AG/Pr), respectively. The 
G/Pr (located at the 3’extremity of the genome) is involved in the control of replication and 
transcription initiation, whereas the AG/Pr (located at the 3’end of the antigenome) is only 
implicated in the replication.  
An important component of the host’s innate immune response in viral infection is the 
production of type I interferons (IFNs). Efforts to understand the molecular mechanisms by 
which viruses and also double-stranded RNA (dsRNA) trigger the induction of IFN have led 
to the identification of cellular sensors of viral infection. One type of sensor is the family of 
cytosolic receptor proteins known as the retinoic acid inducible gene I (RIG-I)-like receptors. 
This family includes RIG-I and Mda5, two DexD/H box helicases with CARD domains that 
were found to participate in the detection of cytoplasmic RNA. dsRNA as well as single-
stranded viral RNA bearing 5’triphosphates (5’pppRNA) are thought to be products of RNA 
virus infections that acts as pathogen-associated molecular patterns (PAMPs) responsible for 
initiating the innate antiviral defence. RIG-I and Mda5 initiate antiviral responses by 
coordinately activating several transcription factors, including NF-κB and IRF-3, that bind to 
the IFNβ promoter forming an enhanceosome, which in turn activates the IFNβ gene. IFNβ is 
secreted and feeds back onto cells in a paracrine manner to prime neighbouring cells for 
possible infection and in a autocrine manner to induce multiple IFN stimulated genes (ISGs) 
leading to the antiviral state of the cell. Many viruses including SeV have developed strategies 
for counteracting the host type interferon I response and this at different levels. For that 
purpose SeV mainly uses the non-structural C and V proteins to act at the level of the IFN 
induction pathway by blocking RIG-I activation and also at the level of the IFN feedback loop 
where C blocks Stat-1 signaling pathway. 
  In the first study, we have used cDNA arrays to compare the activation of various 
cellular genes in response to infection with SeV that contain specific mutations. Mutations 
that disrupt four distinct elements in the SeV genome (the leader RNA, two regions of the C 
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protein, and the V protein) all lead to enhanced levels of IFN-β mRNA, and at least three of 
these viral genes also appear to be involved in preventing activation of IL-8. Our results 
suggest that SeV targets the inflammatory and adaptive immune responses as well as the IFN-
induced intracellular antiviral state by using a multifaceted approach. 
SeV stocks available commercially are known to strongly induce IFNβ and are 
commonly used by many laboratories. Plus, these stocks are known for a long time to contain 
DI genomes. The paramyxoviruses DI genomes can be of two types: internal deletion or 
copyback DI genomes. Copyback DIs have the capacity to form dsRNA by at least two ways: 
1) When the level of the N protein is not sufficient, DI genomes and antigenomes can self-
anneal, and 2) Because some DI genomes contain termini that are perfectly complementary, 
they are free to form dsRNA. Moreover, DIs (especially those from the copyback variety) 
interfere robustly with the ND helper genome by competing for replication and consequently 
reducing the production of viral proteins involved in the antiviral state. The second paper 
shows evidence that the strong induction of IFNβ activation upon SeV infection (SeV stock 
containing DI genomes) is mainly due to the presence of copyback DI genomes. The level of 
IFNβ activation was found to be proportional to that of DI genome replication. Moreover, this 
activation can be inhibited by the overexpression of the C and V proteins, whose 
concentrations are reduced in DI infected cells, because of the strong interference of the DI 
versus the ND genome. 
  In the last paper the contribution of RIG-I (and Mda-5) in the detection of SeV 
infection is examined. Because 5’triphophorylated products have become new potential 
targets of RIG-I, we decided to test whether SeV infections induced IFNβ activation by 
producing pppRNAs as well as dsRNA. The involvement of both helicases was also analysed. 
We used two different Sendai virus infections to study virus-induced IFNβ activation; 1) SeV-
DI-H4, which is composed mostly of small, copyback DI genomes, and whose infection is 
likely to over-produce short 5’ tri-phosphorylated (ppp) trailer RNAs and under-produces the 
viral V and C proteins, and 2) SeV-GFP(+/-), a co-infection that produces WT  amounts of 
viral gene products but also produces both GFP mRNA and its complement, which can form 
dsRNA with capped 5’ ends. We found that 1) virus-induced signaling to IFNβ depended 
predominantly on RIG-I (as opposed to mda-5) for both SeV infections, i.e., that RIG-I senses 
both pppRNAs and dsRNA without 5’ tri-phosphorylated ends, and 2) that it is the viral C 
protein (and not V) that is primarily responsible for countering RIG-I  dependent signaling to 
IFNβ. 
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Résumé en Français 
Introduction générale 
Le virus de Sendaï (SeV) a été découvert en 1953 au Japon et isolé à partir d’un nouveau né 
présentant des troubles respiratoires. Ce virus n’est pas pathogène pour l’homme mais il est 
extrêmement contagieux et virulent chez le rat et la souris de laboratoire. La transmission se 
fait par contact direct et est suivit par une infection des voies respiratoires.  SeV appartient au 
genre Respirovirus de la famille des Paramyxovirus. Cette famille avec celle des 
Rhabdovirus, des Filovirus et des Bornavirus constituent l’ensemble de l’ordre des 
Mononegavirus.  
Il existe plusieurs pathogènes humains appartenant à cette famille, comme par exemple le 
virus de la rougeole, le virus des oreillons ou encore le virus Nipah, un virus apparu 
récemment. Ces virus sont encore très présents dans les pays en voie de développement. 
Effectivement le virus de la rougeole à lui seul tue encore plus d’un million de personnes par 
année. Ainsi, SeV est considéré comme un bon modèle d’étude permettant de mieux 
comprendre les mécanismes moléculaires de cette famille et de trouver des thérapies. 
SeV contient une enveloppe sphérique provenant de la membrane plasmique de l’hôte dans 
laquelle sont ancrées les glycoprotéines virales de fusion (F) et l’hémagglutinine-
neuraminidase (HN), toutes deux impliquées dans l’attachement, la fusion et le relâchement 
des particules virales. Les protéines de la matrice (M) se trouvent contre la surface interne de 
la membrane et jouent un rôle important dans la structure et l’assemblage de la particule 
virale. A l’intérieur de cette particule se trouve le génome à ARN(-) de SeV étroitement 
associé aux protéines de la capside (N), formant une structure hélicoïdal très stable appelée la 
nucléocapside (NC) ou le complexe ribonucléoprotéique. Attachées à ce complexe, les 
protéines virales P et L forment la polymérase à ARN, qui est responsable de la transcription 
et de la réplication du virus. 
Le génome de SeV est long de 15'384 nucléotides et se caractérise par un simple brin d’ARN, 
non-segmenté et de polarité négative. SeV est composé de six gènes : N, P, M, F, HN et L. 
L’ordre de ces gènes est extrêmement bien conservé parmi les paramyxovirus.  Chaque gène 
commence avec une courte séquence régulatrice de transcription de dix nucléotides appelée 
“gene start” et se termine par une séquence de terminaison nommée « gene end ». Entre ces 
deux séquences se trouve une région intergénique (IG) non transcrite de trois nucléotides. Les 
extrémités flanquant les 6 gènes comportent des régions extracistoniques essentielles pour la 
transcription et la réplication, nommées le leader à l’extrémité 3’ et le trailer à l’extrémité 5’. 
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Ces séquences font partie des promoteurs génomiques et antigénomiques, respectivement. Les 
gènes de SeV sont monocistroniques à l’exception du gène P, qui contient différents cadres de 
lecture ouverts ainsi qu’un site d’editing en son milieu. De ce fait, différentes espèces de 
protéines (P, V, W, C’, C, Y1, Y2 and X) peuvent être produites. 
 
Le cycle viral et la synthèse d’ARN viral 
Lors d’une infection, le virus est adsorbé par les récepteurs cellulaires situés à la surface de la 
cellule, ce qui conduit à la fusion entre l’enveloppe du virus et la membrane plasmique. Suite 
à la fusion, la nucléocapside hélicoïdale se trouve libérée dans le cytoplasme de la cellule 
hôte, lieu de toutes les étapes du cycle de multiplication virale. La nucléocapside contenant 
l’ARN génomique est la matrice pour toutes les synthèses d’ARN.  Deux fonctions sont 
assurées par le génome viral : la transcription des ARN messagers et la réplication de l’ARN 
viral. Les protéines N, P/C/V, M, HN et L protéines sont synthétisées par le système de 
traduction de la cellule, et finalement suit l’assemblage du génome viral avec les protéines de 
la capside. La protéine M se place à la surface interne de la membrane plasmique alors que les 
protéines de surface F et HN se trouvent au niveau des patchs créés par la protéine M, 
excluant les protéines cellulaire. Une fois que les nucléocapsides sont associées à la protéine 
M, les nouvelles particules se forment et sortent de la cellule en emportant avec elles une 
partie de la membrane plasmique cellulaire.  
Le génome viral encapsidé sert de matrice à la polymérase virale pour synthétiser dans un 
premier temps les ARN messagers nécessaires pour produire les protéines virales qui sont 
impliquées dans la réplication même du virus. La polymérase virale entre sur le génome à 
l’extrémité 3’ et transcrit en premier le leader qui est un ARN non codant, puis commence la 
transcription des six gènes en six messagers à ARN et ce d’une manière séquentielle et 
polaire. Occasionnellement la polymérase oublie de réinitier le messager suivant la jonction, 
en atténuant par conséquent la transcription des gènes en aval. Ainsi un gradient de messagers 
synthétisés peut être observé, qui est inversement proportionnel à la distance du gène par 
rapport à l’extrémité 3’ du génome. La protéine N est la protéine la plus synthétisée et la 
concentration intracellulaire de sa forme « non-assemblée » est un moyen de contrôler le taux 
de transcription et de réplication à partir de la matrice génomique. Lorsque la quantité de 
protéinés N « non assemblées » est suffisante, la synthèse d’ARN viral est couplée avec 
l’encapsidation concomitante de la chaine naissante. Dans ces conditions la polymérase 
ignore toutes les jonctions, formant ainsi une copie complète du génome de polarité positive 
entièrement encapsidée. Ce dernière est appelé antigénome et servira à son tour à la synthèse 
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d’une nouvelle copie d’ARN génomique, qui à nouveau sera utilisée comme matrice ou alors 
qui sera envoyée et assemblée dans une particule virale naissante.  
 
Les protéines accessoires  
Les protéines C et V de SeV sont désignées comme des protéines « accessoires », car elles ne 
sont pas présentes dans tous les virus de la famille des Paramyxoviridae. Effectivement 
certains virus possèdent les deux protéines alors que d’autres ne possèdent que l’une ou 
l’autre. Les protéines C et V sont exprimées à partir du gène P qui contient 5 codons 
d’initiation ainsi qu’un site d’editing en son milieu, ce qui lui permet de coder pour 8 
protéines : P, V, W, C’, C, Y1, Y2 et X.  
Les protéines C’, C, Y1 et Y2 sont collectivement nommées les « protéines C ». La 
participation des protéines virales C et V dans la contremesure des  réponses innées de la 
cellule, a été intensément étudiée ces 10 dernières années. Apparemment, les Paramyxovirus 
(incluant SeV) utilisent la protéine C pour cette fonction, alors que les autres membres de la 
famille (Rubula-, Morbili- et Henipa-virus) utilisent la protéine V. Les protéines C de SeV 
sont des protéines non-essentielles à la multiplication du virus in vitro, mais sont nécessaires à 
la réplication du virus dans les souris. Cette particularité reste cependant dépendante du type 
cellulaire étudié. Les protéines C contiennent une séquence qui les localise à la membrane 
plasmique de la cellule mais elles sont également retrouvées dans le cytoplasme. Toutes les 
protéines C interagissent physiquement avec Stat1 (Signal transducer and activator of 
transcription 1), dont le rôle est de transduire le signal de l’IFN pour permettre l’expression de 
protéines antivirales.  Cette interactions (C/Stat1) empêche la signalisation de l’IFN par la 
voie de JAK/Stat et en même temps bloque l’établissement d’un état antiviral de la cellule. 
Les quatre protéines C (C’, C, Y1, Y2) partagent la même région C-terminal alors que seul les 
longues protéines C (C’ et C) partagent la même région N-terminale. La partie C-terminal de 
la protéine C est nécessaire et suffisante pour bloquer le signal de l’IFN. Par conséquent les 
protéines Y1 et Y2 peuvent à elle seules garantir cette fonction. Par contre les longues 
protéines de C  (C’,C) provoquent l’instabilité de Stat1, réduisant le niveau de Stat1 tout en 
augmentant celui de Stat1 sous sa forme phosphorylé. Ainsi la partie N-terminal de la protéine 
C est associée avec la dégradation de Stat1 qui permet de renverser l’état antiviral induit par 
l’IFN. Il a aussi été démontré que la partie C1-23 (nucléotides 1-23 de la partie N-terminal) 
était suffisante pour réduire la quantité de Stat1 et agissait comme un signal ciblant la 
membrane plasmique. De plus la localisation des longues protéines C à la membrane 
plasmique est apparemment nécessaire à leur activité. Finalement, il a été montré également 
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que la protéine C pouvait inhiber la signalisation de RIG-I, un détecteur cytoplasmique 
d’ARN viral. Les protéines Y1 et Y2 (partie C terminale) seraient responsables de cette 
inhibition, mais aucun résultat n’a encore été clairement montré.  
 
Leader et Trailer 
Chez les paramyxovirus le promoteur génomique et le promoteur antigénomique (G/Pr et 
AG/Pr) se trouvent à l’extrémité 3’ du génome et à l’extrémité 5’ de l’antigénome, 
respectivement. Chez SeV ces promoteurs ont tous deux une longueur de 96 nucléotides. Le 
leader fait partie du G/Pr, incluant les 55 premiers nucléotides à l’extrémité 3’ du génome (-). 
Cette séquence contient les signaux d’initiation pour la synthèse d’ARN (transcription et 
réplication) par la polymérase virale. Le trailer comporte les 57 premiers nucléotides à 
l’extrémité 3’ de l’antigénome. Cette séquence est essentielle pour la réplication virale. Les 
transcrits du leader et du trailer sont tous deux exempt de régions codantes et ne sont ni 
coiffés, ni polyadenylés. Par contre ils portent chacun à leur extrémité 5’ un triphosphate, qui 
a été récemment déterminé comme une nouvelle signature virale détectée spécifiquement par 
des sentinelles cytoplasmiques de la cellule. L’AG/Pr, responsable de la synthèse du génome 
est plus fort que le G/Pr. Effectivement, l’AG/Pr a une plus grande affinité pour la polymérase 
et la production de génome est dix fois supérieure à celle de l’antigénome. De plus, il a été 
montré que le « gène start » réduisait la force du promoter de réplication du G/Pr. 
 
Les génomes défectifs et interférants: les DIs 
Des formes incomplètes de génome viral générées lors du processus de réplication du virus 
standard ont été observées dans quasiment  tous les virus à ARN et ADN et ont été nommées 
les “génomes défectifs et interférants”. Ce phénomène apparait lorsque le virus est passé à 
haute multiplicité d’infection et dépend de l’ARN polymérase virale. La fréquence des ces 
événements est faible et se manifeste pendant la transcription ou la réplication du génome 
non-défectif (ND). Plusieurs DIs peuvent être générés, mais seul quelques uns sont 
sélectionnés selon leur capacité à interférer avec le génome ND. La notion d’interférence est 
importante car elle permet aux génomes DI de se répliquer et de s’amplifier au dépend du 
génome ND, qui doit rentrer en compétition avec ces derniers afin de générer les protéines 
virales, elles-mêmes impliquées dans la réplication et la maturation du virus. En général, la 
plupart des DIs ne sont pas capables de transcrire, ni de traduire. Ainsi, ils sont entièrement 
dépendants du ND pour leur réplication. Une autre particularité de ces génomes DI est qu’ils 
sont requis dans l’établissement et la maintenance d’infections persistantes. 
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On peut observer principalement deux types de DI: le DI de « délétion interne » et le DI 
d’extrémités symétriques ou « Copyback ». Dans le premier cas, la polymérase à ARN 
commence à synthétiser le génome et à un certain moment saute en avant sur sa matrice pour 
continuer la synthèse. Le DI à « délétion interne » conserve les extrémités 3’ et 5’ mais une 
partie plus ou moins grande du génome manque ou est absente. Dans le cas du DI 
« copyback », la polymérase commence la synthèse normalement, mais à un certain moment 
se détache de sa matrice et au lieu de continuer en avant, elle commence à copier dans le sens 
inverse, utilisant la chaine naissante comme matrice. Par conséquent, dans le DI 
« copyback », il manque une grande partie 3’ du génome ND, mais on trouve le même AG/Pr 
à chaque extrémité. Cette particularité du DI « copyback » lui permet d’avoir une meilleure 
réplication et d’interférer ainsi avec le virus ND. Le fait que les DIs « copyback » n’expriment 
pas de protéines ne veut pas dire qu’ils n’ont aucun rôle. Effectivement, le fait qu’ils 
possèdent deux AG/Pr implique aussi la présence de deux trailers, qui ont un rôle 
antiapoptotique. Ceci expliquerait en partie la mise en place d’une infection persistante, lors 
d’une infection avec un stock de SeV contenant des DIs de type « copyback ». 
 
Le système de l’Interféron 
Lors de leur évolution, les cellules ont développé des défenses efficaces afin de contrecarrer 
les infections virales. La première ligne de défense d’un organisme contre l’invasion d’un 
pathogène se traduit principalement par la sécrétion d’interférons (IFNs). Les IFNs font partie 
de la famille des cytokines identifiées par leur capacité à induire une forte résistance cellulaire 
suite à une infection virale. Leur action a comme effets d’induire un état antiviral aux cellules 
et tissus alentours à l’infection et d’utiliser différents moyens biologiques pour interférer avec 
la réplication virale, moduler la réponse immune et réguler l’apoptose. 
L’ARN double brin est connu pour être un fort inducteur de l’IFN et est potentiellement 
généré lors du processus de la transcription et de la réplication du génome viral. Il existe trois 
types d’IFNs : 1) L’IFN de type I, incluant l’IFNα et IFNβ. 2) L’IFN de type II (également 
appelé IFNγ) comprend les IFNε,κ and ω qui ont été récemment définis. 3) L’IFN de type III 
ou IFNλ est une nouvelle cytokine similaire à IL10. Les IFNs de types I et II sont tous deux 
impliqués dans l’activité antivirale, mais l’IFN de type I joue un rôle plus important dans 
l’immunité innée alors que l’IFNγ est plus impliqué dans l’immunité adaptative. L’IFN de 
type III possède des activités et des fonctions similaires aux IFNs de type I, bien qu’il utilise 
un autre complexe de récepteurs de surface. Les trois types d’IFNs induisent des réponses 
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transcriptionnelles à travers la voie de signalisation de JAK-Stat qui résultent en l’activation 
de multiples gènes.  La régulation de l’expression des IFNs est bien caractérisée et demande 
la participation de différents complexes de facteurs de transcription qui sont déjà présents 
dans la cellule et qui sont activés lors d’une infection virale. Il existe quatre facteurs de 
transcription connus pour lier l’enhancer activatrice de l’IFNβ: ATF-2/ C-Jun, NF-κB et deux 
facteurs de transcriptions (IRFs), IRF-3 and IRF-7. La famille des protéines IRF contient 9 
membres, qui sont extrêmement importants pour un grand nombre de processus incluant la 
réponse immune, la signalisation de cytokines et la croissance cellulaire ainsi que 
l’hématopoïèse. IRF-3 et IRF-7 résident dans le cytoplasme des cellules non infectées et qui, à 
la suite d’une infection virale, sont transloquées dans le noyau.  IRF-3 and IRF-7 sont 
essentiels pour l’induction maximale de l’expression d’IFNα/β. Alors qu’IRF-3 est 
constitutivement exprimé, IRF-7 est principalement dépendant de son induction par l’IFN. A 
la suite d’une infection, IRF3 est activé et s’installe dans le noyau où il initie la synthèse 
d’IFNα/β en se liant aux régions enhancer activatrice. Les IFNα/β sont alors sécrétés et se 
lient à nouveau de façon paracrine sur les cellules voisines afin de les alerter d’une possible 
infection ou alors de façon autocrine pour induire plusieurs gènes ISGs (IFN stimulated 
genes) dans la cellule même. De cette façon la première vague de défense est mise en place 
résultant en un état antiviral des cellules.  
 
Les détecteurs d’infections de virus à ARN 
Plusieurs voies de signalisation conduisant à l’induction des IFNα/β ont été découvertes 
récemment. Elles incluent différents récepteurs cellulaires qui ont la particularité de détecter 
la présence du virus en reconnaissant les signatures moléculaires virales. Ces signatures 
virales font partie des PAMPs (pathogen associated molecular pattern) qui contiennent 
beaucoup de signatures potentielles provenant de différents pathogènes, incluant les virus, les 
bactéries et les champignons. Ces PAMPs sont reconnus par un large spectre de récepteurs 
nommée PRRs (pattern recognition receptors) qui comprennent les « R-proteins » (pathogen-
resistance protein) chez les plantes, les récepteurs Toll-like (TLRs), les récepteurs NOD-like 
(NLRs) ainsi que les récepteurs Rig-like (RLRs) chez les animaux. Les TLRs se trouvent 
essentiellement associées à la membrane plasmique, soit à la surface cellulaire soit dans la 
membrane des endosomes. Les NLRs et les RLRs quant à eux, sont des protéines solubles qui 
surveillent le cytoplasme et qui sont prêts à détecter  la présence de pathogènes à l’intérieure 
de la cellule. Jusqu’à maintenant, la reconnaissance des bactéries dans la cellule reste 
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spécifique aux NLRs, alors que celle des virus reste restreinte aux RLRs. Finalement il 
semblerait que la coopération entre ces PRRs constitue un véritable bouclier contre les 
pathogènes envahissants. 
Il existe trois membres de la famille des RLRs : retinoic-acid-inducible gene 1 (RIG-1), 
melanoma differentiation-associated gene 5 (MDA-5) et laboratory of genetics and 
physiology 2 (LPG2). RIG-I et Mda-5 sont des hélicases, dont le rôle est de distinguer les 
ARNs du soi de la cellule et les ARNs du non soi provenant des virus, et de réguler ainsi le 
signal de transduction en aval. Par contre, LPG2 joue un rôle de régulateur-inhibiteur de RIG-
I et de Mda-5. Des études ont révélé que RIG-I était essentiel à la reconnaissance d’un set 
spécifique de virus incluant les Paramyxoviruses, Flaviviruses, Orthomyxoviruses et 
Rhabdoviruses, alors que Mda-5 était essentiel à la reconnaissance d’un différent set de virus, 
incluant les Picornaviruses et les Alphaviruses. Il a été également démontré que RIG-I était 
activé par de l’ARN double brin ainsi que par des ARN non-cappés, portant un triphosphate à 
leur extrémité 5’. De ce fait, il semblerait que différentes voies d’activation peuvent être 
activées selon le PRRs impliqué dans la reconnaissance de la signature virale et selon le type 
de virus. Malgré ces différences, RIG-I et MDA-5 gardent la même voie de signalisation en 
aval. Ils sont tous deux exprimés ubiquitairement dans la plupart des tissues et font partie des 
ISGs. Il a été montré que la reconnaissance des PAMPs induisait un changement de 
conformation de RIG-I et Mda-5, les rendant capables de se lier à une protéine liée à la 
surface externe de la membrane mitochondriale, nommée Cardif. Cette interaction conduit 
indirectement à l’activation de différentes kinases qui induisent l’activation de IRF-3 et NF-
κB, ce qui finalement résulte dans l’induction de l’IFN de type I et à la mise en place de l’état 
antiviral de la cellule.  
 
Papier 1 : 
Le virus de Sendai cible de multiples façons les réponses inflammatoires ainsi que l’état 
antiviral induit par l’IFN 
Pendant leur évolution, les virus ont développé plusieurs stratégies afin de réguler et 
contrecarrer les réponses innées des cellules hôtes, en particulier la production des IFNs. Pour 
cela, le virus de SeV utilise ses protéines C pour combattre les réponses à l’IFN. Le premier 
papier se base sur des microarrays d’ADN complémentaires afin de comparer l’activation de 
différents gènes cellulaires en réponse aux infections de SeV contenant des mutations 
spécifiques dans le gène C ou dans les régions promotrices du génome (qui ont apparemment 
un rôle dans la prévention de l’apoptose et dans l’infection persistante). Ces analyses ont 
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permis d’observer que le niveau d’activation d’environ 20 ARNm augmentait 
significativement lors d’infection avec les virus SeV mutants, comparé aux infections de SeV 
WT. Trois différents groupes de gènes cellulaires ont pu être mis en évidence selon les 
mutations que porte SeV. Certains des gènes sont connus comme des gènes stimulés par l’IFN 
(ISGs) d’autres, comme IL-6 ou IL-8 ne sont pas directement induits par l’IFN. Le gène de 
l’IFNβ, qui est essentiel pour initier l’état antiviral fut également activé lors d’infection de 
SeV portant des mutations. Ce travail met en avant le fait que SeV portant des mutations 
spécifiques dans le gène de C, par opposition au SeV WT, active l’expression d’IL-6 et IL-8 
ainsi que quelques autres ISGs. Ainsi les protéines accessoires C et V et la présence du leader 
ont un rôle dans la prévention de l’expression de ces gènes cellulaires qui sont essentiels 
autant pour les réponses inflammatoires, que pour les réponses adaptatives et innées de la 
cellule hôte. 
 
Papier 2:  
Les génomes défectifs de SeV (DIs) et l’activation de l’Interféron-beta 
Le promoteur de l’IFNβ est normalement activé lorsque les cellules sont traitées avec de 
l’ARN double brin synthétique (polyI/C) ou lorsqu’elles sont infectées par des virus. SeV est 
généralement utilisé à cet effet, et des stocks de SeV peuvent être facilement obtenus dans le 
commerce. Cette remarquable capacité à induire l’IFN est cependant reliée au fait que ces 
stocks contiennent des génomes défectifs (DIs). Dans ce travail nous avons tout d’abord 
comparé la capacité d’induire l’IFN de plusieurs stocks de SeV, contenant ou non différents 
génomes défectifs. Plusieurs niveaux d’induction de l’IFN ont pu être observés selon le type 
de stock utilisé. Apparemment, cette propriété est particulièrement due à la présence de DI 
copyback et corrèle a priori avec leur capacité à s’hybrider et à former de l’ARN double brin. 
Le niveau d’activation de l’IFN semble également être proportionnel à la réplication même du 
génome défectif et au ratio génomes défectifs/génomes ND lors de l’infection. Dans cette 
étude, on démontre d’autre part que les protéines C et V de SeV sont aptes à bloquer 
l’induction à l’IFN lors d’infection avec les DIs ou lors de traitement avec le polyI/C. Ainsi 
on conclut que les infections de SeV contenant des DIs sont particulièrement de puissants 
inducteurs de l’IFNβ. Effectivement il est probable qu’ils fournissent une grande quantité de 
double brin et qu’ils réduisent en même temps l’expression virale des protéines C et V 
(normalement responsables de contrecarrer la réponse antivirale de l’hôte) favorisant de ce 
fait l’induction à l’IFN. 
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Papier 3: 
Lors d’infections non-naturelles de SeV la voie d’activation de l’IFNβ requiert RIG-I et est 
inhibée par les protéines virales C 
Sachant que SeV-WT n’active que très faiblement l’IFNβ et afin d’étudier l’activation de 
l’IFNβ dans les cellules MEFs, nous avons utilisé deux différentes sorte d’infection de SeV: 
1) Le stock de SeV-DI-H4 est composée en majorité de génomes non-défectifs de type 
“copyback” et lors d’un infection, il produit en grande quantité les ARNs trailer contenant 
trois phosphates en extrémité 5’ et, en quantité moindre, les protéines virales C et V. 2) 
L’infection SeV-GFP(+/-) est une coinfection, qui génère (en plus des produits de gènes 
viraux en quantité équivalente à une infection SeV-WT) des ARN messagers GFP ainsi que 
leurs compléments pouvant former des ARNs double brin synthétiques (polyI/C) comportant 
des extrémités 5’ cappées. Ce travail nous a permis de découvrir 1) que l’activation de l’IFN, 
induit par les deux types de virus, dépendait principalement de RIG-I (et non de Mda-5). Plus 
précisément, que RIG-I détectait les pppARN simple brin ainsi que les ARN double brins ne 
comportant pas les trois phosphates en extrémité 5’ ;  2) que c’est la protéine C (et non la V) 
qui est responsable en premier lieu de contrecarrer l’induction de l’IFN dépendante de RIG-I. 
SeV n’exprimant pas spécifiquement les protéines C, ne peut pas prévenir l’activation de 
l’IFN induite par du polyI/C ou par les pppARN simple brin. Cette activation se trouve même 
amplifiée. D’autre part, de SeV n’exprimant pas de protéine V se comporte comme un SeV-
WT et contrecarre les effets du polyI/C ou des pppARN simple brin. 
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List of abbreviations 
 
AG/Pr       Antigenomic promoter 
CAT       Chloramphenicol acetyl transferase  
DI      Defective interfering  
G/Pr      Genomic promoter 
HPIV 1,2 and 3    Human parainfluenza virus type 1,2 and 3 
ISG       Interferon stimulated gene 
IRF      Interferon regulatory factor  
le       Leader 
Mda-5      Melanoma differentiation-associated gene 5  
MeV      Measles virus 
MV      Mumps virus 
NC      Nucleocapsid 
ND      Non defective 
NDV      Newcastle disease virus 
NNV      Nonsegmented negative stranded RNA virus 
RSV      Respiratory syncytial virus 
RV      Rabies virus 
SeV      Sendai virus 
STAT      Signal transducer and activator of transcription 
SV5      Simian virus 5 
RIG-1      Retinoic-acid-inducible gene 1 
tr      Trailer 
vRNAP     Viral RNA polymerase 
VSV       Vesicular stomatitis virus 
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I. General Introduction 
 
Sendai virus (SeV) was discovered in Japan in 1953. It was isolated in the Tohuku University 
Hospital from a newborn patient presenting pneumonia syndromes. SeV is also referred to as 
murine parainfluenza type I virus as it was found to infect respiratory tract of mice, to cause 
pneumonia and to spread to uninfected animals. SeV is currently an important respiratory 
pathogen of laboratory rodents, causing terrible epidemics with high mortality during the 
acute phase. It is extremely contagious and transmission occurs via contact and aerosol 
infection of the respiratory tract.  
SeV is an enveloped nonsegmented negative stranded RNA virus (NNV) of the 
Paramyxoviridae family, subfamily Paramyxovirinae and genus Paramyxovirus (or 
Respirovirus). It is considered to be a good model to study the Paramyxoviridae family 
because it includes significant human pathogens of infants and children, such as Mumps virus 
(MV), Measles virus (MeV), respiratory syncytial virus (RSV) and Nipah virus. Some of 
these viruses are still importantly present in undeveloped countries (e.g. MeV still causes a 
million deaths/year) and some others have only recently emerged. Thus, studies on SeV can 
offer important information for understanding the molecular mechanisms of this virus family 
and consequently offer medical treatment and therapy. 
The Paramyxoviridae family along with the Rhabdoviridae, the Filoviridae and the 
Bornaviridae families, are all part of the Mononegalvirales order. It is subdivided into two 
subfamilies: the Paramyxovirinae containing the Respiro-, the Rubula-, the Morbilli-, the 
Avula- and the Henipa- viruses; and the Pneumovirinae, containing the Pneumo- and the 
Metapneumo-viruses. Emergence of new paramyxoviruses, such as Hendra and Nipah, 
causing respiratory and neurological disease in cattle and human, has been observed recently 
(Table 1).  
The classification of these different viruses is based on morphologic criteria, the organisation 
of the genome, the biological activities of the proteins, and the sequence relationship of the 
encoded proteins. The Mononegalviruses share a number of fundamental characteristcs: (1) 
Their genome is a single negative stranded RNA, packaged in a helical nucleocapsid (NC); 
(2) nucleocapsids are enclosed within an envelope derived from the plasma membrane of the 
cell; (3) a virus-coded RNA polymerase packaged in the virion synthesizes the viral mRNAs 
by transcribing the RNA as part of the intact NC after it enters the cell; (4) the RNA 
polymerase begins transcribing at the 3’end of the genome RNA and sequentially transcribes 
5-10 genes, terminating and releasing each mRNA before starting the next one. 
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Family Paramyxoviridae 
 
    Subfamily Paramyxovirinae 
Genus Respirovirus (Paramyxovirus) 
               Sendai virus (mouse parainfluenza virus type 1) 
              Human parainfluenza virus type 1 and 3  
              Bovine parainfluenza virus type 3 
Simian virus 10 
 Genus Rubulavirus 
Simian virus 5 (Canine parainfluenza virus type 5) 
Mumps virus 
Human parainfluenza virus type 2, type 4a and 4b (hPIV2/4a/4b) 
Porcine rubulavirus 
               Genus Morbillivirus 
              Measles virus 
                 Dolphin morbillivirus 
              Canine distemper  virus 
               Peste-des-petits-ruminants virus 
              Phocine distemper virus 
              Rinderpest virus 
Cetacean morbillivirus 
  Genus Avulavirus 
Newcastle disease virus (avian paramyxovirus 1) 
  Genus Henipavirus 
   Hendra virus 
   Nipah virus 
               Subfamily Pneumovirinae 
Genus Pneumovirus 
              Human respiratory syncytial virus 
               Bovin respiratory syncytial virus  
Murine pneumonia virus (Pneumonia virus of mice) 
Genus Metapneumovirus 
 Avian pneumovirus  
  Unclassified paramyxoviruses 
 Tupaia Paramyxovirus 
 
 
Table 1: Classification of the Paramyxoviridae family (www.ncbi.nlm.nih.gov/ICTVdb/Ictv/index.htm) 
 
 15
B. Virion  structure of Sendai Virus 
 
 
SeV virions are surrounded by a lipid bilayer envelope that is derived from the plasma 
membrane of the host cell in which the virus has grown (Choppin et al., 1975). The envelope 
contains two surface glycoproteins, F and HN, which mediate the entry and exit of the virus 
from its host cell. The nucleocapsid (NC), which is composed of the viral RNA genome 
tightly surrounded by hundreds of copies of the viral nucleoprotein (N), forms the active viral 
genome inside the envelope. The phosphoprotein (P) and the large (L) protein form the viral 
polymerase complex, which initiate intracellular virus replication. Between the envelope and 
the core lies the viral matrix (M) protein, which interacts with itself, with the lipid bilayer, 
with the NC, and with the cytoplasmic tails of the HN and F proteins (Fig.1). 
 
 
 
 
Figure 1: Schematic representation of SeV particle (From P. Le Mercier) 
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C. Genome & encoded proteins 
 
The genome of SeV is a nonsegmented, single stranded RNA genome of negative polarity, 
which replicates entirely in the cytoplasm, and contains 15’384 nucleotides. SeV is composed 
of 6 genes, the N, P/C/V, M, F, HN and the L, which are flanked by control regions essential 
for transcription and replication. The 3’ extracistronic region is known as the leader (le) and 
the 5’ extracistronic region is known as the trailer (tr). SeV genes are monocistronic except 
for the P gene, which can produce multiple protein species (P,V,W,C’,C,Y1,Y2 and X) via 
overlapping reading frames and mRNA editing. Each mRNA begins with a short transcription 
regulatory sequence of ten nucleotides named the gene start (UCCCANUUNC) and 
terminates with a gene end sequence (UNAUUCU5). There are also intergenic regions located 
between these sequences gene boundaries that are precisely three nucleotides long containing 
GAA, except for the junction between HN and L containing GGG (Fig. 2). 
 
Figure 2: Genomic organisation of SeV (From (Lamb and Kolakofsky, 2001). 
 
 
The N protein 
SeV N protein, also named the nucleoprotein, and genome RNA are assembled in a helicoidal 
helix forming the nucleocapsid (NC), with a stoichiometry of one N protomer for six 
nucleotides. This precise hexamer arrangement is required for an efficient replication and is 
called “the rule of six”, that is also applied to the other Paramyxoviruses of the 
Paramyxovirinae subfamily. In this rule, nucleocapsid assembly presumably begins with the 
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first nucleotide at the 5’ end of the nascent chain, and continues by assembling six nucleotides 
at a time until the 3’ end is reached (Calain and Roux, 1993; Kolakofsky et al., 1998). The NC 
core is composed of 2564 N proteins and approximately 300 P proteins and 50 L proteins 
(Lamb et al., 1976). It is remarkably stable, as it withstands the high salt and gravity forces of 
cesium chloride density gradient centrifugation. Within the NC, the RNA is also resistant to 
nuclease attack at any salt concentration (Lamb and Kolakofsky, 1996). For paramyxoviruses, 
SeV N protein is divided into two regions; the well conserved NCORE (1-400aa) and the 
hypervariable NTAIL (401-524aa) (Houben et al., 2007). The N protein associates with the P-L 
polymerase during replication. In the current model for encapsidation, there is an initial 
sequence specific binding of N to viral leader RNA followed by the cooperative assembly of 
N on the growing chain, presumably through N-N and non-specific N-RNA interactions. 
Several paramyxoviruses N proteins, including those of SeV, MeV, Newcastle disease virus 
(NDV) and parainfluenza virus (PIV) 2, have been shown to self assemble onto cellular RNA 
to form NC–like particles when they are expressed alone, thus providing support for a N-N 
interaction (Buchholz et al., 1993; Errington and Emmerson, 1997; Nishio et al., 1999) 
 
Sendai Virus RNA polymerase: The P and L proteins 
The P protein and the L protein form the core of the viral RNA dependent RNA polymerase 
(vRNAP). The vRNAP is involved in the transcription and the replication, which are two 
important steps in the life-cycle of the virus. For transcription, the polymerase complex is 
constituted only by the P and L proteins, but for efficient replication, the N protein is required 
in addition to the L and P proteins. Several studies indicate that there are two different 
possible states (multiprotein complex) of the polymerase depending on whether it is 
transcribing or replicating. For example, it has been recently shown that the polymerase of 
Vesicular Stomatitis virus (VSV) founds itself in a replicase or in a transcriptase state, 
depending on its protein composition (Qanungo et al., 2004). There is, however, no indication 
that this could be the case for the Paramyxovirus RNA polymerase. 
The polymerase cofactor P protein of SeV forms a tetramer and is named for its highly 
phosphorylated nature. It is a modular protein with distinct functional domains (Deshpande 
and Portner, 1984). It is composed of N-terminal and a C-terminal domain separated by 
hypervariable hinge (Curran and Kolakofsky, 1990). The N-terminal part is a chaperone for 
unassembled N proteins (N°), preventing it from binding to nonviral RNA in the infected cell 
(Curran et al., 1995) and forming a complex (P-N°) whose intracellular concentration is 
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believed to regulate rates of transcription and replication from genomic template (Curran et 
al., 1995; Masters and Banerjee, 1988). The C-terminal part is only functional as an oligomer 
and forms, along with L, the polymerase complex. It has already been shown for some other 
paramyxoviruses that the association of the N and P proteins has an effect on the N 
conformation (MeV) and on the virus assembly (VSV) (Das and Pattnaik, 2005; Kingston et 
al., 2004).  
The L protein is the largest and the least abundant protein of the structural proteins. Its gene is 
also the most promoter-distal in the transcriptional map. It binds to the N:RNA template via 
the P protein and contains all vRNAP catalytic activities like synthesis, 
capping/polyadenylation and methylation of the nascent viral mRNA (Ogino et al., 2005). The 
L protein is highly unstable when expressed alone and needs to bind P to confer a good 
stability and a proper conformation, as co-expression of P and L is necessary for the 
formation of an active polymerase complex (Curran et al., 1995; Horikami and Moyer, 1982; 
Horikami et al., 1997). Until today, no crystal structure of the mononegalvirales L proteins is 
available. However, primary structure conservation among the RNA polymerases suggests 
similar protein architecture. Sequence comparisons of NNV-L proteins have identified 6 
conserved regions, interrupted by variable sequences. These regions have been proposed to 
correspond to functional domains of the protein (Poch et al., 1990; Sidhu et al., 1993). There 
is also new evidence that the L protein could directly interact with itself and that this 
interaction would help RNA synthesis (Smallwood and Moyer, 2004).  
 
The M protein 
The matrix (M) protein is the most abundant protein in SeV virion. It is a quite basic and 
hydrophobic protein. The M protein is considered to be the central organizer in 
paramyxovirus budding and virus morphogenesis (Mottet et al., 1996; Sakaguchi et al., 
1994b). The M protein self-associates and interacts with membranes, forming patches at the 
inner surface of the plasma membrane (Stricker et al., 1994). It also interacts with the 
cytoplasmic tails of integral membrane proteins such as the F and HN proteins, the lipid 
bilayer and the NC (Ali and Nayak, 2000; Yoshida et al., 1979). Moreover, the M protein 
forms vesicles and self-releases from cells when singly expressed from cDNA (Takimoto et 
al., 2001). 
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The HN & F proteins 
The fusion of SeV requires co-expression of both HN (hemagglutinin-neuraminidase) and F 
(fusion) proteins. The HN and the F proteins are integral membrane glycoproteins and are 
essential for regulating morphogenesis and budding (Fouillot-Coriou and Roux, 2000; 
Takimoto et al., 1998). The HN protein is involved in cell attachment and is responsible for 
the adsorption of the virus to sialic acid-containing cell-surface molecules. In addition, it 
mediates enzymatic cleavage of sialic acid, namely neuraminidase activity, from the surface 
of virions and of infected cells. This activity prevents self-aggregation of viral particles during 
budding at the plasma membrane. The F protein mediates viral penetration by fusion between 
the virion envelope and the host cell plasma membrane. The F protein is synthesised as a 
precursor F0 which must be proteolytically cleaved to F1 and F2 for fusion activity 
(Morrison, 2003). The fusion occurs directly at the cell surface in an endosome-independent 
way, suggesting that infection does not require the acid pH of endosomes to activate fusion. 
The F protein has a self-release activity when expressed alone (Takimoto et al., 2001). After 
infection, the F proteins expressed at the plasma membrane of infected cells can mediate 
fusion with neighbouring cells to form syncytia, a cytopathic effect that can lead to tissue 
necrosis in vivo and might be a mechanism of virus spread. 
 
 
D. Viral life cycle 
 
All aspects of the replication of SeV happen in the cytoplasm. In cell culture, single-cycle 
growth generally last for 24 hours. As the infection takes place, the virus is adsorbed to the 
receptors found at the cell surface, and fusion occurs between the viral membrane and the 
cellular plasma membrane. This leads to the release of the helical NCs in the cytoplasm. This 
NC containing the viral RNA genome is the template for all RNA synthesis (Fig.3). Two 
functions are provided by the viral RNA genome: the mRNAs transcription and the viral RNA 
replication. The N, P/C/V, M, HN and L proteins are synthesised by the cellular ribosomes. 
The assembly of the genomes and the N proteins takes place in the cytoplasm. The M protein 
lies in the inner surface of the cytoplasmic membrane whereas the HN and the F float at the 
membrane and concentrate to the M patches, excluding other cellular proteins. Finally, the 
NCs associate with the M proteins and the new viral particles bud out of the cell taking a 
portion of the plasma membrane (Lamb and Kolakofsky, 2001).  
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Figure 3 :  The life cycle of a Paramyxovirus (From Lamb and Kolakofsky, 2001). 
 
 
 
RNA synthesis 
 
Intracellular replication begins with the transcription of the viral genome into capped and 
polyadenylated mRNAs by the vRNAP. The vRNAP first transcribes the leader RNA at the 
3’end of the genome, and then begins the transcription of the genes into six individual 
mRNAs in a sequential and polar manner. This polymerase occasionally fails to reinitiate the 
downstream mRNA at each junction, leading to the loss of transcription of further-
downstream genes, consequently a gradient of mRNA synthesis that is inversely proportional 
to the distance of the gene from the 3’end of the genome is observed. The N protein is the 
most abundant of the structural proteins being synthesized, and the intracellular concentration 
of its unassembled state (N°) is a way of controlling the relative rates of transcription and the 
replication from the genome template. When sufficient amounts of N° are present, viral RNA 
synthesis becomes coupled to the concomitant encapsidation of the nascent (+) RNA chain. 
Under these conditions, vRNAP ignores all the junctions, to produce an exact complementary 
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antigenome (+) chain, in a fully assembled NCs. The antigenome will then be used for the 
synthesis of a new RNA genome, which will be used again as a template or assembled into a 
nascent viral particle. The vRNAP can also initiate RNA synthesis at the 3’end of the 
antigenome in the absence of sufficient N, but only a trailer RNA is made in this case (Fig.4) 
(Lamb and Kolakofsky, 2001). 
 
 
 
 
 
Figure 4 :  RNA synthesis of SeV. The viral polymerase copies the genome into the leader (le) and six 
individual mRNAs from the genomic promoter (G/Pr). When the N° is sufficient, the viral polymerase 
starts replicating the genome into full-length antigenomes, which serve as intermediates in genome 
replication. The viral polymerase synthesises from the antigenomic promoter (AG/Pr) new genomes and 
other small RNA products, the trailer (tr). Both the genome and antigenomes are tightly encapsidated 
with the N proteins. (From (Lamb and Kolakofsky, 2001) 
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E. Accessory Proteins 
 
The P gene of SeV expresses multiple species of proteins by means of using overlapping open 
reading frames (ORFs) (Fig. 5). This gene encodes as many as eight polypeptides via these 
ORFs: the P, V, W, C’, C, Y1, Y2 and X proteins. SeV P gene mRNA contain 5 start codons 
near its 5’ end, four of which are used for a nested set of “C” proteins that initiate at 
ACG81(C’), AUG114 (C), AUG183 (Y1) and  AUG201 (Y2) and terminate at  UAA726. Among 
the four C proteins, the C is the major species expressed in infected cells, at a molar ratio 
several fold higher than that of the other three proteins (Kurotani et al., 1998). The second 
start codon, AUG104, initiates 3 proteins (P, V and W) as a consequence of cotranscriptional 
mRNA editing (Lamb and Kolakofsky, 2001).  The start site (AUG104) for translation of the P 
protein is in a favourable context (kozak) for recognition by the ribosome; and since it is 
placed right after ACG81 (which is normally not a favourable start site) it is more often used. 
For SeV, AUG104, and AUG114 are initiated by leaky scanning, whereas AUG183 and AUG201 
are initiated by ribosomal shunting (Curran and Kolakofsky, 1988; Gupta and Patwardhan, 
1988; Latorre et al., 1998b). 
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Figure 5: The P gene encodes eight proteins. There are five alternative start sites (ACG or AUG) and the 
numbered nucleotides (at bottom) show positions of the initiation codons of P, C', C, Y1 and Y2. 
Transcription stuttering occurs within the P reading frame at sequence shown in the middle, adding one 
or two G residues that change the open reading frame, producing V or W, respectively. 
 
SeV P gene contains an editing site in the middle of its reading frame. At this sequence, the 
vRNAP recognises the 3’-UUU UUU CCC stretch on the template and occasionally stutters. 
This stuttering most likely occurs when the vRNA pauses, and the growing RNA chain slips 
backward on the RNA template by one (or more) nucleotides (Hausmann et al., 1999; Pelet et 
al., 1991; Vidal et al., 1992; Hausmann et al., 1999). The vRNAP then resumes elongation. 
When this happens in the run of three G’s, an extra G is added in the growing chain changing 
the reading frame. Addition of one G at the editing site produces an mRNA that encodes the 
V protein, whereas addition of two Gs leads to the W protein. The frequency of V and W 
production can vary depending on the kind of virus (Lamb and Kolakofsky, 2001). 
 
 
F. Role of the C and V proteins  
 
The C proteins are relatively small (175-215 residues), highly basic proteins and non-essential 
for the virus multiplication in vitro. Together with the V protein, they are referred to as 
“accessory” proteins (Tapparel et al., 1997), because viruses that do not express them are still 
viable in cell culture. SeV like many other members of the paramyxovirinae subfamily uses 
one or more products of its P/V/C gene to modulate viral RNA synthesis and to antagonize 
innate immunity. During the last decade, the involvement of the paramyxoviruses C and V 
proteins in counteracting the innate immune response was intensively studied. The 
Paramyxoviruses are likely to use their C proteins for this function by opposition to the 
Rubula-, Morbili-, and Henipa-viruses that use their V protein.   
 
SeV C proteins 
The localisation of the C proteins is likely to be at the membrane for two reasons: First, the C 
proteins were found to interact with a host protein involved in apoptosis and endosomal 
membrane trafficking, called Alix (Sakaguchi et al., 2005). Secondly, the C proteins contain a 
specific sequence at the N-terminus that functions as a membrane targeting signal and 
membrane anchor (Marq et al., 2007).  
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The C proteins are also required for virus replication because they act as inhibitors of the 
replication of the antigenomes in a promoter-specific fashion. More precisely, as the C 
proteins slowly reach a certain concentration during the course of infection, the genomic 
promoter (G/Pr) gets particularly sensitive to their presence, and the replication of the 
antigenome is reduced (Cadd et al., 1996a; Tapparel et al., 1997).  
As mentioned before (Fig. 5), all four C proteins (C’, C, Y1, Y2) of SeV share the same C-
terminal region and only the long proteins (C’ and C) contain the same N-terminal region. 
SeV that cannot express any of the C proteins are at the limit of viability. SeV mutants that 
can only express the short C proteins (Y1 and Y2) block IFN signaling like SeV-WT but are 
highly debilitated. The four C proteins physically interact with signal transducer and activator 
of transcription 1 (Stat1), which is a specific intracellular protein whose role is to protect and 
signal pathogen invasion. Activated Stat1 is phosphorylated on tyrosine 701, and is referred to 
as p-Stat1. As a consequence, these interaction between C and Stat1 will prevent IFN 
signaling through the JAK/Stat pathway and at the same time block the establishment of the 
antiviral state (Stark et al., 1998). Moreover, the SeV C proteins have also a role in disrupting 
Stat2 phophorylation (Gotoh et al., 2003; Li et al., 2006). It was shown that the C terminal 
domain of C is necessary and sufficient for blocking the IFN signaling, suggesting that the Y1 
and Y2 proteins are able to guarantee this function on their own. On the other hand, only the 
longer C proteins (C’, C) provoke the instability of Stat1, by reducing Stat1 levels and 
inducing p-Stat1 formation in an IFN-independent manner throughout the course of infection 
(Fig.6) (Garcin et al., 2003). Consequently, the pre-existing IFN-induced antiviral state is 
reversed and this suggests that the N-terminal domain of the C protein is associated with the 
degradation of Stat-1 in the cell (Garcin et al., 2002). Furthermore, C1-23 (23 residues at the N-
terminal of the C proteins) was shown to be sufficient for reducing Stat1 levels and to act as a 
membrane targeting signal. Moreover, the activities of the longer C proteins are required for 
the localisation of C at the plasma membrane (Marq et al., 2007). Finally, recent data suggest 
that the C protein is able to inhibit the IFNβ signaling of RIG-I, a cytoplasmic viral sensor 
involved in the induction of IFNβ, by a yet unknown mechanism. The Y protein domain 
would presumably be responsible for the inhibition of RIG-I but no binding between the C 
protein and RIG-I has been shown yet. 
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Figure 6 : SeV C proteins counteract the host interferon response by at least two mechanisms. 
All four C proteins (C’, C, Y1, Y2) of SeV share the same C-terminal region and only the long proteins (C’ 
and C) contain the same N-terminal region. These 2 regions are associated with different functions. 
a) The C-terminal domain is necessary for the binding to Stat1, preventing its activation in response to 
IFN. b) The N-terminal domain (1-23 residus) is associated with the degradation of Stat-1, in this case only 
the C’ and C target Stat1 for degradation.  
 
 
 
SeV V protein  
The V protein seems to display similar functions to the C proteins. Elimination of V by 
mutating the editing site, or mutations in the C-terminal domain specific to V, reduces the 
virulence of SeV in mice, indicating that V is essential for efficient virus replication and 
pathogenesis in mice. Therefore, the SeV V protein seems to interfere with some host 
mechanisms that reduce virus replication or spread (Sakaguchi et al., 2003). SeV V protein as 
well as other V proteins of the paramyxoviruses, has been shown to limit IFNβ induction 
upon synthetic dsRNA poly(rI)-poly(rC) (PolyI/C) treatment(Andrejeva et al., 2004; Childs et 
al., 2007).  
The role of the V protein, in inhibiting the host interferon response, has been discovered only 
recently and can act differently depending on the virus. Indeed, expression of the Rubulavirus 
V proteins (MV, SV5 and HPIV2) was demonstrated to induce polyubiquylation of their 
target Stat (Stat1,2 or 3 depending on the virus) resulting in efficient proteasomal degradation 
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(Horvath, 2004; Ulane et al., 2003; Yokosawa et al., 2002). Nipah and Hendra viruses share 
the V-dependent IFN signaling evasion properties with other paramyxoviruses, but unlike the 
Rubulaviruses, they do not induce Stat destabilization. Indeed, they subvert IFN responses by 
sequestering Stat1 and Stat2 in high molecular weight complexes without inducing their 
degradation (Rodriguez et al., 2003).  Finally, MeV encodes a V protein distinct form both the 
Rubula- and Henipa-viruses genera. Its expression effectively prevents both IFNα/β and 
IFNγ-induced transcriptional response. It does not degrade Stat or prevent Stat 
phosphorylation, but blocks IFN-induced Stat1 and Stat2 nuclear import (Palosaari et al., 
2003).  
  
 
 
G. Leader and Trailer RNAs  
 
The genomic and antigenomic replication promoters (G/Pr and AG/Pr) of paramyxoviruses 
are found within the terminal 96 nucleotides of each RNA and are bi-partite in nature 
(Murphy et al., 1998; Pelet et al., 1996; Tapparel et al., 1998) (Fig 7).  
 
 
 
Figure 7: Primary structure of the SeV replication promoters.  
The 96 nt of the genomic (G/Pr) and antigenomic (AG/Pr) promoters are presented as RNA sequence in 
‘hexamers’, numbered 1–16 from the 3' end (-OH 3'). In the G/Pr, the leader coding sequence is outlined, 
as well as the N gene transcription start signal (nt 56–65), which constitutes the first transcription start 
signal (N gs1) seen by the viral polymerase. In the AG/Pr, the trailer coding sequence is shown, as well as 
the complement of the L gene polyadenylation site (L ge).  (From (Vulliemoz et al., 2005). 
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SeV leader and trailer RNAs are short transcripts generated during abortive antigenome and 
other hand, the trailer is believed to include the last 57 nucleotides at the 3’end of the 
genome synthesis, respectively. They both contain no coding region, and are neither capped 
nor polyadenylated, and carry triphosphates at their 5’ends that are believed to be potential 
targets for cellular antiviral genes (Plumet et al., 2007). The leader is part of the G/Pr and 
includes the first 55 nucleotides at the 3’end of the negative-strand genome RNA. Its 
sequence contains signals for initiation of RNA synthesis by the vRNAP, and is also thought 
to contain the encapsidation signal that direct packaging of full-length plus-strand copies of 
the viral genome in NCs, as it is the case for the leader of VSV (Smallwood and Moyer, 
1993). 
On the 
antigenome RNA. This sequence, very rich in A/U is essential for the viral transcription and 
replication and also contains signals for genome packaging. Moreover, it has been shown by 
Iseni et al. in 2002, that a U-rich trailer sequence, nucleotides 31-41, has been found to bind 
the cellular TIAR protein, involved in the induction of apoptosis. Recombinants of SeV 
expressing the TIAR binding domain from both the G/Pr and the AG/Pr, which was modified 
in order to contain the U-rich sequence, exhibited a reduced cythopathic effect, and lead to 
infected cells survival (Iseni et al., 2002a). This result underlines the fact that, although G/Pr 
and AG/Pr carry out similar functions, they also have distinct properties. Indeed, the exchange 
of these sequences has interesting effects on virus infections. One of the main differences 
between the AG/Pr and the G/P is their strength: It has been shown that the AG/Pr has a 
stronger affinity with the polymerase and that there is 10 times more genome than antigenome 
produced (Lamb and Kolakofsky, 2001). Plus, an excess of 5-10 fold of genome over 
antigenome has also been observed for VSV (Kiley and Wagner, 1972); and an excess of 20 
to 50 fold of genome over antigenome has also been shown for Rabies virus (RV). Further 
analysis on SeV showed the important role played by the gene start gs1 in decreasing the 
strength of the replication activity of the G/Pr (Le et al., 2003). Indeed, when gs1 was 
introduced in the AG/Pr sequence, the balance between genome and antigenome RNAs was 
equalized by weakening AG/Pr replication. Finally, the presence of the leader (containing the 
start site), instead of the trailer in the G/Pr also favours the hypothesis that the AG/Pr is 
stronger than the G/Pr. 
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H. Sendai Virus strains  
 
There are two known lineages of SeV: Z/H/Fushimi and Ohita M/Hamamatsu (Fujii et al., 
2002; Itoh et al., 1997). The nucleotide sequences within each lineage are 99% identical and 
they are 89% identical between lineages.  
Z/H/Fushimi come from viruses isolated in Japan in 1956 after an epidemic of newborn 
infants and adapted to grow in embryonated chicken’s eggs (Ishida and Homma, 1978; 
Skiadopoulos et al., 2002). These adapted viruses, which were continuously passaged in eggs 
over a period of several decades are moderatly virulent for mice (50% lethal dose [LD50] = 
103 to 104 PFU) (Sakaguchi et al., 1994a).  
Ohita M (SeVM) and Hamanatsu, in contrast, are highly virulent (LD50, <102). They were both 
isolated from two completely separate, very severe epidemics of animal houses in Japan and 
were low-egg-“passaged”. This virus is presumably closer to the virus in its natural host, and 
it is known that SeV passage in eggs attenuates its virulence in mice. For instance, in an 
infectious model, in which Kiyotani et al used three-year old mice, the Hamamatsu strain was 
very virulent; but when serially “passaged” 30 times in eggs, it strain became attenuated. 
(Kiyotani et al., 2001).  
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I. The Defective Interfering (DI) genomes 
General aspects: 
The generation of uncompleted forms of the viral genome during the viral replication process 
called Defective Interfering (DI) genomes has been observed in almost all the RNA and DNA 
viruses including SeV (Huang and Baltimore, 1970). A table is represented summarizing the 
occurrence of DI in negative stranded RNA viruses (Table 2). The ease with which DIs are 
produced varies widely within different virus groups and depends on many different factors. 
These include growth conditions, multiplicities of infection, the host cell, relative rates of 
standard virus replication and DI enrichment, virus strain differences, and intrinsic rates of DI 
generation. The appearance of DI genomes arises during passage at high multiplicities of 
infection because of the need for complementation by the helper virus. It has also been 
reported that single clones from certain viruses (SeV, VSV and Influenza I) have a genetic 
capacity to regularly generate the same DI species (Holland et al., 1980; Kolakofsky, 1979). 
A good way to get rid of most or all DI genomes in a given virus stock is to “plaque” the virus 
stock several times in a row (Baltimore and Huang, 1975). Since DI RNAs are not 
antigenetically distinct from their parent virus, their biological properties are attributable to 
the genome deletions that they contain. Most of the time, the DI genome can be separated by 
velocity gradient, because they are smaller than the standard helper virus genome.  
. 
Table 2: 
Virus Group Member name References 
Negative Strand   
Rhabdo Vesicular stomatisis, rabies, others Reichmann and Schniztlein (1979) 
Paramyxo  Sendai Kolakofsky (1979) 
 Newcastle disease Roman and Simon (1976) 
 Measles Rima et al. (1977) 
 Mumps Norval (1979) 
Orthomyxo Influenza, fowl plague Nayak (1980) 
Arena Lymphocytic choriomenengitis, others Pedersen (1979) 
 Tacariibe Gimenez and Compans (1980) 
Bunya Bunyavera Kascsak and Lyon (1978) 
 Lacrosse Bishop and Shope (1980) 
   
Positive strand   
Picorna Poliovirus Lundquist et al. (1979) 
Toga  Sindbis, Semliki Forest, West Nile Stollar (1979) 
Corona Mouse hepatitis Robb and Bond (1979)  
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The Origin of DI RNAs: 
DI genomes (DIs) stocks are defective viruses that contain only a fraction of genetic 
information of the infectious non defective (ND) virus genome and that require homologous 
parental virus as helper for replication. They also contain virus structural proteins and exhibit 
the capacity to replicate preferentially at the expense of the infectious helper virus in cells 
infected by both. DI RNAs originate from low frequency events during the replication or 
transcription of standard virus RNAs. Many different DIs can be generated but only a few are 
selected, depending on their capacity to interfere with the ND genome. By “interference”, we 
mean that DI particles can replicate and amplify their genome preferentially at the expense of 
the replication of the helper virus. Indeed, the latter encodes replication and encapsidation 
proteins and must compete with the DIs for these gene products. Small DIs are likely to be the 
majority that are selected, but defective full-size genomes can also be found to exert 
interference (Roux et al., 1991). In general, most of the DI particles of RNA viruses are only 
replicative entities that are not capable of transcription or translation. They can undergo 
extensive mutational changes but must conserve the segments that are necessary for efficient 
replication and encapsidation. It is important to underline the fact that there must be a balance 
between the generation of DIs and the rate of viral production. If the DI interference is too 
strong, there will be insufficient virus helper to support significant DI particle replication, 
leading to an increased yield of infectious virus and to a reduced yield of DI. 
The formation of DI particles is expected to be a consequence of the viral polymerase. It has 
been suggested that DIs arise by virus rearrangement or recombination as a result of viral 
replicase “leaping” or skipping from one virus RNA template to another or from one segment 
of a template to another (Huang, 1977). During this “leaping” the RNA replicase carries 
uncompleted nascent strand to a new template, then uses this nascent strand as a primer for 
continuation of chain elongation at the new template elongation site. Depending on the 
leaving sites or continuation sites, different DIs can be observed. There are mainly two 
different forms of DIs that can be generated: the Internal deletion DI and the Copyback DI 
genomes (Fig 8). In the case of the internal deletion DI the viral polymerase starts 
synthesising the genome and at a certain point jumps forwards on its template. The internal 
deletion DI genome still conserve the 3’ and the 5’ ends of the ND genome and lacks various 
portions of the internal transcription units. It carries both the minus- and plus-strand polarity 
RNAs containing both promoters enabling the DI to transcribe from the minus-strand and 
replicate from both the minus- and plus-strand. In the case of the copycack DIs, the viral 
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polymerase detaches itself from the template, and instead of going forwards, it initiates 
copying in reverse direction using the nascent strand as template. Consequently, the copyback 
DI genome lacks most of the genomic 3’ end sequence from the ND genome and in addition, 
it contains complementary extremities to the genomic 5’end, as inverted repeats (Kolakofsky, 
1976; Leppert et al., 1977) (Fig 8). The origin of terminal sequence complementarity in SeV 
and VSV DIs is generally thought to occur by some sort of strand-switching event during 
polymerisation, where the polymerase would drop off the template and start the synthesis of 
the daughter or another template. In this way the features of terminal sequence 
complementarity in DI genomes provide strong argument for the involvement of the viral 
polymerase in the origin of DIs.  
The presence of inverted complementarity sequences (not found in the standard genome) was 
defined as the hall mark of the most abundant class of VSV DI (DI_011) RNAs also called the 
“snapback” DI. The first evidence for this structural feature came from electronic microscopic 
observations of circular DI RNAs with characteristic small panhandle or stems in SeV (e.g. 
the natural copyback DI-H4), (Kolakofsky, 1976) and in VSV (Perrault and Leavitt, 1978). 
The shortest inverted repeat reported for Paramyxoviruses amounts to 94 nucleotides, with a 
range between 94 and 168 nucleotides (110 nucleotides for SeV DI-H4) (Calain et al., 1992; 
Calain and Roux, 1993). In this case, the copy-back DI carries both the minus- and plus-
strand polarity RNAs but contains the antigenomic (AG) promoter at both the genomes and 
antigenomes ends. Furthermore, copyback DIs in SeV seem to interfere more with the ND 
genome than other conventional DIs, presumably because of the strength of the two strong 
AG promoters they contain. As mentioned before, the replication efficiency of the copyback 
DI (e.g. DI-H4) is 20 fold higher than the one of the Internal Deletion DI-E307 (Calain and 
Roux, 1995). For VSV, the presence of the specific sequences at the 3’-terminus of both the 
genomic and antigenomic DI RNAs may also explain in part the replicative dominance of DI 
genome over the full-length genome, which contains these sequences only at the 3’-terminus 
of the antigenome (Pattnaik et al., 1995). Finally, it has been observed that some DI copyback 
particles could modulate the course of infection by interfering indirectly with the helper virus 
by inducing IFN activation. This aspect is likely dependent on the kind of DI genomes 
involved in the infection. The VSV “snapback” DI has been shown to strongly induce the IFN 
and interestingly, it was the minimal multiplicity of DI infection that was required to promote 
maximal effects on IFN induction (Marcus and Gaccione, 1989). 
Another important aspect of DI genomes is that they are required for the establishment and/or 
maintenance of persistent infections in cell culture (Holland et al., 1979). This characteristic 
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can be observed in several different virus systems, such as RV (Kawai and Matsumoto 1977), 
VSV (Horodyski and Holland, 1980) and NDV. For SeV infection, this property can be 
explained (in part) by the fact that copyback DIs contain two trailer sequences that can bind to 
TIAR and thus prevent apoptosis leading to the establishment of a persistent infection (Iseni 
et al., 2002b). Even though the ability of DI genomes to modulate the intensity and the course 
of viral infections has been studied widely in in vitro systems, their possible roles in natural 
infections remain largely unexplored and unconfirmed (Barrett and Dimmock, 1986).  
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Figure 8:  A schematic representation of DI genomes synthesis. 
During the replication process, the viral polymerase synthesizes new SeV genomes from the antigenomic 
promoter (AG/Pr) and occasionally generates uncompleted forms of the viral genome called the Defective 
Interfering (DI) genomes. The dotted lines below the SeV antigenome indicate the path of the viral 
polymerase when it generates internal deletion DI genome (e.g. E307) or copyback DI genomes (e.g. DI-
H4). 
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J. The reverse genetics system 
In contrast to the positive RNA virus, which are potentially infectious by forming directly 
viral proteins, neither the genome nor the antigenome RNA of NNV are infectious. Indeed, 
they need to be transcribed before they can produce active proteins, such as the polymerase or 
the nucleoprotein, that are required for the synthesis of the viral proteins and the RNA 
encapsidation, respectively. For this reason, the recovery of infectious virus from cDNA 
(reverse genetics), which requires the co-expression of the N, P and L proteins in trans, has 
been delayed compared to the one of positive stranded viruses (Racaniello and Baltimore, 
1981). Influenza virus was the first NNV to be recovered from cDNA. Luytjes et al. have 
described a system in which they use purified N proteins and synthetic RNA to assemble a 
synthetic gene-like RNA into a biologically active ribonucleoprotein (Luytjes et al., 1989). 
In contrast to influenza virus the paramyxo-ribonucleoproteins have resisted for a long time to 
be assembled in a functional form in vitro, probably because they are much more tightly 
structured (Baudin et al., 1994; Iseni et al., 1998). Indeed even after banding in CsCl density 
gradients, they remain highly active and the RNA within this structure remains resistant to 
RNase treatment at any salt concentration (Enami and Palese, 1991; Lynch and Kolakofsky, 
1978). In 1991, paramyxoviridae derived RNA corresponding to a SeV minigenome was 
rescued for the first time (Krystal et al., 1986; Park et al., 1991). This artificial SeV RNA, 
containing the antisens coding region of the CAT gene flanked by the entire 5’ and 3’ 
noncoding termini of SeV, was generated in vitro by the T7 polymerase from a linearized 
plasmid. When introduced into cells that was infected with SeV, this RNA construct was 
transcribed, replicated, and packaged into infectious virions and significant CAT activity was 
observed. This further confirmed the fact that the cis-acting sequences necessary for the 
encapsidation, replication and transcription of SeV are located in the terminal sequences and 
that the helper virus provides the necessary viral proteins for the RNA recognition.  
The concept of replicating mini-genomes using support plasmids providing N, P, and L 
proteins in trans was finally the key to the development of the technology. Indeed, the use of 
mini-genome RNA transcripts carrying only a reporter gene facilitated in vivo experiments, in 
which RNA encapsidation was strongly required. Moreover, a system named the Vac-T7 
system, in which a recombinant Vaccinia virus encoding the bacteriophage T7 RNA 
polymerase was established (Fuerst et al., 1986). Cell were infected with the recombinant 
Vaccinia virus and transfected with plasmids encoding all the required viral genes and the 
viral RNA genome, which were all expressed under the control of the T7 polymerase 
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promoter. This approach conferred several advantages: (1) it provids the T7 polymerase, 
whose function is absolutely necessary for producing RNA genomes and for increasing the 
expression level of the N, P and L mRNA in the cytoplasm; (2) it allows further analysis 
regarding the individual function of each viral gene involved or not in the RNA amplification. 
The vac T7 system required the generation of correct viral RNA termini. Indeed, while the 
exact 5’ends were determined by the position of the T7 promoter transcription start signal, 
generation of the correct 3’ends required a ribozyme activity sequence derived from the 
antigenomic strand of the hepatitis delta virus RNA (Gershon et al., 1991; Perrotta and Been, 
1990; Shih and Been, 2002). 
More refinements to the original technique have been made using stably transfected cell lines 
BHK, which express the bacteriophage T7 RNA polymerase instead of vac-T7 infection. 
(Buchholz et al., 1999). This approach based on the critical thought that the assembly of free 
genome (or antigenome) RNA into a functional NC could be accomplished in a living cell, 
has been successful for rescuing VSV and SeV DIs (Calain et al., 1992; Calain and Roux, 
1993; Curran and Kolakofsky, 1991; Pattnaik and Wertz, 1990). 
With time, this approach has been successful for many negative-stranded RNA viruses: RV 
(Conzelmann and Schnell, 1994), VSV (Pattnaik and Wertz, 1990), SeV (Garcin et al., 1995), 
RSV (Collins et al., 1991), MeV (Radecke et al., 1995), SV5 (Murphy et al., 1998), 
Rinderpest virus (Baron and Barrett, 1997), Canine distemper virus  (Gassen et al., 2000) and 
Nipah virus (Yoneda et al., 2006). 
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K.  The Interferon System 
During evolution cells were forced to develop sophisticated defences for counteracting virus 
infection. Secretion of cytokines and chemokines is one of the first responses of an organism 
to pathogen infection. Among the cytokines are the interferons (IFNs). The IFNs are an 
heterogeneous family of cytokines, originally identified on the basis of their ability to strongly 
induce cellular resistance to viral infections (Pestka et al., 1987; Vilcek, 1996). The IFNs’ 
action on virus-infected cells and surrounding calls and tissues elicits an antiviral state. The 
IFNs exert various biological effects such as interference with virus replication, modulation of 
the immune response, antiproliferative activities and apoptosis. A potent inducer of IFNs is 
intracellular double stranded RNA (dsRNA) which is generated during replication and 
transcription of viral genome. There are three types of IFNs: 1) Type I IFNs includes IFNα 
and IFNβ, plus additional IFNs recently defined: IFNε,κ and ω; 2) Type II IFNs, containing 
IFNγ, also called “immune interferon”; 3) Type III IFNs or IFNλ a novel interleukin 10-
related cytokines (Fig. 9). IFNα is produced by peripheral blood leucocytes and many other 
cell types in response to viral infection or treatment with dsRNA. IFNβ is mainly produced by 
fibroblasts or epithelial cells. IFNγ is produced exclusively by immune cells. Although both 
classes of IFNs exhibit potent antiviral activity, Type I IFNs play a more important role in the 
innate immune response to viral infection, whereas IFNγ plays a much more significant role 
in the subsequent acquired immune response (Schindler, 1999).  
A common property of both IFN types is to induce immediate transcriptional responses 
through a JAK-Stat signal transduction pathway (Schindler and Darnell, Jr., 1995). All type I 
IFNs bind to a class II cytokine receptor composed of IFNα receptor 1 (IFNAR1) and 
IFNAR2 chains (Novick et al., 1994), which are associated with the Janus kinase (JAKs) 
TYK2 and JAK1 respectively (Darnell, Jr. et al., 1994). Ligand-bound, tyrosine-
phosphorylated receptor complexes bind the SH2 domains of signal transducers and activators 
of transcription (Stats) 1 and 2, causing phosphorylation of the proteins on tyrosines 701 and 
692, respectively. Interaction of Stats through reciprocal SH2 domain-phosphotyrosine 
binding results in the formation of two distinct transcription factor complexes: 1) ISGF3, a 
heteromeric complex consisting of Stat1 and Stat2 in association with a third protein, p48 or 
IRF9, associates specifically with and transactivates genes containing the interferon-
stimulated response elements (ISRE) in their promoter or enhancer regions. 2) A simpler 
complex, consisting solely of the Stat1 homodimer, is also active as a transcription factor and 
binds to different DNA sequences, termed IFNγ activated site (GAS) elements (Katze et al., 
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2002). The receptor for IFNγ is structurally related to that for IFN type I. It consists in IFNγ 
receptor 1 (IFNGR1) and IFNGR2 chains in association with Jak1 and Jak2 kinases. Once 
tyrosine-phosphorylated in the presence of ligand, it binds Stat1 and causes phosphorylation 
of tyrosine 701. Stat1 homodimers are formed, move to the nucleus, and regulates 
transcription of promoters containing GAS sequences (Decker et al., 2002). Finally, type III 
IFNs display activities and functions much like the type I IFNs and utilise a different receptor 
complex to signal (IL10R2 and IFNLR1 chains).  
 
Figure 9:  Interferon signaling by the JAK-Stat pathway. (See text for details ) (Samuel, 2007) 
 
The regulation of IFNs synthesis is well characterized and requires the participation of several 
transcriptional factor complexes that already pre-exist in the cell and are activated upon virus 
infection. These factors bind to regulatory sequences called positive regulatory domains, 
which lie within 200 nucleotides upstream of the transcription start sites on both IFNα and 
IFNβ genes. Four different transcription factors are known to bind to the IFNβ enhancer: the 
ATF-2/ C-Jun heterodimer, the NF-kB heterodimer and two interferon-regulatory factors 
(IRFs), IRF-3 and IRF-7. Together with general transcription factors including TFIID and 
RNA polymerase II, this collection of DNA-bound proteins assembles to form an 
“enhanceosome” (Thanos and Maniatis, 1995). The IFNα enhancer also contains multiple 
positive regulatory domains and is activated by binding to similar transcription factors. The 
IRFs are extremely important and function in a number of processes such as pathogen 
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response, cytokine signaling, cell growth regulation, and hematopoiesis. IRF-3 and IRF-7 are 
two of the nine members of the IRF family (Mamane et al., 1999), residing in the cytoplasm 
of uninfected cells, and undergoing nuclear translocation upon viral infection. IRF-3 and IRF-
7 are crucial to maximally induce the expression of IFNα/β (Sato et al., 2000). IRF-3 is 
constitutively expressed in normally growing cells, whereas IRF7 is mainly dependent on 
IFNα/β signaling. Upon viral infection, IRF3 is activated by phosphorylation on its serine 
residues by IKKε and TANK-binding kinase-1 (TBK-1) (Fitzgerald et al., 2003; Sharma et 
al., 2003). Phosphorylated IRF-3 homodimerizes and translocates to the nucleus, where it 
recruits the transcriptional coactivators p300 and CREB-binding protein (CBP) to initiate 
IFNα/β mRNA synthesis by binding to the IFNα/β enhancer regions (Hiscott et al., 1999). 
IFNα/β are secreted and feed back onto cells in a paracrine manner to prime neighbouring 
cells for possible infection and in a autocrine manner to induce multiple IFN stimulated genes 
(ISGs) including ISGF3 and IRF-7. As a result the “first wave” of IFN leading to the cellular 
antiviral state is in place (Sato et al., 1998) (Fig. 10). 
 
Figure 10: Type I IFN induction, signaling and action. Left panel: RNA, a characteristic by-product of 
virus replication, leads to activation of the transcription factors NF-κB, IRF-3 and AP-1. The cooperative 
action of these factors is required for full activation of the IFNβ promoter. IRF-3 is phosphorylated by the 
kinases IKK and TBK-1 which in turn are activated by the RNA-sensing complex of RIG-I, Mda5 and 
IPS-1/MAVS. Right panel: Newly synthesized IFNβ binds to the type I IFN receptor (IFNAR) and 
activates the expression of numerous ISGs via the JAK/Stat pathway. IRF-7 amplifies the IFN response by 
inducing the expression of several IFNβ subtypes. Mx, ISG20, OAS and PKR are examples of proteins 
with antiviral activity (Haller et al., 2006). 
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Interferons confer the first line of defence against pathogen invasion by activating the ISGs. 
The ISGs carry antiviral functions, targeting the stability or translation of viral RNA. The 
three main IFN-induced systems are the following: the Mx proteins, 2’-5’oligo (A) synthetase 
(OAS) and ribonuclease L, and the dsRNA-dependent protein kinase PKR. Mx (for 
“myxovirus”) proteins are inducible-IFN proteins with the ability to hydrolyse GTP (Haller et 
al., 2007). Expression of Mx affects virus replication by interfering with the transcription of 
influenza virus and other negative-single stranded viruses. Mx proteins inhibit the activity of 
the vRNAP, thus blocking viral mRNA production. They also interfere with the transport of 
influenza virus RNP complexes from the cytoplasm to the nucleus. The exact function/action 
of Mx is not yet understood and the role of the GTPase activity also remains unclear. The 2’-
5’oligo (A) synthetase is produced in IFN-treated cells, and is activated by binding to dsRNA 
in virus infected cells. This enzyme has the sole ability to produce oligomers of ATP via a 2’, 
5’ linkage in contrast to the normal 3’, 5’ linkage found in the natural RNAs. These oligomers 
bind to and activate ribonuclease L, which degrades viral and cellular RNAs (Player and 
Torrence, 1998). PKR is a well characterized effector of anti-viral responses in mammals. 
PKR is a serine-threonine protein kinase that is present in normal cells at low levels. Like 2’-
5’oligo (A) synthetase, PKR is activated by dsRNA or stem loop RNA structures. Activated 
PKR phosphorylates a variety of cellular proteins, such as the α-subunit of translation 
initiation factor eIF-2, thus inhibiting the translation. When PKR is overexpressed, 
programmed cell death is activated (Takizawa et al., 1996). Additionally PKR is believed to 
play an important role in regulation of cellular protein synthesis in absence of virus infection 
(Williams, 1999), as well as in signal transduction and cell growth (Koromilas et al., 1992).  
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L. Sensors of RNA virus infection 
Many signaling pathways leading to the IFNα/β induction upon virus infection, have been 
recently discovered. These involve specific cellular receptors that can detect the presence of 
virus by recognising viral molecular signatures. These viral molecular signatures are part of 
the PAMPs (Pathogen-Associated Molecular Patterns) that contain many other potential 
patterns from other pathogen, including bacteria and funghi. The PAMPs are recognised by a 
wide range of receptors, called PRRs (Pattern Recognition Receptors) that comprise the 
Pathogen-Resistance Protein (R-protein) in plants, the Toll-Like Receptors (TLRs), the Nod-
Like Receptors (NLRs) and the recently discovered Rig-like receptors (RLRs) in animals 
(Fig.11). 
The R proteins were the first PRR to be discovered. These are crucial for immune defence 
against all the possible pathogen-derived molecules invading plants. Considering the fact that 
these R genes are of real importance for the survival of plants, it is not surprising to find that 
kind of pathogen-resistance protein in other organisms (Nimchuk et al., 2003). The next PRR 
to be discovered was the Toll receptor that was identified in the fruit fly, Drosophila 
melanogaster, as an essential receptor for the establishment of the dorso-ventral pattern in 
developing embryos. In the mid-90s, toll-mutant flies were shown to be highly susceptible to 
fungal infection (Lemaitre et al., 1996; Yamamoto and Akirz, 2005). The receptor Toll was 
identified as a key mediator of innate immune defences in Drosophila melanogaster. A year 
later, the identification of a Toll-like receptor (TLR) in the human genome was reported and it 
was later called TLR4 (Medzhitov et al., 1997). Sequencing of human and murine genomes 
further allowed the identification of 11 TLRs in mice and 10 TLRs in human. The ability of 
the TLRs to recognise microbes and directly initiate specific signal transduction cascades that 
alert the host defences, can also be observed in the two additional families of innate receptors: 
the NLRs and the RLRs. Unlike the TLRs that are essentially found at the plasma membrane, 
these families consist of soluble proteins that survey the cytoplasm for signs that broadcast the 
presence of intracellular invaders. Until now, the NLRs have been shown to detect bacteria 
and many other pathogens, whereas the RLRs only recognise viruses (Creagh and O'Neill, 
2006). NLRs share high structural and functional homology with plant R genes and search of 
the human genome database revealed 22 R-gene homologous classified in two main 
subclasses: the NODs (Nucleotides Oligomerization Domain leucine-rich repeat protein) 
counting 5 members and the NALPs (NACHT Leucine rich domain and Pyrin-containing 
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protein) containing 14 members. Some of the NLRs activation is proposed to occur via a 
mechanism similar to the mechanism described for the apoptosome (Reith and Mach, 2001). 
 
 
NACHT  
TLRs
RLRs
Pattern recognition receptors (PRRs)
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Figure 11: Domain organization of the PRRs. All of the proteins have the NACHT-LRR configuration, 
with the exception of the RLRs, which contain a helicase domain. The A and B represent the Walker A 
and Walker B motifs. Not all of the possible N-terminal domains are represented; the caspase-
recruitement domains (CARD) are specific to the RLRs and are also present in the NLRs when there are 
no BIR (baculoviral inhibitory repeat) or acidic domains. The Toll-IL-1 receptor or coiled-coil domains 
(TIR/CC) are N-terminal domains specific to the R protein or the TLRs (Adapted from (Ting and Davis, 
2005). 
 
It is likely that the initiation of innate immunity involves an important cooperation between 
the TLRs, the NLRs and the RLRs depending on the pathogen, providing a tightly controlled 
combinatorial repertoire for triggering host defences. TLRs seem to be specifically active in 
immune cells such as dendritic cells whereas NLRs and especially RLRs are expressed in 
more various cell lines. The RLR family comprises three DExD/H-box-containing RNA 
helicases: retinoic-acid-inducible gene 1 (RIG-1), melanoma differentiation-associated gene 5 
(Mda-5) and laboratory of genetics and physiology 2 (LGP2). RIG-I and Mda-5 are both 
ubiquitously expressed in most tissues and are part of the ISGs, which allows autocrine and 
paracrine amplification of the sensing system. RIG-I and Mda-5 encode two caspase 
recruitment domains (CARD) at the N-terminus, followed by an RNA helicase domain. The 
helicase domain recognises viral RNA and regulates signal transduction in an ATPase-
dependent manner, whereas the CARD domain is involved in the signal transduction 
downstream (Kang et al., 2004). LGP2 lacks completely the CARD domains and functions as 
a dominant-negative regulator of RIG-I/Mda-5 mediated signaling (Rothenfusser et al., 2005; 
Yoneyama et al., 2005). The recognition of the molecular viral signature via the helicase 
domain of RIG-I and Mda-5 likely induces a conformationnal change enabling their CARD 
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domains to interact with the CARD-like domain of a protein anchored to the outer 
mitochondrial membrane called Cardif (MAVS/IPS-1/VISA) (Kawai et al., 2005; Meylan et 
al., 2005; Seth et al., 2005; Xu et al., 2005). This interaction leads indirectly to the activation 
of several different kinases such as TBK-1/IKKε and IKKγ and activate IRF-3 and NF-κB 
respectively, inducing type I IFNs and the antiviral state of the cell (Fig. 12) (Hornung et al., 
2006; Pichlmair et al., 2006). 
 
 
Figure 12: RIG-I and Mda-5 are cellular RNA helicases that, upon activation, stimulate IFN gene 
expression.  RIG-I recognises RNAs with 5’triphosphates, whereas Mda-5 recognises dsRNA 
(From (Basler and Garcia-Sastre, 2007). 
 
Studies of RIG-I and Mda-5-deficient mice have revealed that RIG-I is essential for the 
recognition of a set of specific ssRNA viruses, including Paramyxoviruses, Flaviviruses, 
Orthomyxoviruses and Rhabdoviruses, whereas Mda-5 is important for the recognition of a 
different set of RNA virus that includes Picornaviruses and alphaviruses (Basler and Garcia-
Sastre, 2007; Kato et al., 2006). In vitro studies have also shown that both RIG-I and Mda-5 
can bind to polyI/C and respond to polyI/C and RNA viruses (Yoneyama et al., 2005). In 
addition to this, it has been shown that RIG-I is more likely to recognise RNAs with 
5’triphosphates than dsRNA, whereas Mda-5 specifically recognises dsRNA (Basler and 
Garcia-Sastre, 2007). The role of these helicases is to distinguish between self RNA and non-
self RNA coming from the viruses. At the end of the year 2006, Veit Hornung et al. provided 
evidence that uncapped unmodifided 5’-triphosphate RNA present in viruses known to be 
recognised by RIG-I, but absent in viruses known to be detected by Mda-5, serves as PAMP 
for the detection of viral infection by RIG-I in the cytosol of eukaryotic cells and that this 
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property is not confined to immune cells. They further observed that RIG-I does not activate 
the IFNβ activation with RNA containing 5’di- or 5’-monophosphate (Hornung et al., 2006). 
Many of the RNA species in the cytosol are known to lack free 5’-triphosphate group 
although all RNA transcripts generated in the nucleus of a eukaryotic cell initially contain a 
5’tri-phophate. Indeed cellular self RNA escapes detection by RIG-I because they are known 
to undergo several modifications before being transported to the cytoplasm: messenger RNA 
acquires a 7-methyl-guanosine cap structure at its 5′-end; transfer RNA undergoes 5′ cleavage 
and a series of nucleotide modifications; and ribosomal RNA undergoes several cleavages and 
finally associates with ribosomal proteins (Bowie and Fitzgerald, 2007) (Fig. 13). 
 
Figure 13: Discrimination of self and non-self RNA by RIG-I. Viral infection leads to the accumulation of 
non-self RNAs in the cytoplasm, such as dsRNA and 5-triphosphate RNA. Cellular RNA synthesis takes 
place in the nucleus by 3 different RNA polymerases. The 5’ ppp of these RNA are eventually removed or 
masked, thus self RNA species do not activate RIG-I (From (Yoneyama and Fujita, 2007).  
 
 
M. Viral antagonists of the interferon system 
 
Many viruses including SeV have developed strategies for counteracting the host type 
interferon I response and this at different levels. For that purpose viruses use most of the time 
non-structural proteins which are non-essential for virus growth. These antagonists are often 
multifunctional proteins that interact with multiple viral or host cell components and are 
involved in regulating many different functions in infected cells. Hence the IFN system can be 
triggered at different levels: 1) the IFN induction pathway comprising the IRF-3 activation, 2) 
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the basic transcription level, such as the inhibition of mRNA exportation or inhibition of polII 
from Flu, 3) IFN signaling pathway including the JAK-Stat activation and 4) the IFN effectors 
level. Some viruses can contain more than one antagonist inhibiting one or several different 
components of the IFN induction and signaling pathway. Moreover, the virus-induced IFN 
response is generated in a cascade-like manner. Consequently, viral proteins blocking one 
cellular component in this circuit also affect distant signaling molecules or effectors, which 
amplify their inhibitory effect. Figure 14, from O. Haller et al. illustrates the range of 
activities mediated by IFN antagonists of various viruses (Fig. 14). As mentioned before, SeV 
mainly uses the non-structural C and V proteins to act at the level of the IFN induction 
pathway by blocking RIG-I activation and also at the level of the IFN feedback loop where C 
blocks Stat-1 signaling pathway. In many NNV, the phosphoprotein is the main antagonist. 
The P protein of RV prevents IRF-3 phosphorylation by TBK-I (Brzozka et al., 2005). In the 
same way, the P protein of Ebola Virus interferes with IRF-3 activation (Basler et al., 2003). 
The P protein of Borna disease virus directly binds to TBK-I and reduces its activity 
(Unterstab et al., 2005). 
                     
 
Figure 14: Viral inhibitors of the virus-induced IFNα/β response loop: Viral gene products interfere with 
the type I IFN system at all levels. For example, V of paramyxoviruses were found to be IFN antagonists 
at the level of the IFN induction pathway. Many others viral proteins are involved in bloking the IFN 
activation at different levels.  For more details see review (From (Haller et al., 2006). 
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Vaccinia Virus from the Poxvirus family, as well as Influenza I virus, also possess genes that 
can interfere with the cellular activation pathway of IFN signaling. E3L and NS1 are viral 
regulatory protein found in Vaccinia Virus and Influenza virus respectively. E3L can bind to 
dsRNA and inhibit the dsRNA-stimulated enzymes, PKR and RNA-specific adenosine 
deaminase. A vaccinia deficient in E3L is highly sensitive to the activity to type I IFN and 
restricted growth in some cell lines such as Hela but not in other as chicken fibroblasts 
(Fischer et al., 2006). NS1 from Influenza A virus can also act against the IFN type I 
response. It has been suggested that NS1 can prevent IFNβ induction in several ways: by 
sequestering dsRNA through its amino terminus (Donelan et al., 2003; Hatada and Fukuda, 
1992), by forming a complex with RIG-I to abrogate RIG-I signaling (Pichlmair et al., 2006), 
by binding to PKR (Li et al., 2006), and by inhibiting posttranscriptional processing of the 
3’end of cellular specificity factor and poly(A)-binding protein II (Chen et al., 1999; Fortes et 
al., 1994; Li et al., 2006). 
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INTRODUCTION TO PAPER ONE: 
 
 Upon viral infection, cells respond by protecting themselves by inducing specific 
antiviral responses, such as IFNs. IFNs induce an antiviral state via the JAK/Stat pathway that 
leads to the activation of the ISGs expression. On the other hand, SeV infection counteracts 
IFN action by producing several specific proteins. SeV is known to use its C protein 1) to 
evade the host IFN response by binding to Stat1, preventing its activation in response to IFN, 
and 2) to target Stat1 for degradation. The leader and trailer products are short promoter-
proximal products generated during abortive antigenome and genome synthesis. Moreover, 
the trailer is known to play a role in the regulation of programmed cell death, which is part of 
the antiviral program.  
We have based our study on cDNA microarrays done in collaboration with Ian Kerr’s 
laboratory in London (ICRF) (Schlaak et al., 2002) to study the cellular response to IFNα/βs. 
These genes comprise known ISGs and genes of intrinsic interest that might or might not be 
induced by IFNs in different cell systems. They also include genes involved in cell 
proliferation, immune response, and response to a variety of cytokines. We have used these 
arrays to compare the activation of various cellular genes in response to infection by different 
strains and mutants of SeV in 2FTGH cells (human fibroblasts). Knowing the importance of 
the C gene and the promoter region in disturbing the antiviral system of the cell, two different 
SeV strains (SeVM or SeVZ) containing specific mutations in their C proteins (SeV C F170Sand 
SeV C Δ1015) or in the promoter regions (SeV GP31-42 and SeV GP42) were used in our study. 
The mutant SeV C F170S, represents a SeVM strain that has been isolated after 5 passages in 
LLC-MK2 cells. It has three mutations and one, F170S is located in the carboxyl-terminal of 
all four C proteins (C’,C Y1 and Y2) (Itoh et al., 1997). This base change is silent in the Open 
reading frame of P, V and W but this phenylalanine at position 170 of C is critical for 
blocking STAT1 activation, thus inhibiting the IFN signaling (Garcin et al., 2002; Gotho et al. 
2001). This strain appears to be strongly attenuated in mice (LD50 of > 8.105 PFU) (Wang et 
al., 1994). The mutant SeV C Δ1015 is a recombinant of SeVZ. The codons 13 to 18 of P (W and 
V) and the codons 10 to 15 of C have been deleted. These deletions affect the N-terminal part 
of the C protein, a region essential for Stat1 degradation. It is an attenuated strain containing 
mutated C and C’ and WT Y1 and Y2 proteins. This deletion might alter the function of P, W 
and V, even though the P protein seems to be fully functional. Mutants SeV GP31-42 and SeV 
GP42 are SeV Z stocks carrying specific mutations in the leader region within the genomic 
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promoter. Compared with the WT SeV, SeV GP42 has its first 42 nucleotides from the leader 
promoter replaced into those of the trailer promoter. SeV GP31-42 has nucleotides from the 
leader promoter between the 31st and 42nd changed into those of the trailer promoter (Fig.15). 
Nucleotides 31-41 of the trailer promoter are important for binding to TIAR, a host RNA 
binding protein important for virus-induced apoptosis. Consequently, infections with mutants 
SeV GP42 and SeV GP31-42 lead to persistent infection. Finally, it is important to take into 
account that this gain of function can be due to either the over-expression of the trailer or the 
absence of the leader. 
 
 
Figure 15: SeV mutants carrying mutations in the leader region, which is part of the genomic promoter. 
SeV GP42 has its first 42 nucleotides replaced by the 42 first nucleotides of the trailer region. SeV GP31-
42 contains nucleotides 31 to 42 from the trailer region. 
 
Upon infection with SeV mutant viruses (SeV CF170S, SeV CΔ10-15, SeV GP31-42 and SeV 
GP42) 15 mRNA levels were found to increase significantly and three distinct patterns of 
gene activation could be observed. But, the levels of these mRNAs remain unchanged upon 
SeV WT infection (SeVM and SeVZ), presumably because these SeV stocks carry functions to 
counteract the cellular host defence. (Fig. 16): 
A) The first group includes a series of genes that have their mRNA level increased by 
SeV CF170S alone. SeV CΔ10-15 and others SeV mutant infections have on the other hand 
no effect on these mRNA levels. The CF170S substitution inactivates the ability of all 
four C proteins (C’, C Y1 and Y2) to bind STAT1 in a stable manner and to counteract 
IFN signaling. It is likely that any of the four C proteins can block the increase of 
mRNA levels upon SeV infection.  
B)  The second group is only represented by the IL-6 gene. It is activated by SeV CF170S 
as well as SeV Δ10-15, but not by the WT viruses or other promoter mutants. Consistant 
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with this, the N-terminal region in the longer viral C proteins has a role in preventing 
the increase of IL-6 messengers upon SeV infection.  
C) The third group includes genes whose mRNA levels increase upon SeV CF170S, SeV 
CΔ10-15 and SeV GP42 infection, but not upon WT viruses or the SeV GP31-42 mutant. 
A function provided by either the C or the first 30 nucleotides of the genomic 
promoter (le) is required to prevent activation of these genes. 
 
 
 
Figure 16: Schematic representation of the viral mutations and their effects on the host gene activation. 
The C proteins are shown as two telescoping boxes representing the longer (C’ and C) and the shorter (Y1 
and Y2) C proteins. The requirement for the various WT genetic elements to prevent host gene activation 
is shown (Instab: instability; sig: signaling) (From Strahle et al., 2003). 
 
We then decided to confirm the above results by a more quantitative method, Real-time PCR 
(Taqman). The following host genes activated by our mutant SeV infections were selected, 
each one representative of one group: 6-16 (ISG) for group 1, IL-6 for group 2 and IL-8 for 
group 3. Since 6-16 is an ISG, we used it as a positive control. The chemokines, IL-6 and IL-8 
were chosen because they are not part of the ISGs (as they are not activated upon simple IFN 
treatment) and are presumably involved in other different signaling pathways induced by 
virus infection. We also decided to examine the IFNβ gene, because of its role in the early 
host response upon viral infection and the cellular gene GAPDH as an internal control to 
normalize the level of mRNAs. 
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We examined the levels of each gene (as well as protein secretion in the case of IL-8) in 
different conditions: 1) upon WT and mutated SeV infections to confirm the microarrays; 2) 
upon dsRNA treatment or IRF-3 overexpression followed by WT and mutated SeV infections, 
to observe whether the antiviral response was enhanced by these pre-treatments; 3) by 
changing cell types: we used U5A and U3A cells that are 2fTGH cells, which have been 
generated by X irradiation. U5A are defective in the IFNα/β receptor 2 chain (IFNAR2) and 
U3A are defective in the Stat 1 gene. The use of these cells allowed us to determine whether 
induction of our genes upon WT and mutated SeV infections were dependent on IFN 
signaling and required Stat1; 4) Because SeV appears to use the V and C proteins to 
counteract the IFNβ expression and because the influence of the presence of the leader and 
the trailer RNAs is still unclear, we examined our SeV mutants as well as other recombinants 
SeV for their relative activation of IFNβ: I) SeV AGP55 which transcribes two leader RNAs 
from both promoters; II) SeV GP48 which transcribes two trailer RNAs and carries the same 
phenotype than SeV GP1-42; III) and SeV V minus/W++ that do not expressed any V proteins.  
The results of our study revealed that infection of SeV containing specific mutations in their C 
proteins and leader region activates specific cellular genes. The absence of the leader (1-42), 
C Δ1015, C F170S, and V-/W++ mutations appear to disrupt four distinct elements in the SeV 
program to counteract the cellular antiviral response. This means that the products of the C 
and V proteins together with the presence of the leader RNA transcripts prevent the 
expression of these cellular genes involved in the IFN-induced antiviral state and in the 
inflammatory responses (Fig. 17). 
 
Cellular  
responses 
Cellular 
antiviral  
response 
(activation 
IL-8, IFNβ...) 
C protein (2 ways) 
V protein 
leader  
SeV  
accessory 
functions 
Virus 
Infection 
 
Figure 17: Upon SeV infection, the V and C accessory proteins with the leader have a role in preventing 
the expression of specific cellular genes central to the host antiviral response as well as inflammatory 
response. 
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We have used cDNA arrays to compare the activation of various cellular genes in response to infection with
Sendai viruses (SeV) that contain specific mutations. Three groups of cellular genes activated by mutant SeV
infection, but not by wild-type SeV, were identified in this way. While some of these genes are well known inter-
feron (IFN)-stimulated genes, others, such as those for interleukin-6 (IL-6) and IL-8, are not directly induced
by IFN. The gene for beta IFN (IFN-), which is critical for initiating an antiviral response, was also specifi-
cally activated in mutant SeV infections. The SeV-induced activation of IFN- was found to depend on IFN reg-
ulatory factor 3, and the activation of all three cellular genes was independent of IFN signaling. Mutations that
disrupt four distinct elements in the SeV genome (the leader RNA, two regions of the C protein, and the V
protein) all lead to enhanced levels of IFN- mRNA, and at least three of these viral genes also appear to be
involved in preventing activation of IL-8. Our results suggest that SeV targets the inflammatory and adaptive
immune responses as well as the IFN-induced intracellular antiviral state by using a multifaceted approach.
Alpha/beta interferons (IFN-/) are cytokines that act in a
pleiotropic manner to limit viral replication and spread (2, 57).
In fibroblasts (e.g., the bronchial epithelial target of many
paramyxoviruses), the product of the single IFN- gene is
directly induced by viral infection, and IFN- feeds back onto
cells in an autocrine manner to induce multiple IFN- genes
and in a paracrine manner to prime neighboring cells for their
possible infection (60). Since most viruses induce IFN- to
some extent, intracellular double-stranded RNA (dsRNA)
generated from the viral genome is traditionally assumed to be
the common signature of virus replication that sets the IFN
system in motion (22, 32). dsRNA is thought to induce the
formation of an enhanceosome at the IFN- promoter that
includes IFN regulatory factor 3 (IRF-3) and NF-B (among
other transcription factors) (65). IFNs induce a cellular state
that is nonconducive for viral replication by signaling through
their cell surface receptor, leading to the phosphorylation of
cytoplasmic STAT proteins and their nuclear translocation.
IFN-/ responses are regulated primarily via IFN-stimulated
gene (ISG) factor 3, a heterotrimeric transcription factor com-
posed of STAT1, STAT2, and IRF-9 (p48). ISG factor 3 binds
to a DNA element (IFN-stimulated response element) in the
promoters of ISGs and activates their expression (7).
The extravasation of neutrophils, eosinophils, basophils, and
mononuclear cells is the salient feature of the innate response
to microorganisms in the lung. Localized and systemic pro- and
anti-inflammatory cytokines thus also play an important role in
the outcome of viral infection and pathogenicity of this organ
(58). The CC chemokine interleukin-8 (IL-8) is secreted from
epithelial surfaces in a polar fashion during infection with
pathogenic bacteria such as Salmonella enterica serovar Typhi-
murium and sets up a subepithelial chemotactic gradient di-
recting neutrophils and other immune cells to the site of in-
fection (27). In polarized epithelial monolayers, S. enterica
serovar Typhimurium-induced IL-8 expression is controlled via
the activation of the mitogen-activated protein kinase cascade
and IB kinase, followed by NF-B translocation to the nu-
cleus and production of IL-8 mRNA. IL-8 secretion by primary
human monocytes in response to dengue virus infection is also
tightly linked to NF-B activation (3). Sendai virus (SeV) in-
fection of human embryonic kidney 293 cells induces the
expression of the CXC chemokine RANTES in an IRF-3-
and NF-B-dependent manner (23, 41). NF-B, like IRF-3,
is found in the cytoplasm of unstimulated cells, retained in a
complex with the inhibitory IB proteins. Upon stimulation
with many inducers, including dsRNA and virus infection, IB
is rapidly phosphorylated and degraded, resulting in NF-B
release and translocation to the nucleus (30, 33).
Given the importance of the host innate immune response to
virus infection, viruses have, during their coevolution with
cells, developed strategies to regulate cytokine synthesis and
action. SeV, a model paramyxovirus and respiratory pathogen
of mice, is known to use its C protein to evade the host inter-
feron response by at least two mechanisms. (i) C binds STAT1,
preventing its activation in response to IFN, and the carboxyl
part of the C protein (i.e., residues 24 to 204, or the Y proteins)
is sufficient for this activity. A phenylalanine at position 170 of
C is also critical for blocking STAT1 activation (18, 59). (ii) C
also targets STAT1 for degradation, and the amino-terminal
residues of the C proteins (residues 1 to 23, which are absent
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in the Y proteins) are essential for this activity (reference 17
and references therein).
This paper reports that SeVs carrying specific mutations in
the C gene, in contrast to wild-type SeV (SeV-wt), activate
IL-8 and IFN- expression as well as that of several ISGs. Our
results suggest that the products of virtually all of the viral
accessory genes (C and V proteins and leader RNA) act to
prevent the expression of these cellular genes that are central
to the overall host antiviral response.
MATERIALS AND METHODS
Cells and viruses. 2C4 cells (39), 2fTGH cells (48), and their derived cell lines
U3A (45) and U5A and U5AIFNAR (43) were obtained from IM Kerr (Im-
perial Cancer Research Fund, London, United Kingdom) and grown in Dulbec-
co’s modified Eagle’s medium supplemented with 10% fetal bovine serum in the
presence of the relevant maintenance drug (hygromycin at 250 g/ml or G418 at
400 g/ml). The generation of recombinant SeV (rSeV) expressing alternate C
and V (and P) proteins is described elsewhere (8, 19, 37, 38). All SeV stocks were
grown in the allantoic cavities of 10-day-old embryonated chicken eggs. Virus
present in the allantoic fluid was analyzed by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis and Coomassie blue staining after virus pel-
leting. Virus titers were determined by plaquing on LLC-MK2 cells.
Virus infections. Cells were infected at a multiplicity of infection of 20 in
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum. After
an absorption period of 1 to 2 h, the inoculum was removed and replaced with
fresh medium.
Plasmids, transient transfections, and luciferase assay. IRF-3 (54), IRF-3N
(41), and IRF-3-ribozyme (67) were obtained from John Hiscott and Paula Pitha.
pDsRed2, expressing red fluorescent protein (RFP), was from Clontech. The
reporter plasmid with the firefly luciferase gene under the control of the human
IFN- promoter was described by King and Goodbourn (35) and is referred to
here as p-IFN-fl-lucter. pTK-rl-lucter, used as a transfection standard, contains
the herpes simplex virus thymidine kinase promoter region upstream of the
Renilla luciferase gene (Promega). For transfections, 100,000 cells were plated in
six-well plates 20 h before transfection with 1 g of p-IFN-fl-lucter, 0.3 g of
pTK-rl-lucter, 1 g of IRF-3-expressing plasmid, and 6.9 l of Fugene (Roche)
according to the manufacturer’s instructions. At 24 h posttransfection, the cells
were (or were not) infected with SeV recombinants or treated with 50 g of
poly(I)-poly(C) (Sigma, St. Louis, Mo.) per ml. Twenty hours later, cells were
harvested and assayed for firefly and Renilla luciferase activities (dual-luciferase
reporter assay system; Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of Renilla luciferase.
RNA extraction and quantification. Total RNA was extracted with Trizol
reagent (Invitrogen), and two dilutions were electrophoresed on agarose-HCHO
gels. The gels were stained with ethidium bromide, and the intensities of the 18S
and 28S rRNA bands were quantified by using the ChemiDoc System (Bio-Rad)
and One-D-scan software. All samples were diluted to a final concentration of
1 g/l so that their subsequent transcription into DNA, if not quantitative,
would be little influenced by this parameter.
RT and real-time PCR via TaqMan. Ten microliters of total RNA was mixed
with 0.5 g of random hexamer primer (Promega) and subjected to a reverse
transcription (RT) reaction with Superscript enzyme (Gibco), as described by the
manufacturer, in a total volume of 50 l. Two microliters of each cDNA was then
combined with 1 l of internal control (either 20 ribosomal 18S or human
glyceraldehyde-3-phosphate dehydrogenase [GAPDH] [Applied Biosystems]),
11 l of MasterMix (Eurogentec), 20 pmol (each) of forward and reverse prim-
ers, and 4.4 pmol of TaqMan probe in a total volume of 22 l. The following
primers and probes (Eurogentec or Microsynth) were used: for the IFN- gene,
5-CAGCAATTTTCAGTGTCAGAAGCT-5 (forward), 5-TCATCCTGTCCT
TGAGGCAGT-3 (reverse), and 5-CTGTGGCAATTGAATGGGAGGCTTG
A-3 (probe); for the IL-8 gene, 5-CGGTGGCTCTCTTGGCAG-3 (forward),
5-TTAGCACTCCTTGGCAAAACT-3 (reverse), and 5-CTTCCTGATTTCT
GCAGCTCTGTGTGAAGGT-3 (probe); for the IL-6 gene, 5-TCCAGGAG
CCCAGCTATGAA-3 (forward), 5-CCCAGGGAGAAGGCAACTG-3 (re-
verse), and 5-TCCTTCTCCACAAGCGCCTTCGG-3 (probe); for the 6-16
gene, 5-CCTGCTGCTCTTCACTTGCA-3 (forward), 5-AGCCGCTGTCCG
AGCTC-3 (reverse), and 5-TGGAGGCAGGTAAGAAAAAGTGCTGCTCG
G-3 (probe); for the N gene of SeVZ, 5-GCAATAACGGTGTCGATCACG-3
(forward), 5-GATCCTAGATTCCTCCTACCCCA-3 (reverse), and 5-CGA
AGATGACGATACCGCAGCAGTAGC-3 (probe); and for the N gene of
SeVM, 5-CGAAGAGGATGATGCCGC-3 (forward), 5-GGGTCATGTAT
CCTAAATCCTCGT-3 (reverse), and 5-CAGCAGCTGGGATGGGAGGAA
T-3 (probe). Real-time PCR was carried out in a 7700 sequence detector
(Applied Biosystems, Foster City, Calif.).
Generation of customized cDNA arrays. Macroarrays were prepared as de-
scribed previously (55). 5 IMAGE clones 0.5 to 0.8 kb in length were chosen and
obtained from the Human Genome Mapping Project (Hinxton, United King-
dom), plated onto L agar plates and grown overnight at 37°C. Single colonies
were picked and propagated overnight in Luria-Bertani medium containing 50
g of ampicillin per ml. Bacterial lysates were generated by 1:10 dilution in
distilled water. From these lysates, inserts were amplified by PCR as described
above. After purification (QIAquick PCR purification kit; Qiagen, Crawley,
United Kingdom), PCR products were sequenced (ABI Prism; Applied Biosys-
tems). PCR-amplified cDNAs were transferred into 96-well plates and spotted
manually onto dry nylon membranes (Hybond N; Amersham Pharmacia, Little
Chalfont, United Kingdom) in triplicates by using 96-pin replicators (Nalge
Nunc, Naperville, Ill.; V&P Scientific, San Diego, Calif.). Membranes were air
dried, denatured by alkaline treatment, and then neutralized. The membranes
were again air dried and UV cross-linked prior to the experiment.
Generation of labeled cDNA, hybridization, washing of membranes and anal-
ysis. Radiolabeled cDNA was generated from 10 g of total RNA by RT with
400 U of reverse transcriptase (Superscript II; Gibco) in the presence of 30 Ci
of [-33P]dCTP. After RT, residual RNA was hydrolyzed by alkaline treatment
at 70°C for 20 min. For removal of unincorporated nucleotides, the cDNA was
purified by using G-50 columns (Amersham Pharmacia) according to the instruc-
tions of the manufacturer. Before hybridization to the arrays, the labeled cDNA
was mixed with 50 g of COT-DNA (Gibco) and 10 g of poly(A) DNA (Sigma),
denatured at 95°C for 5 min, and hybridized for 1 h to minimize nonspecific
binding. The cDNA was then added directly to the membranes, which had been
prehybridized in 20 ml of hybridization buffer for at least 30 min. The membranes
were hybridized for 16 h at 65°C in hybridization bottles (Amersham Pharmacia)
in a rotary hybridization oven. After hybridization, the hybridization buffer was
discarded and replaced by 150 ml of washing buffer. The membranes were
washed once in 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–
0.1% SDS, twice in 0.2 SSC–0.1% SDS, and once in 0.1 SSC–0.1% SDS for
20 min each at 65°C. The membranes were then exposed to phoshorimage
screens for 48 h and scanned with a phosphorimager (Storm; Molecular Dynam-
ics, Little Chalfont, United Kingdom). For analysis, images were analyzed with
ImageQuant (Molecular Dynamics). Further data analysis was performed with
Excel (Microsoft).
IL-8 assay. Levels of IL-8 in supernatants and in cell lysates were determined
by a sandwich enzyme-linked immunosorbent assay with paired monoclonal
antibodies (Pierce) as described by the manufacturer. The IL-8 concentrations
were normalized by using total protein levels in the lysate.
RESULTS
In our experiments we have used two strains (or lineages) of
SeV whose history is relevant to studies of virulence. The
natural host of SeV has not been clearly identified, and this
virus is sometimes referred to as murine parainfluenza virus
type I because it efficiently infects mice, causes disease, and
spreads readily to uninfected animals. However, there is no
virologic or serologic evidence of SeV in wild mouse popula-
tions (29). There are two known lineages of SeV, Z/H/Fushimi
and Ohita M/Hamanatsu (12, 31, 53, 62). The nucleotide se-
quences within each lineage are 99% identical, and they are
89% identical between lineages. Z/H/Fushimi comes from vi-
ruses isolated in the early 1950s after an epidemic of pneumo-
nitis of newborn infants in Sendai, Japan (29, 56). These SeVs
have been passaged extensively in eggs in various labs since the
1950s, and they are moderately virulent for mice (50% lethal
dose [LD50] 	 10
3 to 104 PFU). All of the SeVZ strains used
in this study (including the wt) are recombinants.
Ohita M (SeVM) and Hamanatsu, in contrast, are highly
virulent (LD50, 
10
2), low-egg-passage (nonrecombinant) vi-
ruses isolated from two completely separate, very severe epi-
demics of animal houses in Japan. This lineage is presumably
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closer to the virus in its natural (unknown) host, and it is known
that SeV passage in eggs attenuates its virulence in mice. SeVM
grew poorly in cell culture, and a clear-plaque variant emerged
that was avirulent (LD50, 10
5) and contained only two amino
acid substitutions, CF170S and LE2050A (31). When placed in the
rSeVZ background, the CF170S mutation was found to account
for most or all of the loss of virulence (15). This virus is
referred to here as SeVM-CF170S. SeVM-CF170S appeared to
initiate the infection of mice normally, but the infection was
limited to the first day. This was the first evidence that the C
gene, like the SeV V gene (34), was involved in countering host
innate defenses. Although SeVZ-wt is attenuated relative to
SeVM-wt in laboratory mice, rSeVZ-wt still replicates as effi-
ciently in the monkey and chimpanzee models of human re-
spiratory disease as human parainfluenza virus type 1 (56), the
virus which is most closely related to SeV and which is endemic
in children.
We have used a cDNA array designed to study the human
cell response to IFN-/ (55) to monitor the effects of various
SeV infections on host mRNA levels. Around 150 genes of
interest were selected from the UniGene database. These
genes comprise known ISGs and genes of intrinsic interest
which might or might not be induced by IFNs in different cell
systems. They include genes involved in cell proliferation, im-
mune responses, and the responses to a variety of cytokines
(see Table 1 of reference 55). We compared matched sets of
SeV carrying two different mutations in the C gene (SeVM-
CF170S and SeVZ-C10-15), whose products interact with
STAT1 in different ways (to interfere with IFN signaling and to
induce STAT1 instability, respectively) (Fig. 1D). We also used
matched sets of SeV carrying mutations in the viral replication
promoters (SeVZ-GP1-42 and -GP31-42) that prevent apopto-
sis and lead to persistent infections (the numbers refer to the
nucleotides of the genomic promoter that have been replaced
with the equivalent sequences of the antigenomic promoter)
(16, 20). Promoter mutations are thought to act via mutant
leader RNAs that are abundantly transcribed from the geno-
mic replication promoter and which bind to cellular RNA-
binding proteins that regulate mRNA fate (28).
Upon infection with SeVM-wt or SeVZ-wt, many of these
mRNA levels remain unchanged (Fig. 1A to C). This lack of
response is presumably due in part to active SeV countermea-
sures that neutralize the cell’s antiviral response (24). Upon
infection with the mutant viruses, the mRNA levels of 15 of the
150 genes examined were elevated, and three patterns of gene
activation were seen (all values are triplicates, and a twofold
difference is very significant [55]). One series of genes (group
1, nine genes) (Fig. 1A) is activated by SeV-CF170S infection
alone; these mRNA levels are unchanged in SeV-C10-15 and
SeV-GP1/31-42 infections. The CF170S substitution inactivates
the ability of all four C proteins (C, C, Y1, and Y2) to stably
bind STAT1 and to interdict IFN signaling (18, 59). According
to this view, any of the four C proteins may function to prevent
these mRNA levels from increasing during SeV infection (Fig.
1D) (14). The IL-6 gene is the sole representative of group 2;
it is activated by SeV-C10-15 as well as SeV-CF170S, but not
by the promoter mutants or the wt viruses (Fig. 1B). According
to this view, a second function of the C gene, specific to the
NH2-terminal 23 amino acids present only in the longer C
proteins, is also required for SeV to prevent IL-6 activation.
The third group, consisting of five genes, is activated by SeV-
C10-15 and SeV-GP1-42 infections as well as SeV-CF170S, but
not by SeV-GP31-42 or SeV-wt infections (Fig. 1C). Appar-
ently, a third function provided specifically by the first 30 nu-
cleotides (nt) of the genomic promoter (or leader RNA) is also
required to prevent activation of genes such as that of IL-8
(Fig. 1C). This third function is not the ability of mutant leader
RNA to bind TIAR, a host RNA-binding protein important for
virus-induced apoptosis, as this occurs with SeV-GP31-42 as
well (28). In summary, comparative analysis of host gene acti-
vation with SeV with specific mutations has identified three
groups of cellular genes that respond differently to SeV infec-
tion.
Real-time RT-PCR estimations of mRNA levels. IFN signal-
ing through the JAK/STAT pathway activates many ISGs (such
as 6-16, PKR, etc.) that collectively contribute to the cellular
antiviral response. SeVs that interdict IFN signaling would
therefore also prevent the activation of these ISGs. While
many of the genes activated by the mutant SeVs are well
known ISGs, IL-6 and IL-8 are known to be non-ISGs; treat-
ment of 2fTGH cells with 1,000 IU of IFN- does not increase
IL-6 or IL-8 mRNA levels over those of the untreated control
(55). We therefore continued our study of selected host genes
activated by SeV by real-time RT-PCR (TaqMan), a method
that is more quantitative than DNA arrays. We first examined
IL-8 (a chemokine) and IFN-, an early host response protein
whose gene was absent in the DNA array. 2C4 cells (a 2fTGH-
derived cell line) were infected with 20 PFU of the various
SeVs per cell, and the levels of various host mRNAs were
determined, including that of GADPH as an internal control
(see Materials and Methods). All four SeVs (SeVM-wt, CF170S,
SeVZ-wt, and C10-15) grow relatively well in 2C4 cells, as
indicated by their accumulated N mRNAs (Fig. 2 and 3) or N
proteins (data not shown); however, the SeVM-wt infections
accumulated ca. 2-fold less N mRNA than the three other SeV
infections (Fig. 2C). The relative levels of virus replication are
presumably important in stimulating the host response, and
SeVM-wt infections might therefore be expected to activate
IL-8 and IFN- less strongly than the other SeVs for this
reason alone. We found that IL-8 and IFN- mRNA levels
were elevated 20-fold in SeVM-CF170S versus SeVM-C-wt
infections. A strong difference was also found between SeVZ-
C10-15 and SeVZ-C-wt infections, where N mRNAs had ac-
cumulated identically (Fig. 2). Moreover, IL-8 and IFN-
mRNA levels were also elevated in other SeVM-CF170S versus
SeVM-C-wt infections of 2C4 cells, where N mRNAs had ac-
cumulated identically (Fig. 3). Thus, specific mutations in two
different regions of the SeV C proteins lead to increased acti-
vation of IL-8 and IFN-. In all cases, IL-8 and IFN- mRNA
levels were more strongly increased by SeVM-CF170S than by
SeVZ-C10-15.
We also examined the effects of various SeV infections of
cells transfected with plasmids expressing IRF-3 (or RFP as a
neutral control), and in some cases the cells were also treated
with 50 g of poly(I)-poly(C) (dsRNA) per ml. Elevated IRF-3
levels should enhance the antiviral response of the cells to SeV
infection, and the combined treatment is thought to approxi-
mate a virus infection in itself and should potentiate the anti-
viral response. This appears to be so, as the levels of IL-6, IL-8,
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FIG. 1. Comparison of host mRNA levels in 2fTGH cells infected with various SeVs. (A to C) Parallel cultures of 2fTGH cells were infected
with 20 PFU of the various SeVs per cell. Total cytoplasmic RNA was prepared with Trizol at 24 hpi, and equal amounts (10 g) were used as
a template for oligo(dT)-primed [33P]cDNA synthesis. The [33P]cDNA was annealed to triplicate DNAs arrayed on nylon membranes, and the
[33P]cDNA bound was quantitated in a PhosphorImager. The graphs show the fold increase in each mRNA relative to the mock control. (D)
Schematic representation of the viral mutations and their effects on host gene activation. The C proteins are shown as two telescoping boxes
representing the longer (C and C) and shorter (Y1 and Y2) C proteins, whose activities during infection, and the mutations investigated, are
indicated. The promoter mutation GP42 is thought to exert its effect via mutant leader (Le) RNA. The presumed requirement for the various wt
genetic elements to prevent host gene activation is shown. The names of the mutant SeVs used are also indicated. Instab., instability; sig., signaling.
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and IFN- mRNAs induced by SeV infection in general in-
creased with increasing proresponse treatment (i.e., RFP,
IRF-3, and IRF-3 plus dsRNA) (Fig. 3). IRF-3 overexpression
(Fig. 3A to C, IRF-3 versus RFP) enhanced IFN- and IL-6
activation by SeV but did not enhance that of IL-8. The addi-
tional dsRNA treatment had little effect on further enhancing
IFN- and IL-6 mRNA levels but strongly enhanced IL-8
mRNA levels. These differences in the enhancement of IL-6
and -8 and IFN- activation upon treatment with IRF-3 with or
without dsRNA presumably reflect different activation path-
ways in response to SeV infection. It is possible that IL-8
activation requires both IRF-3 and dsRNA, whereas IRF-3 is
sufficient for IL-6 and IFN- activation.
SeV activation of IL-6, IL-8, and IFN- is independent of
IFN signaling. 2fTGH human fibrosarcoma cells were chosen
for these experiments because sublines defective in specific
components of the IFN signaling system have been generated
from these cells by X irradiation (48). U5A cells, for example,
are defective in the IFN-/ receptor 2 chain, which is essential
for IFN-/ signaling, and these cells have been restored to
IFN sensitivity by complementation with the IFNAR2 gene
(U5AIFNAR2 cells) (43). Even though IL-6 and -8 are not
activated upon simple IFN treatment of uninfected cells, IFN
secreted during SeV infection may act differently, as additional
signaling pathways are being induced by the virus infection.
Moreover, CF170S (in contrast to C10-15) does not prevent
IFN signaling, and it is important to know whether this phe-
notype is responsible for the activation of IL-6 and -8. We
therefore examined the various SeV infections of U5A as well
U5AIFNAR2 cells to determine whether activation of IL-6
and IFN- by SeV-CF170S and SeV-C10-15 required IFN
signaling. We also examined the activation of the 6-16 gene, a
known ISG, as a positive control (10). As shown in Fig. 4, both
SeV-CF170S and SeV-C10-15 activated IL-6, IL-8, and IFN-
in U5A cells relative to SeV-wt infection. The IFNAR2-com-
plemented cell line yielded similar results, except that the
activation of these genes was paradoxically reduced in U5A
IFNAR2 cells relative to U5A cells. In contrast to the case for
IL-6, IL-8, and IFN-, little or no activation of 6-16 occurred
in SeV-C mutant-infected U5A cells, whereas a modest acti-
vation was evident in U5AIFNAR2 cells. Moreover, 6-16 was
the only mRNA whose levels in U5AIFNAR2 cells exceeded
those in U5A cells. The activation of IL-6, IL-8, and IFN-
during SeV infection, in contrast to that of 6-16, is thus largely
independent of IFN signaling.
STAT1-defective U3A cells. The SeV C proteins interact
with STAT1 in two ways (Fig. 1D). C and STAT1 form a stable
complex in vitro and during SeV infection, and this complex is
associated with a loss of IFN signaling. These events are
blocked by the CF170S mutation but not by C10-15. The
shorter Y proteins are also active in this respect. The longer C
proteins alone also induce STAT1 instability, and in contrast to
their effects on IFN signaling, this effect does not require F170
(Fig. 1D). To examine whether SeV-C mutant-induced activa-
tion of IL-6, IL-8, and IFN- requires STAT1, U3A cells,
which are known to be defective for STAT1, were examined
(45). However, we were unable to examine the companion
U3ASTAT1 cells, as these cells were found to have lost
STAT1 expression. Moreover, attempts to recomplement U3A
cells with STAT1 failed (data not shown).
The results of the U3A cell infections are shown in Fig. 5. As
before, IL-6 and -8 and IFN- mRNA levels were all clearly
increased in SeV-CF170S infections relative to SeV-wt infec-
tions. However, in contrast to the case for U5A and 2fTGH
cells, SeV-C10-15 infections did not contain enhanced
mRNA levels relative to SeV-wt infections. Given that STAT1
is probably not the only gene that has been lost in U3A cells
that have been X irradiated (which randomly destroys chro-
mosomal DNA), we can conclude only that enhanced mRNA
levels due to SeV-C10-15 infection require STAT1 and/or
FIG. 1—Continued.
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another, unknown gene, whereas activation due to SeV-CF170S
requires neither STAT1 nor any other gene destroyed in U3A
cells.
IL-8 gene activation and IL-8 secretion. IL-8 is not known to
act intracellularly. We therefore examined whether the SeV-
induced IL-8 gene activation in U5A/U5AIFNAR2 cells also
led to increased IL-8 protein synthesis and secretion. When
IL-8 protein levels in cytoplasmic extracts of the various SeV-
infected cells were examined, they were found to roughly mir-
ror the mRNA levels (Fig. 4E). However, when the culture
supernatants were examined, a somewhat different result was
found (Fig. 4F). Whereas the increased IL-8 mRNA level of
SeV-C10-15-infected U5A cells was accompanied by strongly
increased IL-8 secretion, that of U5AIFNAR2 cells led to
only a modest increase in IL-8 secretion. Moreover, the in-
FIG. 2. Effects of SeV C gene mutations on IFN- and IL-8 mRNA
levels during infection. Parallel cultures of 2C4 cells were infected (or
not) in triplicate for 24 h with 20 PFU of the various SeVs per cell.
Total cytoplasmic RNA was prepared from each culture, and the same
amount of RNA (ca. 1 g) was transcribed into cDNA with random
hexadeoxynucleotides and murine leukemia virus reverse transcrip-
tase. The relative amounts of IFN- and IL-8 gene sequences, relative
to that of GADPH as an internal control, were determined by real-
time PCR (see Materials and Methods). The average levels of the
mRNAs and their deviations in the triplicate infections are shown. The
relative SeV N mRNA levels of the SeVZ-C-wt and -C10-15 infec-
tions were also determined (SeVZ and SeVM are 10% different in
sequence, and their detection requires different primers and probes).
FIG. 3. Effects of IRF-3 and dsRNA treatment on SeV-induced
host gene activation. Parallel cultures of 2C4 cells were transfected
with pRFP or pIRF-3. The cultures were then infected (or not) with 20
PFU of the various SeVs per cell at 20 h posttransfection, and some of
the cultures were also treated with 50 g of poly(I)-poly(C) per ml.
The cells were harvested at 24 hpi. The relative amounts of IFN-,
IL-6, and IL-8 gene sequences present were determined as described
for Fig. 2.
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creased IL-8 mRNA levels in either SeV-CF170S-infected cell
line did not lead to clearly increased IL-8 secretion.
IL-8 expression can be controlled at both the transcriptional
and posttranscriptional levels. In polarized epithelial monolay-
ers, S. enterica serovar Typhimurium-induced IL-8 secretion
requires not only the activation of NF-B and production of
IL-8 mRNA but also the activation of the small, Rho family
GTPases Cdc42 and Rac1, which regulate endocytic protein
traffic from the Golgi network to the basolateral surface of the
cell. In the absence of Cdc42 or Rac1 function, IL-8 mRNA
levels increase in response to bacterial infection but IL-8 is not
secreted (3), similar to the case for our SeV-CF170S-infected
FIG. 4. SeV infection of cells defective for the IFN receptor and their complemented pseudo-wt derivatives. (A to D) Parallel cultures of U5A
or U5AIFNAR2 cells were infected (or not) in duplicate with 20 PFU of the various SeVs per cell for 24 h. The relative amounts of IFN-, IL-6,
IL-8, and 6-16 mRNAs present were determined as described for Fig. 2. (E and F) Equal samples of the culture supernatants (F) or cytoplasmic
extracts of the cultures (E) were analyzed for IL-8 protein levels by enzyme-linked immunosorbent assay.
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U5A cells. The requirement for Cdc42 and Rac1 activation,
moreover, is cell type dependent (9). The CF170S and C10-15
mutations thus appear to affect IL-8 secretion differently.
SeV prevents IFN- gene activation in several ways. The
manner in which IFN- transcription is induced by virus infec-
tion is well studied, and the activation of IRF-3 is central to this
process. IRF-3 is expressed constitutively and is found in the
cytoplasm in an inactive, unphosphorylated state. Upon virus
infection or dsRNA treatment of cells, IRF-3 is phosphory-
lated by an unknown kinase and translocates to the nucleus,
where, together with other transcription factors such as NF-B
(which is itself also directly activated by virus infection or
dsRNA), it activates IFN- transcription (41, 65, 68). Phos-
phorylation of IRF-3 after viral infection is the first step in the
activation of a gene program that includes a positive feedback
loop of IFN-/ and IRF family members (60). The results
described above suggest that the SeV C gene encodes func-
tions that prevent virus-induced IFN- transcription (directly
or indirectly). During the course of this work, it was reported
that the SeV V protein, as well as the V proteins of the
rubulaviruses SV5 and hPIV2, also prevented IFN- transcrip-
tion (26, 50, 64).
Given that SeV appears to use two viral genes (C and V) to
neutralize IFN- expression, we have examined a broader
panel of mutant rSeV infections for their relative activation of
the IFN- promoter compared to that of dsRNA treatment.
Besides SeV-CF170S and C10-15, we examined two promoter
mutants, SeV-AGP55, in which the first 55 nt of the antigeno-
mic promoter is replaced with the equivalent leader sequences
of the genomic promoter (38). SeV-AGP55 transcribes leader
RNA from both promoters (and no trailer RNA). The con-
verse SeV-GP48 has the first 48 nt of the genomic promoter
replaced with the equivalent trailer sequences, and SeV-GP48
transcribes basically trailer RNA from both promoters (and no
leader RNA; GP48 and GP1-42 are identical in this respect
[data not shown]) (19, 20). Finally, we examined SeV-V/
W, which contains a stop codon at the beginning of the V
open reading frame (ORF), such that edited V mRNAs are
translated into W-like proteins, and specifically no V protein is
expressed (8).
2fTGH cells were transfected with a reporter plasmid in
which luciferase is controlled by the IFN- promoter (pIFN-
luciferase). To determine whether virus-induced IFN- tran-
scription required IRF-3 activation, the cells were cotransfect-
ed with either a dominant-negative mutant of IRF-3 (IRF-3N),
an anti-IRF-3 ribozyme, or an empty control plasmid (see
Materials and Methods). The transfected cultures were then
infected (or not) with the various SeVs (or treated with
dsRNA) 24 h later and were harvested at 20 h postinfection
(hpi). As shown in Fig. 6, with the notable exception of SeV-
AGP55, all of the mutant SeV infections induced the reporter
more strongly than SeV-wt and as well as dsRNA treatment. In
all cases, the coexpression of IRF-3N or an anti-IRF-3 ri-
bozyme prevented the SeV-induced expression of the reporter.
Thus, mutations in two regions of the C protein that carry out
different functions, as well as the loss of leader RNA expres-
sion or the expression of the V protein, all lead to IFN-
promoter activation in an IRF-3-dependent manner. Overex-
pression of the W protein cannot compensate for the lack of V
protein, so the highly conserved Cys-rich carboxyl domain of V
is specifically required. Only the loss of trailer RNA expression
(SeV-AGP55) did not result in IFN- activation.
Leader and trailer RNAs, the promoter-proximal products
of viral RNA synthesis, are AU rich and are thought to bind to
cellular RNA-binding proteins that bind AU-rich elements
(28). In contrast to leader RNA, trailer RNA is expressed
relatively late in infection (upon antigenome accumulation)
and would not be expected to counteract immediate-early re-
sponse genes. However, many of the other viral products that
do not have a dedicated essential role in the replication ma-
FIG. 5. SeV infection of cells defective for STAT1. Parallel cul-
tures of U3A cells were infected (or not) in duplicate with 20 PFU of
the various SeVs per cell for 24 h. The relative amounts of IFN-, IL-6,
and IL-8 mRNAs present were determined as described for Fig. 2.
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chinery per se (C and V proteins and leader RNA) appear to
be pressed into service to coordinately prevent IFN- activa-
tion.
DISCUSSION
We have used cDNA arrays to compare the activation of
various cellular genes in response to infection with SeVs that
contain mutations in their C proteins or leader regions. Three
groups of cellular genes were identified in this way (Fig. 1). Of
the mutant SeV examined by DNA arrays, only the leader(31-
42) mutation failed to activate any of the cellular genes relative
to SeV-wt, and consistent with this failure, SeV-GP31-42 was
the only one of the four mutant SeVs not to have lost virulence
in mice (M. Itoh, unpublished data). The CF170S mutation is
associated with a ca. 5-log-unit increase in LD50 (31), and this
mutation appears to be the most important in cell culture
infections as well as in mice (15). This mutation activates IL-6,
IL-8, and IFN- more strongly than C10-15, and only this
mutation activates all three groups of cellular genes that re-
spond to SeV infection.
The IFN- gene is both a primary response gene and an
ISG, and it plays a central role in initiating the IFN-induced
antiviral response. This is the first report that the SeV C pro-
teins and leader RNA counteract the expression of this key
primary response gene, and it confirms that the report of Poole
et al. (50) that the product of our hemagglutinin-tagged V gene
is active in this respect. As expected, activation of IFN- re-
quired activation of IRF-3 (Fig. 6) and was independent of IFN
signaling (Fig. 4), but the details of how this occurs remain to
be elucidated. We have also provided evidence that the SeV C
proteins and leader RNA counteract the expression of the
chemokine IL-8. Infections by other viruses, e.g., respiratory
syncytial virus (RSV) (44), dengue virus (3), hepatitis C virus
(49), and human immunodeficiency virus type 1 (46, 52), are
known to induce IL-8 secretion, as do infections by bacteria
and parasites, including Mycobacterium tuberculosis (66). In a
related vein, cytomegalovirus, a large DNA virus, encodes a
chemokine receptor that may facilitate virus replication (13),
and human herpesvirus 8/Kaposi’s sarcoma virus carries four
ORFs whose products are related to chemokines (42). Viral
modulation of chemokine expression presumably represents
one aspect of the continuous battle between viral parasites and
antiviral, inflammatory, and immune responses of the host.
SeV infection has been reported to induce the CXC chemo-
kine RANTES via the activation of IRF-3 and NF-B (23, 40).
IL-8 may not have been noticed in these earlier studies, be-
cause SeV-wt induces very little IL-8 (Fig. 2). Our results
suggest that SeV targets the inflammatory and adaptive im-
mune responses (IL-6 and IL-8) as well as the IFN-induced
intracellular antiviral state (IFN- and STAT1). As IFN- and
IL-8 transcription both depend on NF-B activation, SeV may
target this key transcription factor as well.
The leader(1-42), C10-15, CF170S, and V/W mutations
appear to disrupt four distinct elements in the SeV program to
counteract the cellular antiviral response. The facts that they
all lead to enhanced levels of IFN- mRNA and that at least
three of them increase IL-8 mRNA levels suggest that SeV
employs a multifaceted approach to inhibit viral clearance by
inflammatory cells as well as to prevent the IFN-induced an-
tiviral state, sometimes using the same viral macromolecules
due to its limited coding capacity. The best-studied example of
paramyxovirus-induced activation of IL-8 is that of RSV (21,
69). The IL-8 promoter in A549 cells can be induced by RSV
infection in at least three distinct pathways: via tumor necrosis
factor alpha (which requires only an intact NF-B binding
site), directly by intracellular RSV replication (which also re-
quires other transcription factor binding sites) (5), and via the
interaction of the viral F protein with Toll-like receptor 4 (in
which IRF-3 plays an important role) (36). Measles virus H
protein interaction with Toll-like receptor 2 also activates IL-8
(1). If all three parallel cellular pathways for IL-8 expression
operate during SeV infection of 2fTGH cells, several different
SeV products will be required to effectively prevent IL-8 acti-
vation (Fig. 1D).
Rubulaviruses do not express C proteins, but their V pro-
teins have recently been found to prevent IFN- expression by
preventing the activation of IRF-3 and NF-B, as well as in-
FIG. 6. Effect of SeV infection on IFN- promoter reporter gene
expression. Parallel cultures of 2fTGH cells were transfected with a
mixture of pINF-fl-lucter and pTK-rl-lucter along with pIRF-3-N,
pAnti-IRF-3-ribozyme, or an empty plasmid (Ctrl), as indicated in
Materials and Methods. Duplicate cultures were infected (or not) with
20 PFU of the various SeVs per cell or treated with dsRNA and
harvested at 20 hpi. The relative activities of the fl- and rl-luciferases
were determined. Error bars indicate standard deviations.
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ducing the degradation of STAT1 or STAT2 (26, 50). The
Rubulavirus V proteins thus also counteract more than one
arm of the innate antiviral response. The versatility of these
viral gene products continues to surprise us. The SeV C pro-
teins have been more intensively studied than SeV V protein
or leader RNA. Like the influenza A virus NS1 protein (6, 63)
and hepatitis C virus NS5A protein (49), the SeV C proteins
are pleiotropic polypeptides that have multiple activities dur-
ing infection, presumably due to their interaction with various
viral and cellular proteins. Their multiple functions, deci-
phered in large part via C gene mutations, include (i) stimu-
lation of viral RNA synthesis early in infection (SeV-C/C
infections exhibit a 10-h delay in the accumulation of viral
products) (37); (ii) inhibition of viral RNA synthesis in a pro-
moter-specific manner late in infection, by interacting with the
P4-L vRdRP (this selective inhibition may promote the switch
from mRNA synthesis to genome replication and increase the
fidelity of vRdRP promoter recognition) (4, 61); (iii) a role in
virion assembly, possibly by interaction with the matrix (M)
protein (SeV-4C particles are poorly infectious and amor-
phic) (25); (iv) interaction with STAT1 in two separate ways, to
inhibit IFN signaling and to induce STAT1 instability (17); and
(v) inhibition of the IRF-3-dependent activation of IFN- and
the activation of IL-8 expression in an IFN signaling-indepen-
dent manner (this work).
How C interacts specifically with all of its viral and cellular
partners remains an enigma and is reminiscent of acidic acti-
vation domains of transcription factors that interact with mul-
tiple partners. Acidic activation domains are “natively disor-
dered” (11, 51), and this property apparently allows them to
bind different surfaces with high specificity (multiple induced
fits) and limited stability. The NH2-terminal portion of the
measles virus P protein that contains the overlapping C protein
ORF is, in fact, a recent example of such natively disordered
proteins, in accordance with the prediction of algorithms that
detect unstructured regions (47). By using the same algorithms
(PONDR), the SeV C protein is strongly predicted to be na-
tively disordered, and this property is shared with the common
NH2-terminal portions of rubulavirus V, I, and P proteins (17,
26). The C10-15 deletion, moreover, is in a region of C with
the highest prediction of disorder. It will be of interest to
examine whether purified SeV C proteins are indeed natively
disordered.
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ADDENDUM IN PROOF
Fujii et al. (Y. Fujii, T. Sakaguchi, K. Kiyotani, C. Huang, N.
Fukuhara, Y. Egi, and T. Yoshida, J. Virol. 76:8540–8547,
2002) have shown that mutations in the leader region specifi-
cally attenuate virus virulence in mice.
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INTRODUCTION TO PAPER TWO: 
 
dsRNA is known to be a common viral molecular signature that is generated during virus 
replication and acts a pathogen-associated molecular pattern (PAMP). These PAMPs are 
recognised in the cytoplasm by RIG-I and Mda-5, which activate TBK1 and IKKε leading to 
the phosphorylation and dimerization of IRF-3 and IRF-7. Activated IRF-3 and IRF-7 
translocate into the nucleus where transcription of early specific genes are activated. IFNβ is 
first secreted and feeds back onto cells in an autocrine manner, to induce multiple ISGs 
resulting in an antiviral state and in a paracrine manner, to prime neighbouring cells for 
possible infection.  
SeV stocks available commercially are known to induce IFNβ and are commonly used by 
many laboratories. Plus, these stocks are known for a long time to contain DI genomes. The 
paramyxoviruses DI genomes can be of two types: internal deletion or copyback DI genomes 
(cf. Introduction). DI genomes have the capacity to form dsRNA by at least two ways: 1) if 
the level of the N protein is not sufficient, DI genomes (and antigenomes) can self-anneal; and 
2) some DI genomes contain termini that are perfectly complementary, thus are likely free to 
form dsRNA. Moreover, DI genomes (especially those from the copyback variety) interfere 
robustly with the ND helper genome by competing for replication and consequently reducing 
the production of viral proteins involved in counteracting the antiviral state. The effect of 
reduced level of SeV accessory proteins on the innate antiviral response is confirmed by the 
fact that mutated SeV stocks (containing deficient V and C proteins or leader) lead effectively 
to enhanced levels of IFNβ mRNA (cf. Paper one). 
 
Because the induction of the IFNβ activation is known to be due to the presence of DI 
genomes, we investigate in this study whether the induction of IFNβ is truly due to the 
presence of DIs (since plaqued purified WT SeV does not activate IFNβ) and whether this 
property is specific to a certain type of DI genome. Moreover, the interference between both 
the DI and the ND genomes was also examined. Finally, because of the involvement of the 
viral C and V proteins in the counteraction of the innate immune response, their effect on the 
IFNβ activation were tested upon DI infection (Fig. 19). 
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Figure 19: Upon DI infection, a strong IFNβ activation is observed. Two questions are raised in this 
paper: (1) Is the IFNβ activation dependent on the presence of the DI genome? And what kind of DI is 
responsible? (2) Does overexpression of the viral C and V proteins inhibit IFNβ induction upon DI 
infection? 
 
We first compared three SeV stocks containing different kind of DI genomes and their ability 
to activate IFNβ in non-IFN sensitive cells (293T). Levels of IFNβ were monitored depending 
on the different SeV stocks, but the copyback DI variety (DI-H4) was found to be the most 
potent IFNβ inducer. Moreover, because IFNβ activation requires modification of IRF-3, the 
dimerization and the phosphorylated forms of IRF-3 were analysed upon DI infection. The 
formation of dimers, as well as hyper-phosphorylated forms of IRF-3 were observed in DI 
infections, as opposed to SeV ND infection. 
In order to estimate independently the DI and the ND genomes by RT/PCR, we generated a 
tagged version of the copyback DI-H4 genome, containing a sequence from the YFP gene. 
This enabled us to follow the evolution of this new stock, containing both the DI and ND 
genomes (generated by multiple passages in embyonated chicken eggs), in parallel with the 
activation of IFNβ. The correlation between the level of DI genomes and the level of IFNβ 
activation was also observed. We found that the activation of the induction of IFNβ upon DI-
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H4 infection was proportional to DI genome replication and that the ratio of DI to ND 
genomes during infection. 
Finally, we used IFN competent cells (2fTGH) to study the general aspect of the DI-H4 
infection. Since the C and V proteins can block dsRNA signaling, we examined the effect of 
their overexpression upon DI-H4 infection, considering that DI infection produces less viral 
proteins. Indeed, overexpression of C and V proteins was effective in blocking the DI-H4-
induced activation of IFNβ as well as the poly(I/C) activation. This result further confirms the 
idea that DI-H4 induces IFNβ via dsRNA. 
 
This study provides evidence that the strong induction of IFNβ activation upon SeV infection 
(SeV stock containing DI genomes) is mainly due to the presence of copyback DI genomes. 
The level of IFNβ activation was found to be proportional to that of DI genome replication. 
This activation can be inhibited by the overexpression of the C and V proteins, whose 
concentrations are reduced in DI infected cells, because of the strong interference of the DI 
versus the ND genome. 
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The ability of some Sendai virus stocks to strongly activate IFNβ has long been known to be associated with defective-interfering (DI)
genomes. We have compared SeV stocks containing various copyback and internal deletion DI genomes (and those containing only nondefective
(ND) genomes) for their ability to activate reporter genes driven by the IFNβ promoter. We found that this property was primarily due to the
presence of copyback DI genomes and correlated with their ability to self-anneal and form dsRNA. The level of IFNβ activation was found to be
proportional to that of DI genome replication and to the ratio of DI to ND genomes during infection. Over-expression of the viral Vand C proteins
was as effective in blocking the copyback DI-induced activation of the IFNβ promoter as it was in reducing poly-I/C-induced activation, providing
evidence that these DI infections activate IFNβ via dsRNA. Infection with an SeV stock that is highly contaminated with copyback DI genomes is
thus a very particular way of potently activating IFNβ, presumably by providing plentiful dsRNA under conditions of reduced expression of viral
products which block the host antiviral response.
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an innate antiviral response to intracellular RNA virus
replication has recently made great progress. Two DexD/H
box helicases with CARD domains, RIG-I and Mda5/Helicard,
were found to participate in the detection of cytoplasmic
dsRNA (Andrejeva et al., 2004; Yoneyama et al., 2004). dsRNA
is thought to be a common product of RNAvirus infections that
acts as a pathogen-associated molecular pattern (PAMP)
responsible for initiating the innate antiviral response. RIG-I
and Mda5 initiate antiviral responses by coordinately activating
several transcription factors, including NF-κB and IRF-3, that
bind to the IFNβ promoter forming an enhanceosome that
activates this primary host-response gene (McWhirter et al.,
2005). Upon binding dsRNA, the CARD domains of these
helicases are thought to be freed for interaction with the
synonymous domain of MAVS/VISA/cardif/IPS-1, a mitochon-
drial protein which in turn is required for recruiting the kinases
that activate these transcription factors (Xu et al., 2005; Meylan⁎ Corresponding author.
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doi:10.1016/j.virol.2006.03.022et al., 2005; Seth et al., 2005; Kawai et al., 2005). Autocrine
interaction of secreted IFNβ with its cell surface receptor then
closes the “innate immunity loop”, leading to increased IFN-
stimulated gene (ISG) products, such as other IFNs and the
intracellular effectors of the antiviral state (Sen, 2001).
The role of Mda5 in dsRNA signaling to IFNβ was
uncovered because Mda5 binds to the paramyxovirus SV5 V
protein (Andrejeva et al., 2004). This interaction, and that of
other paramyxovirus V proteins, blocks dsRNA signaling, and
this property of V maps to the highly conserved cys-rich domain
at their C-termini (Poole et al., 2002; Andrejeva et al., 2004). V
proteins of different paramyxoviruses, however, are very
different at their N-terminal portions, which accounts for their
otherwise very different properties (Lamb and Kolakofsky,
2001). Rubulavirus V proteins (e.g., SV5, PIV2) are associated
with intracellular and virion nucleocapsids (NCs) and are
important in promoting virus growth. PIV2 which cannot
express the entire V protein is highly debilitated even in the most
permissive cell culture (Nishio et al., 2005). Respirovirus (e.g.,
Sendai virus (SeV)) V proteins, in contrast, are nonstructural
proteins, are not associated with NCs and their expression
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although V expression is not required for replication in cell
culture, SeVVexpression is essential for virulence in mice (Kato
et al., 1997; Delenda et al., 1998). This requirement is
presumably due to its ability to block dsRNA-induced activation
of the IFNβ promoter (Poole et al., 2002) as infection with SeV
that cannot specifically express the V protein strongly activates
IFNβ (Strahle et al., 2003). Finally, in contrast to rubulaviruses,
respirovirus VmRNAs express a nested set of C proteins from an
overlapping ORF, and these C proteins also block the innate
antiviral response, in several ways (e.g., by blocking IFN
signaling) (Gotoh et al., 1999; Garcin et al., 1999).
It is noteworthy that infection with wild-type SeV or SV5
does not normally activate IFNβ. In contrast, infections with
SV5 VΔC (which produces a C-terminally truncated V protein)
or infections with SeV with mutations in either the leader
region, two regions of the C protein or the V protein all lead to
enhanced levels of IFNβ mRNA (He et al., 2002; Strahle et al.,
2003). In the case of SeV, these viral genes also appear to be
involved in preventing activation of inflammatory cytokines
such as IL-8. For SeV, all the viral products that are not known
to play essential roles in the replication process itself (the Vand
C proteins, and leader and trailer RNAs) appear to function in
countering the innate antiviral response. In the context of a
normal, wild-type infection of cells in culture, the effect of these
various viral anti-host-response products is apparently sufficient
to prevent, or severely limit, IFNβ activation.
The IFNβ promoter is normally activated in cells treated
with dsRNA (poly I:poly C, or poly-I/C) or infected with virus.
Sendai virus infection is often used in this respect, and virus
stocks which strongly activate IFNβ are also available
commercially. However, it has long been known that the
remarkable ability of some SeV stocks to induce IFN secretion
in macrophage and other cell lines is related to the presence of
defective-interfering (DI) particles (Johnston, 1981; Poole et al.,
2002), but the nature of the IFN-inducing agent in these stocks
was not examined. Moreover, for VSV, another mononegavirus,
DI particles containing “snap-back” DI genomes (see below)
were found to be very potent inducers of IFN, even in the
absence of co-infecting nondefective (ND) helper virus (Marcus
and Sekellick, 1977; Sekellick and Marcus, 1982). DI particles
contain deleted viral genomes which are generated spontane-
ously as by-products of ND genome replication. DI genomes
have, sine qua non, gained the ability to successfully compete
with their helper ND genomes for the viral replication substrates
provided by the latter; hence, they are also “interfering”
(Perrault, 1981; Lazzarini et al., 1981). Because of their
replicative advantage over ND genomes, DI genomes invariably
accumulate in SeV stocks that are repeatedly passed in eggs,
unless steps to prevent this accumulation are taken.
Nonsegmented negative-strand RNA viruses (NNV) DI
genomes can be of two types, internal deletion or copyback
(Fig. 1). The replicative advantage of internal deletion DI
genomes over ND genomes is not well understood (Garcin et
al., 1994), but that of copyback DI genomes is well studied.
Copyback DI genomes have always replaced the weaker
genomic replication promoter at the 3′ ends of their minusstrands with the stronger antigenomic promoter, and thus both
DI genomes and antigenomes initiate from the same strong
antigenomic promoter. Paramyxovirus replication promoters are
contained within the 3′ terminal 91–96 nt of the genomic RNA
(narrow boxes, Fig. 1), and all natural copyback DI genomes
have copied back 91 nt or more while carrying out this promoter
exchange (see Fig. 1). Although these RNAs contain termini
that are perfectly complementary for ca. 100 nt, DI genomes are
normally present within nucleocapsids (NCs), where their RNA
ends are not free to anneal. However, when SDS is used to
gently dissociate the N protein from RNA, copyback DI
genomes (and antigenomes) rapidly form ssRNA circles with
dsRNA panhandles, as seen in the EM and on biochemical
analysis (Kolakofsky, 1976). Several copyback DI genomes
from independent virus stocks were characterized initially. They
all contained complementary termini of ca. 100 nt in length, and
as expected, the rate at which they circularized on SDS
treatment was inversely proportional to their length.
Similar copyback DI genomes with limited terminal
complementarity are common for VSV. However, VSV, unlike
SeV, also generates an extreme form of copyback DI genome
whose sequences are complementary over their entire length of
ca. 2 kb (snapback DIs) and which form long dsRNA “hairpins”
(of ca. 1000 bp) rather than ss circles upon SDS treatment
(Lazzarini et al., 1981; Perrault, 1981). It is these VSV snapback
DI genomes, like DI 011, that were reported to strongly induce
IFN by themselves, in aged chick embryo fibroblasts (CEFs)
and mouse L cells (Marcus and Gaccione, 1989; Marcus and
Sekellick, 1977). These reports have remained controversial,
however, because this IFN induction was independent of co-
infecting helper virus, whereas Youngner and colleagues found
that it correlated with contaminating ND virus in L cells. These
latter workers, moreover, were unable to find a correlation
between the snapback content of their DIs and IFN induction
(Frey et al., 1979). Sekellick and Marcus also reported that
snapback DI induction of IFN was unaffected by heat treatment
that would inactivate its RNA polymerase, or UV treatment that
would prevent its genome from being copied, and concluded
that this IFN induction was due to a pre-existing molecule that
did not require any synthetic events for its formation (Sekellick
and Marcus, 1982; Marcus and Gaccione, 1989). Disassembly
of DI 011 NCs intracellularly would then appear to be the only
explanation for dsRNA formation. However, as the infection of
a single DI 011 particle per CEF was sufficient to induce a
quantum (maximum) yield of IFN, the manner in which the DI
011 NC is presumably disassembled so efficiently in vivo (to
permit dsRNA formation) remains an enigma as NCs are
generally very stable in vivo.
Given the growing appreciation that dsRNAmay be a common
product of RNAvirus infection that participates in the induction of
the innate antiviral response, we have reexamined the requirement
of SeV DI genomes for the activation of the IFNβ promoter.
Results
Three SeV stocks containing DI genomes (Figs. 1, 2a), as
well as a stock containing only ND genomes, were examined for
Fig. 1. A schematic view of SeV RNA synthesis and DI genomes. The ND (−) genome is shown above, with its 3′ end genomic replication promoter (on the left) and
the complement of the antigenomic replication promoter (at the 5′ end), both contained within the terminal 96 nt, shown as thin boxes. The central protein coding
region, from the beginning of the N ORF to the end of the L ORF, is shown as thicker boxes; these regions are not drawn to scale. Only the N/P junction is shown, the
remaining genes are lumped together as a P/V/C … L. The (+) RNAs transcribed from the ND genome (le RNA and the 6 mRNAs) are shown below the ND genome.
The sole transcript of the ND-antigenome, tr RNA, is shown above. The lines below the ND genome indicate the progress of the replicase when generating internal
deletion (E307) or copyback (H4/ChR1) DI genomes. The structure of the DI (−) genomes is shown below; the dark shading on the left indicates the extent of the
terminal complementarity, which is also indicated in brackets on the left. The inverted triangle indicates the yfp sequence used to tag H4. The arrows below the DI
genomes show the PCR amplification strategy used to clone the DI RNA of the Charles River SeV stock.
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IFNβ promoter. The DI-H4 stock is composed predominantly
of a natural 1410 nt long copyback DI genome, whose termini
are perfectly complementary for 110 nt (Calain et al., 1992).
The DI-S104 stock, like H4, was generated by passage in eggs,
but this stock is composed of 5 major DI species. Only the
smallest DI of this stock has been cloned as DNA and found to
be an internal deletion DI of 1794 nt (called E307) (Engelhorn
et al., 1993). Their termini are complementary for only 12 nt,
like those of ND genomes. However, Northern analysis with a
leader/N gene probe, which anneals specifically to internal
deletion DI genomes, shows that this stock contains 3 internal
deletion as well as 2 copyback DI genomes (the latter of ca.
2500 and 3500 nt in length) (Fig. 2a). DI-GP55, in contrast to
the others, was produced and rescued by recombinant means
(Garcin et al., 1995) and is identical to E307 except that it
contains the 55 nt trailer region at the (−) DI genome 3′ end, in
place of the leader region. DI-GP55 is thus a copyback DI
genome whose termini are complementary for 55 nt (Fig. 1). As
mentioned above, copyback DI genomes with more extensive
terminal complementarity, such VSV DI 011, have not been
reported for SeV, and we have no stable SeV stocks that contain
only internal deletion DI genomes.
Infection of 293T cells with all 3 DI stocks was found to
activate the IFNβ reporter, but to very different extents (Fig. 2c).H4 was the most potent, followed by GP55, and S104 was the
least potent. In contrast, infection with ND genomes alone barely
activated the reporter gene, even though the ND infection
accumulated as much or more viral proteins than the DI
infections (Fig. 2b). In these and other experiments, there is often
an inverse correlation between the accumulation of viral proteins
and the extent of IFNβ activation, as might be expected if
activation is due to the presence of DI genomes. More
importantly, plaque purification of the H4 stock yields a virus
preparation that does not contain DI genomes and which does
not activate the IFNβ promoter during infection (ND-H4, Fig.
3). The ability of the DI-H4 stock to activate IFNβ is thus not due
to mutations within the ND genome, which could have arisen
because of the presence of the DI genomes.
IFNβ activation requires modification of IRF-3, which is
hyper-phosphorylated in response to viral infection, or dsRNA
(Fitzgerald et al., 2003; Sharma et al., 2003). Activated IRF-3
dimerizes andmigrates to the nucleus where it binds to the PRD I
and III elements of the IFNβ promoter, as part of an
enhanceosome (Maniatis et al., 1998). The activation of the
IFNβ promoter by SeV DI infection appears to require IRF-3
since this activation is largely ablated by co-expression of a
dominant-negative form of IRF-3 (data not shown). When the
extent of IRF-3 dimerization was examined, a significant
fraction of the IRF-3 was found as dimers (on non-denaturing
Fig. 2. Only DI infections activate IFNβ in 293T cells. (a) Northern blot of encapsidated (CsCl banded) RNAs from the various infections as indicated, using a (+)
riboprobe from the end of the L gene (which detects all DI genomes) or a (+) riboprobe from the leader/N gene region, which detects only internal deletion DI genomes.
The DI-H4 and GP-55 genomes do not anneal with the leader/N gene probe. (b) A Western blot of equal amounts of cell extracts (total proteins) of the various
infections, using anti-P and anti-N antibodies. (c) 293T cells were transfected with a luciferase reporter plasmid under the control of the IFNβ promoter (and control
plasmid) for 24 h then infected (or not) with the various SeV stocks for 20 h. Cell extracts were prepared, and levels of the renilla and firefly luciferases were
determined. The cumulative results of 3 experiments are shown. (d) Two different amounts (1× and 5×) of total cell proteins from extracts of the various infections were
separated on nondenaturing gels andWestern blotted with anti-IRF-3. (e) Equal amounts of cell extracts of the various infections (total proteins) were separated on SDS
gels andWestern blotted with anti-IRF-3. The right-hand lane shows uninfected cells that express transfected IRF-3 5D. The 5 isoforms, numbered 1 to 5, are indicated.
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formation was roughly in proportion to the degree of IFNβ
activation (Fig. 2d). In contrast, there was no evidence of dimers
in the ND extract.We also examined the electrophoretic mobility
of IRF-3 on SDS-PAGE as this mobility is sensitive to IRF-3
phosphorylation status (Hiscott et al., 2003; Hasegawa et al.,
1992; Yoneyama et al., 2002). We could distinguish 5
electrophoretic forms of IRF-3 in our extracts (Fig. 2e). Mock-
infected extracts predominantly contained forms 2 and 3.
Infection with ND SeV led to the strong appearance of faster
form 5, without loss of 2 and 3. In contrast, infection with DI-H4
and GP55 led to the appearance of the slightly slower form 4,
reduction in the intensity of forms 2 and 3, and the appearance of
the slowest form 1, which co-migrates with phospho-mimetic
IRF-3 5D that is constitutively active (Lin et al., 1999). IRF-3 isthus being modified in response to the ND infection, but these
modifications do not lead to dimerization or the activation of the
IFNβ promoter. The presence of DI genomes during infection
somehow causes IRF-3 to be modified differently, leading to its
dimerization and IFNβ promoter activation.
DI-H4-induced activation of IFNβ is proportional to DI
genome replication
The relative amounts of DI and ND genomes in cell extracts
can be examined by Northern blotting (Figs. 2 and 3), but this
analysis is linear only over a relatively narrow range and often
unequally estimates RNAs that vary significantly in length
(>10-fold in this case). RT/PCR is better suited to this task, but
this method cannot differentiate between DI-H4 and ND
Fig. 4. Evolution of the DI-H4+yfp stock on passage in eggs. (a) The DI-
H4+yfp genome was prepared from DNA by reverse genetics (Methods and
materials) and rescued by superinfecting the BSR T7 culture with ND SeV
(Methods and materials). The culture supernatant was inoculated into eggs, and
the resulting allantoic fluid was diluted 1 to 500 for reinoculation, for a total of 20
times. The stocks from each passage level were assayed for their ability to
activate a GFP gene under the control of the IFNβ promoter. Only the results
from passage levels 8 and 16 to 20 are shown, along with DI-H4 as positive
control and mock-infected as a negative control. (b) Total RNA was prepared
from cells infected with passage levels 8 and 16 to 20 and examined by RT/PCR
for their levels of ND genome (N gene) and DI genome (YFP) relative to that of
GADPH mRNAs. Total RNA from a mock-infected culture served as the
negative control. (c) Equal amounts of extracts from cells infected with passage
levels 8 and 16 to 19 were examined by Western blotting with anti-N and anti-P/
V/C and anti-actin as a loading control.
Fig. 3. Allantoic fluid stocks prepared from plaque-purified SeV do not activate
IFNβ. The DI-H4 and ChR stocks were titered on LLC-MK2 cells in the
absence of serum. Single plaques from the highest positive dilution (10−7) were
picked, and 3/10 of each plaque was inoculated into hen's eggs that were
incubated at 33 °C for 3 days. The allantoic fluid stocks resulting from the
plaque-purified virus (ca. 109 pfu/ml) were compared with the original stocks
containing the same amount of viral proteins (as determined by Coomassie blue
staining of SDS gels) for their ability to activate pIFNβ-GFP in 293T cells. A
Northern blot of encapsidated (CsCl banded) RNAs from equal amounts of ND-,
H4-, and ChR1-infected cells, using a (+) riboprobe from the end of the L gene,
is shown in the insert.
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amplification. However, the dsRNA panhandles of circular DI
genome RNAs are exceedingly stable and cannot be invaded by
primers extended by RTase even at elevated temperatures. To
circumvent these technical problems, we prepared a tagged
version of the DI-H4 genome containing a 162 nt insertion
from the YFP gene (Fig. 1), such that the DI and ND genomes
could be independently and accurately estimated by RT/PCR,
over a large range of values. A second reason for preparing DI-
H4+yfp is that, although our H4 stocks are composed
predominantly of the 1410 nt long species cloned as DNA,
overexposure of Northern blots shows that several other RNAs
are present in much lower amounts and which have not
otherwise been characterized. As we do not know whether all
the DI genomes in the H4 stock contribute equally to inducing
IFNβ activation or whether activation is due to a particular (and
perhaps uncharacterized) species, we cannot be sure that IFNβ
activation is in fact due to the 1410 nt copyback DI genome.
Recapitulation of these results with a tagged copy of the DI-H4
genome would settle this issue as well.
DI-H4+yfp genomes were recovered from DNA in BSR T7
cells that were subsequently co-infected with ND SeV. Stocks
containing this DI genome were then generated by multiple
passages in embyonated chicken eggs (Methods and materials),
and each passage was tested for its ability to activate a GFP
reporter gene under the control of the IFNβ promoter (pIFNβ-
GFP) upon infection of 293T cells. Although some IFNβ
activation above background appeared by passage 3, this
activation increased slowly and erratically at first and eventually
reached activation levels approximately half those of the
reference H4 stock by passage 20 (Fig. 4a), During the later
passages (16 to 20), the level of intracellular ND genomes
steadily decreased (Fig. 4b), leading to a reduction in the levels
of viral proteins (Fig. 4c), whereas the levels of DI-H4+yfpgenomes steadily increased (Fig. 4b). The ability of SeV DI
stocks to induce IFNβ activation thus correlates with the
relative levels of DI genomes during infection. As DI and ND
genome NCs are relatively stable structures, these levels reflect
the rates that DI and ND genomes are synthesized during
infection with the various passage levels. The evolution of the
DI-H4+yfp stock towards IFNβ activation (during relatively
undiluted passage in eggs) thus correlates with the level of DI
genome synthesis during infection. The remarkable ability of
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predominant 1410-nt-long copyback DI genome.
Examination of the UV inactivation kinetics of DI-induced
IFNβ activation, as compared to the UV inactivation kinetics of
ND and DI genome replication, can provide broad information
on the nature of this IFNβ activation. DI-H4+yfp (P(passage)
17, insert, Fig. 5) was irradiated with 256 nm UV light for
various times (0.5 to 8 min) and used to infect 293T cells
containing pIFNβ-GFP. Intracellular RNA was isolated at
20 hpi, and the levels of ND genome RNA and DI-H4+yfp
genome RNAwere measured by RT/PCR. GFP expression was
monitored by FACS (Fig. 5a). DI-H4+yfp (1572 nt) is 1/10 the
length of the ND genome (15,384 nt) and thus proportionately
less sensitive to UV inactivation. This difference in the loss of
ND and DI genome levels is most apparent at the shortest times
of UV irradiation and is lost at the higher doses, presumably
because DI genome replication ultimately depends on ND
genomes to provide all the replication substrates (N, P and L
proteins). The reduction of GFP expression levels uponFig. 5. UV inactivation kinetics of DI-H4+yfp infections. (a) The allantoic fluid
of DI-H4+yfp passage level 17 was irradiated with 254 nm light (110 μW/cm2)
from 0.5 to 8min and then used to infect 293Tcells that had been transfected with
pIFNβ-GFP. Total RNA was prepared at 24 hpi, and the levels of DI-H4+yfp
genome and ND genome were determined by RT/PCR. GFP expression levels
were monitored by FACS. The results are shown relative to RNA from cells
infected with non-irradiated allantoic fluid. The cumulative results of 2
experiments are shown. The error bars, always <20%, are not shown for clarity.
(b) A Northern blot of encapsidated RNAs fromND, DI-H4 and DI-H4+yfp P17
infections, using a (+) probe from the end of the L gene.increasing UV irradiation parallels that of ND and DI genomes
and most closely follows the loss of the DI genomes at the
lowest doses of UV. More importantly, as the reduction of GFP
expression levels closely follows that of DI genomes over a
range of 2 logs, IFNβ activation is clearly proportional to the
level of copyback DI genome replication (in 293T cells) for a
given stock as well.
The manner in which SeV DI genomes presumably generate
dsRNA that induces IFN is thus quite different from that of
VSV DI 011. SeV DI genomes not only require co-infection
with ND helper virus, IFN induction here (293T cells) is strictly
proportional to the level of DI genome replication, in contrast to
VSV snapback DI IFN induction (in aged CEFs) where viral
RNA synthesis is not required.
The SeV stock of Charles Rivers Laboratory
As mentioned above, SeV stocks (Cantell strain) whose
infection of cultured cells strongly activates IFNβ, are available
from Charles River Laboratory. A fresh allantoic fluid stock of
this virus preparation was found to activate IFNβ to levels
similar to those of DI-H4 (Fig. 3), and this stock was found to
contain a very small DI genome (of ∼600 nt) by Northern
analysis (insert, Fig. 3). When the ND virus of this preparation
was plaque purified on LLC-MK2 cells, allantoic fluid stocks
prepared from the purified virus had lost the ability to activate
IFNβ (ND-ChR1, Fig. 3). Thus, similar to DI-H4, the ability of
the Charles River virus preparation to activate IFNβ appears to
be due to the presence of the DI genome(s), and not to mutations
within its ND genome.
To determine the nature of this DI genome, we cloned the
DI genome as DNA, as illustrated in Fig. 1 (small horizontal
arrows are primers). We used one set of primers to amplify
the common right end of all DIs (arrows under GP55, Fig. 1)
and 3 sets of primers that were specific to the left end of
either internal deletion (arrows under E307, Fig. 1) or
copyback DIs (arrows under H4, Fig. 1). The common right
end primer set and the 3 copyback-specific left-end primer
sets all yielded a PCR product of the expected size, whereas
the 3 internal-deletion-specific left-end primers failed to
produce visible DNA (not shown). When these amplified
DNA fragments were sequenced, DI-ChR1 was deduced to be
a simple copyback DI genome of 546 nt (453 nt are co-linear
with the 5′ end of the ND (−) genome), with terminal
complementarity over 93 nt. To our knowledge, this is the
smallest natural SeV DI genome described to date, and this
property may be related to its ability to activate IFNβ so
strongly.
The SeV V and/or C proteins inhibit DI-H4-induced IFNβ
activation
Although our 293T cells produce IFN in response to DI-
H4 infection, they do not respond to added IFN. 293T cells
are thus useful in studying IFNβ activation in isolation
because the activation is not also driven by positive feedback
via ISGs. However, to study the broader aspects of the
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IFN in response to infection and respond as well to the
secreted IFN. When 2fTGH cells containing a pIFNβ-luc
reporter are treated with poly-I/C (either added to the
medium or via transfection (*)) or IFNα, poly-I/C* and H4
infection strongly activate IFNβ promoter, whereas IFNα has
no effect and poly-I/C treatment has little effect (IFNβ is not
an ISG, and TLR3 may be poorly expressed in these
fibroblasts). Moreover, whereas poly-I/C* and IFNα clearly
increased ISG levels (STAT1, RIG-I, ISG15 and ISG56), H4
infection failed to increase these ISG levels above the
untreated control. The SeV V protein blocks poly-I/C-
induced IFNβ activation (Poole et al., 2002) and presumably
should also block that induced by DI-H4 infection. We
reasoned that, if DI-H4 infections generated abnormally large
amounts of dsRNA, the amount of V expressed from the ND
genome during DI infections might be insufficient to block
dsRNA signaling via RIG-I and Mda5. We therefore over-
expressed the V and C proteins by plasmid transfection in
2fTGH cells containing pIFNβ-luc and re-examined the
effects of the various treatments. As shown in Fig. 6a, over-
expression of the V and C proteins was as effective in
blocking the DI-H4-induced activation of the IFNβ promoter
as it was in reducing the poly-I/C*-induced activation. This
result is consistent with the notion that DI-H4 infection
induces IFNβ activation, at least in part, via dsRNA. Over-
expression of the V and C proteins also partially blocked the
poly-I/C*- and IFNα-induced increase in ISG levels,
including that of RIG-I.
To examine whether DI-H4 infection was indeed able to
block IFN signaling, we similarly treated 2fTGH cells
containing a pIRSE-luc reporter and examined the effects on
the reporter gene and ISG protein levels (Fig. 6b). In contrast
to IFNα and poly-I/C* treatment which activated this
promoter and increased ISG levels, DI-H4 infection did not
activate the ISRE reporter over the untreated control, and the
levels of STAT1, RIG-I, ISG15 and ISG56 were not increasedFig. 6. (a) The effect of poly I/C, DI-H4 infection and IFNα treatment on IFNβ
and ISGs in 2fTGH cells, in the presence and absence of the SeV V and C
proteins. 2fTGH cells were transfected with a luciferase reporter plasmid under
the control of the IFNβ promoter (and the TK-renilla control plasmid) and pSeV-
V/C that expresses V and C proteins from the same mRNA (or and empty
plasmid) for 24 h. Parallel cultures were then either treated with 100 μg/ml of
poly I/C in MEM (poly-I/C), transfected with 1 μg of poly I/C (poly I/C*),
infected with DI-H4 or treated with 1000 IU of IFNα. Cell extracts were
prepared 20 h later, and the levels of the renilla and firefly luciferase activities
were determined. The cumulative results of 2 experiments are shown. Equal
amounts of total protein of each extract were also examined for their levels of
STAT1 (and actin), RIG-I, SeV P, V and C proteins and ISG-15 and ISG-56 by
Western blotting with specific antibodies (Methods and materials). (b) The effect
of poly I/C, DI-H4 infection and IFNα treatment on ISGs in 2fTGH cells.
2fTGH cells were transfected with a luciferase reporter plasmid under the
control of an ISRE promoter (and the TK-renilla control plasmid) for 24 h.
Parallel cultures were then treated as in panel A. Cell extracts were prepared 20 h
later, and the levels of the renilla and firefly luciferase activities were
determined. The cumulative results of 2 experiments are shown. Equal amounts
of total protein of each extract were also examined for their levels of STAT1 (and
actin), RIG-I and ISG-15 and ISG-56 by Western blotting.in these extracts. Thus, there appears to be sufficient viral
proteins expressed during DI-H4 infection to block IFN
signaling.
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dsRNA is thought to be a common product or PAMP of RNA
virus infections that initiates the innate antiviral response, in part
by activating IFNβ. However, the source of this dsRNA is
presumably different for different viruses. (+) RNA virus
genomes contain highly conserved 2° and 3° structures at their
5′ and 3′ ends that are essential for virus replication (Simmonds
et al., 2004), and these highly structured RNA regions by
themselves can initiate signaling to IFNβ upon binding to RIG-I
(Sumpter et al., 2005). In contrast, NNV genomes are not known
to contain conserved 2° structures, and, moreover, NNV
genomes function in RNA synthesis not as free RNAs but as
assembled NCs, in which the genome RNA cannot normally
anneal (Lamb and Kolakofsky, 2001). One possible source of
dsRNA during NDSeVreplication is the occasional extension of
the trailer RNA beyond the trailer/L gene junction (see Fig. 1),
producing run-on trailer RNAswhose 3′ sequences can anneal to
those of the L mRNA (Vidal and Kolakofsky, 1989). In a similar
vein, the transcriptase which synthesizes the L mRNA
presumably reads through the L gene-end site at a frequency
of ca. 5% (similar to other gene junctions; Le Mercier et al.,
2002) and terminates at the genome 5′ end, thus providing read-
through L transcripts that can anneal to trailer RNAs. Although
the NNV replication strategy appears to minimize dsRNA
potential during intracellular replication, this strategy presum-
ably cannot exclude the generation of small amounts of dsRNA.
It is reasonable that the levels of V and C expressed during ND
genome replication are designed to counteract the small amounts
of dsRNA generated. If so, the presence of significant amounts
of copyback DI genomes during intracellular replication will
certainly change the nature of the SeV infection.
The most important new finding of this study is that not all
SeV stocks that are heavily contaminated by DI genomes are
equally able to activate IFNβ. The H4, GP55 and S104 stocks all
contain the H strain ND genome as helper and can be directly
compared. S104 infections accumulate more viral products than
H4 infections as the S104 DI genomes appear to interfere less
with their helper virus replication than those of H4 (Fig. 2b). At
the same time, S104 infections activated IFNβ 10 to 20-fold less
strongly than H4 infections in multiple experiments (Fig. 2a and
data not shown). Besides the different extents to which S104 and
H4 DI genomes interfere with ND genome expression and thus
affect the intracellular concentration of the viral VandC proteins,
H4 stocks are composed exclusively of copyback DI genomes,
whereas S104 stocks are composed predominantly (>70%) of
internal deletion DI genomes. Moreover, the two copyback DI
genomes in this stock are both longer than DI-H4. DI-GP55 is
also longer than DI-H4, its termini are complementary for only
half the length as H4 (55 nt), and DI-GP55 interferes with ND
genome expression less than DI-H4. Taken together, these data
suggest that the ability of SeV DI stocks to activate IFNβ is
related both to (i) their ability to interfere with helper genome
expression, which leads to lower levels of Vand C intracellularly,
and (ii) their relative content of copyback DI genomes. The size
of the DI genome may also play a role in this latter respect.
However, it will be necessary to examine these properties of SeVDI genomes more directly, e.g., by extending the terminal
complementarity of DI-GP55 to 110 nt, or by altering the length
of DI-H4+yfp, to be more certain of these conclusions.
Copyback DI genomes may be stronger activators of IFNβ
than internal deletion DI genomes because they have a stronger
potential to form dsRNA. Copyback DI genomes are composed
of equal amounts of genomes and antigenomes (rather than a
10-fold excess of genomes), and their termini can self-anneal
intramolecularly as well. The question then remains of how this
dsRNA potential is expressed as the synthesis of DI genomes,
like that of ND genomes, is thought to be coupled to their
assembly into NCs. The vast majority of these NCs, once
formed, are very stable in vivo and band in CsCl density
gradients as fully assembled NCs. However, it is not rare to find
small amounts of DI-H4 genomes and antigenomes in extracts
of infected cells which pellet through these gradients as free
RNAs (<5%, unpublished). It is not clear whether these non-
assembled DI genomes were normally made as NCs which
subsequently disassembled or were actually made de novo
without concurrent assembly with N protein, as reported for
some conditions of VSV DI genome replication in vitro
(Chanda et al., 1980). Independent of how non-assembled DI-
H4 genomes are presumably generated in vivo, their formation
appears to be proportional to their synthesis (Fig. 4). Their
presence would represent a vast increase in the dsRNA potential
of SeV DI vs. ND infections, under conditions where there is
less V protein available to dampen dsRNA signaling to IFNβ
(Fig. 4c). The relatively short lengths of the H4 and ChR1 DI
genomes may play a role in how frequently their non-assembled
RNAs are formed in vivo, but this needs to be investigated.
There is one further aspect of SeV copyback DI infections that
should be mentioned to explain their ability to induce IFN so
efficiently, coupled with the remarkable fact that these DI
genomes with dsRNA potential are actually selected for on
passage in eggs (e.g., Fig. 4) (Le Mercier et al., 2002). We have
previously prepared ambisense ND SeV in which an additional
mRNA was expressed from the 3′ end of the antigenome. In
contrast to copyback DI genomes, genomes and antigenomes of
the ambisense SeV contain the weaker genomic promoter. These
ambisense SeV grew poorly in IFN-sensitive cultures and were
relatively IFN-sensitive. They were also highly unstable on
passage in eggs and reverted to virus that grows well even in IFN-
pretreated cells that restrict vesicular stomatitis virus replication,
i.e., the wild-type SeV phenotype. Since this reversion was
always associated with a point mutation in the ambi-mRNA start
site that severely limited its expression, we concluded that the
selection ofmutants unable to express ambi-mRNAon passage in
chicken eggs was presumably due to increased levels of dsRNA
during infection (vRdRp read-through of the ambi-mRNA stop
site creates a capped transcript that can potentially extend the
entire length of the antigenome, whereas extension of the
uncapped trailer RNA (wt SeV) is limited by the poor processivity
of its vRdRp). If ND ambisense SeV with dsRNA potential are
strongly selected against in eggs, then how are DI genomes with
dsRNA potential positively selected under the same conditions?
There are two possible explanations for this conundrum.
Firstly, the dsRNA potential of ambisense SeV is not associated
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ambi-mRNA promoter will largely eliminate this potential. The
ND genomes of SeV stocks containing copyback DI genomes,
in contrast, cannot escape their DI genomes by simple mutation,
and the dsRNA potential of copyback DI genomes is always
associated with a strong selective advantage as copyback DI
genomes outcompete their ND genomes for the replication
substrates provided by the latter. Secondly, and perhaps more
importantly, copyback DI infections are relatively non-cyto-
pathic and often end as persistent infections (Roux et al., 1991).
This is in part due to the ectopic expression of trailer RNA (in
place of leader RNA) from the copyback DI (−) genome (Garcin
et al., 1998) (Fig. 1). Trailer RNA is known to interact with
TIAR, a protein with many links to apoptosis, and this
interaction is important in suppressing SeV-induced PCD
(Iseni et al., 2002). The relative absence of leader RNAs during
copyback DI infections may also contribute to this DI
phenotype as mutations in the SeV leader region are associated
with virulence in mice (Fujii et al., 2002), and the normal
expression of leader RNA appears to be required to prevent
IFNβ activation (Strahle et al., 2003). The ability of copyback
DI infections to delay, and in many cases completely prevent
PCD, may compensate for the negative consequences of
increased dsRNA during infection, which presumably selects
against SeV that express ambi-mRNAs.
In summary, infection with an SeV stock that is highly
contaminated with copyback DI genomes is a potent way of
activating IFNβ. These DI infections presumably provide
plentiful dsRNA, under conditions of reduced expression of
viral products which block the host response to dsRNA, and
with minimal cytopathic effects that lead to persistent infection.
In contrast, infection with an SeV stock that is not contaminated
with copyback DI genomes does not activate IFNβ and is
highly cytopathic. These are two very different virus infections,
and they should not be confused when SeV stocks of unknown
composition are used to activate IFNβ.
Methods and materials
Cells, viruses, and antibodies
BSR-T7 cells were grown in BHK-21 Medium (Glasgow
MEM, Gibco) supplemented with 5% fetal calf serum (FCS) in
the presence of the relevant maintenance drug (G418 at 400 μg/
ml). 2fTGH cells and 293T cells were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf
serum (FCS).
SeV stocks were grown in the allantoic cavities of 9-day-old
embryonated chicken eggs for 3 days at 33 °C. For ND stocks
(109 pfu/ml), 0.1 ml of a 105 dilution (ca. 1000 pfu) was
inoculated per egg. In the case of DI stocks, 0.1 ml of a 102 to
104 dilution was used. In all cases, the amount of viral proteins
present in the resulting allantoic fluid was analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and
Coomassie blue staining of pelleted virus. Virus titers were
determined by plaquing on LLC-MK2 cells. Anti-IRF-3 (Santa
Cruz), anti-actin (Chemicon), anti-Stat1 (C-terminus) (Trans-duction Laboratories), anti-N-877 and anti-PCV, anti-ISG-15
and anti-ISG-56 were provided by Dr. Ganes Sen from The
Cleveland Clinic Institute. Anti-Rig-I was provided by Tadaatsu
Imaizumi from Hirosaki University School of Medicine.
Plasmids, transient transfections, luciferase assay and FACS
pβ-IFN-fl-lucter, which contains the firefly luciferase gene
under the control of the human IFNβ promoter, is described in
King and Goodbourn (1994). The IFNα/β-responsive reporter
plasmid, p(9–27)4tkD(239)lucter, referred to here as pISRE-fl-
lucter, contains four tandem repeats of the IFN-inducible gene
9–27 ISRE fused to the firefly luciferase gene (Didcock et al.,
1999). pTK-rl-lucter used as a transfection standard contains the
herpes simplex virus TK promoter region upstream of the renilla
luciferase gene (Promega). pIRF-3ΔN, which expresses a
dominant negative form of IRF-3, and pIRF-3 5D, which is
constitutively active, were obtained from John Hiscott and
Paula Pitha (Lin et al., 1998).
For transfections, 100,000 cells were plated in six-well plates
20 h before transfection with 1 μg of pβ-IFN-fl-lucter or pISRE-
fl-lucter, 0.3 μg of pTK-rl-lucter, with or without 1 μg of IRF-
3ΔN, or 1 μg of EBS plasmid expressing SeV-V protein (Nishio
et al., 2005), and Fugene (Roche) according to the manufac-
turer's instructions. At 24 h post-transfection, the cells were (or
were not) infected with various Sendai virus stocks or treated
with 100 μg of poly(I)–poly(C) (Sigma, St. Louis, MO) per ml or
transfected with 1 μg of poly(I)–poly(C) using Fugene. Twenty
hours later, cells were harvested and assayed for firefly and
renilla luciferase activity (dual-luciferase reporter assay system;
Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of renilla
luciferase. pIFNβ-GFP, which expresses GFP under the control
of the IFNβ promoter, was constructed by cloning the IFNβ
promoter region from pIFNβ-fl-lucter into pEGFP-N3 (BD
Biosciences Clontech), between the AseI and HindIII sites. For
transfections, 100,000 cells were plated in six-well plates 20 h
before transfection with 1 μg of pIFNβ-GFP and CaPO4
(Stratagene) according to the manufacturer's instructions. At
24 h post-transfection, the cells were (or were not) infected with
Sendai virus or different DI stocks. Twenty hours later, cells were
harvested and assayed for GFP expression by FACS analysis.
Preparation of DI-H4+yfp
100,000 BSR-T7 cells were plated in six-well plates 20 h
before transfection with a mix containing 0.75 μg of pTM1-L,
1.5 μg of pTM1-N, 1.5 μg of pTM1-P/Cstop (which does not
express C proteins), 1 μg of the various pDI constructs and
Fugene. Six hours later, the transfection mix was discarded and
replaced with 2 ml of Glasgow MEM supplemented with 5%
FCS. Twenty four hours post-transfection, the cells were
infected with ND SeV. Forty eight hours post-infection, the
cells were scraped into their medium and injected directly into
the allantoic cavity of 9-day embryonated chicken eggs. Three
days later, the allantoic fluids were harvested and injected
undiluted into eggs. For further passages, the virus stocks were
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500 before injection. The presence of viruses in the resulting
stock was determined by pelleting allantoic fluids (100 μl)
through a TNE (10 mM Tris–HCl [pH 8.0], 100 mM NaCl,
1 mM EDTA)–25% glycerol cushion for 20 min at 14,000 rpm
in an Eppendorf 5417C centrifuge. Virus pellets were
resuspended in sample buffer, and the proteins were separated
by sodium dodecyl sulfate–10% PAGE and stained with
Coomassie brilliant blue, alongside an ND stock of known titer.
Analysis of encapsidated RNAs
Confluent 293T cells in 9 cm ∅ Petri dishes (2 × 107 cells)
were infected with 10 pfu/cell of ND stocks, and an equivalent
amount of viral protein for DI stocks. Two days post-infection,
the cells were collected, and the intracellular viral nucleocapsids
(NC) were purified by 20–40% (w/w) CsCl density gradient
centrifugation and pelleted. After treatment with SDS and
proteinase K, the nucleocapsid RNAs were phenol-extracted
and ethanol-precipitated. The resulting RNAs were character-
ized by Taqman analysis using specifics oligonucleotides and
Taqman probes and by Northern blotting using a biotinylated
riboprobe generated in vitro by T7 RNA polymerase transcrip-
tion of plus strands complementary to nucleotides 13,397–
14,850 of the (−) ND genome.
Reverse transcription and real-time PCR via Taqman
Total RNA was extracted using Trizol (Invitrogen). Twenty
micrograms of total RNA was mixed with 0.5 μg Random
Hexamers (Promega) and subjected to a Superscript reverse
transcription (RT) reaction as described by the manufacturer
(Gibco) in a total volume of 50 μl. Two microliters of each
cDNA was then combined with 1 μl of internal control
Human GAPDH (Applied Biosystems), 11 μl MasterMix
(Eurogentec), 20 pmol (each) of forward and reverse primers
and 4.4 pmol of Taqman probe in a total volume of 22 μl.
The following primers and probes (Eurogentec or Microsynth)
were used: N gene: 5′-GCAATAACGGTGTCGATCACG-3′
(Fwd); 5′-TGCCTGAGCCGATCGG-3′ (Rev); 5′-CGAAGAT-
GACGATACCGCAGCAGTAGC-3′ (Probe). YFP gene:
5′-CCGACAACCACTACCTGAGCTA-3′ (Fwd); 5′-GAACTC-
CAGCAGGACCATGTG-3′ (Rev); 5′-AAAGACCCCAACGA-
GAAGCGCGA-3′ (Probe). Real-time PCR was carried out in the
7700 Sequence Detector (Applied Biosystems).
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INTRODUCTION TO PAPER THREE: 
 
All viruses have evolved to evade the cellular innate immune system including the IFN 
system by various mechanisms. Interestingly, for the Paramyxoviruses, the C and V accessory 
proteins are likely to be responsible for this counteraction of the innate immune response. 
Paper one showed that mutations within distinct regions of the V and C proteins or of the 
leader (absence of leader or over-expression of the trailer) all increased the level of IFNβ 
mRNAs. SeV V and C proteins as well as the region of the leader are thus important for 
antagonizing IFN signaling. Paper two showed that the SeV stocks containing specifically 
copyback DI genomes were responsible for the strong IFNβ activation. This phenomenon 
upon DI infection seemed to be due 1) to the ability of the DI genomes (and antigenomes) to 
self-anneal and form dsRNA, and 2) to the reduced production of the viral V and C proteins.  
Innate immunity upon viral infection has been extensively studied these past few years. As 
mentioned previously the two helicases RIG-I and Mda-5 were discovered to be important 
components responding to cytoplasmic RNA. Although these helicases transmit an identical 
signal leading to the activation of IRF-3, IRF-7 and NF-kB, they appear to target different 
viral products. In addition to this, RIG-I was found to detect other viral products than dsRNA. 
Indeed Sousa et al. showed that influenza A virus infection does not generate dsRNA and that 
RIG-I could be activated by single-stranded viral genomic RNA bearing 5’triphosphates 
(5’pppRNA) . 
In this study, the contribution of RIG-I (and Mda-5) in the detection of SeV infection is 
examined in mouse embryo fibroblasts (MEFs). Because 5’triphophorylated products have 
become new potential targets of RIG-I, we decided to test whether SeV infections induced 
IFNβ activation by producing pppRNAs as well as dsRNA. The involvement of both 
helicases was also analysed. For this, we used polyI/C, in vitro pppRNA (leader and trailer 
RNAs) and two different types of SeV infection: 1) SeV-DI-H4, containing copyback DI 
genomes and overexpressing 5’ppptrailer RNAs, as well as small amount of unencapsidated 
DI H4-genome RNA that can self anneal to form dsRNA panhandles with 5’ppp ends and 2) 
SeV-GFP(+/-), a mixed stock of SeV capable of producing dsRNA with capped ends. For the 
mixted stock, we produced two different SeV stocks: one of them carries a GPF sequence, 
producing + mRNA that is translated in GFP expressing proteins, the other contains the 
inverse GFP sequence. The coinfection of these viruses produces dsRNA from both mRNA 
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GFP + and - , which enabled us to test more precisely the effect of dsRNA (annealed capped 
mRNAs) on the activation of IFNβ (Fig. 20).  
 
 
  
Genome (-)
N P/C/V) M F HN L 5’3’ 
GFP mRNA (+)
GFPSeV-GFP(+) :
Protein GFP 
Genome (-)
N P/C/V) M F HN L 5’3’ 
GFP mRNA (-)
PFGSeV-GFP(-) :
No Protein GFP 
 
Coinfection SeV-GFP(+) and SeV-GFP(-) : SeV-GFP(+/-) 
  
 
 
 
 
   Æ dsRNA formation (capped ends) 
   Æ IFNβ activation ??? 
GFP mRNA (+)
GFP mRNA (-)                    
 
Little/No protein GPF 
Figure 20: SeV-GFP(+) expresses the protein GFP from a transgene between the M and the F genes. SeV-
GFP(-) synthesises a mRNA containing the complement of the GFP ORF, but no GFP protein can be 
expressed. Upon coinfection (= SeV-GFP(+/-)), both messengers (GFP+ and GFP-) are generated and can 
form dsRNA with capped 5’ppp ends. These infections are tested for their induction of IFNβ activation.  
 
The formation of dsRNA in the coinfection was tested by using the dsRNA-binding domain 
of E3L (Vacinia virus) proteins. We also used a dominant-negative form of RIG-I to examine 
whether the activation of the IFNβ upon RNA treatment or different SeV infections was 
dependent on RIG-I.  
Finally, since the viral C and V proteins are responsible for counteracting the host innate 
immune response, we over-expressed the V or C proteins in infected (SeV-DI-H4 or SeV-
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GFP(+/-))(Fig.21), or transfected (dsRNA or pppRNA) cells and also used SeV infections 
carrying mutation within the C or V genes (SeV-Cminus or SeV-Vminus ). We also tested 
whether they could inhibit the RIG-I dependent-IFNβ activation. In order to see which region 
was responsible for the inhibition of RIG-I, two different domains of the C protein (C1-23 and 
C24-204) carrying different function were also compared. 
 
 
 
IFNβ 
HELICASE CARD CARD 
RIG-I 
      
a) SeV-GFP(+/-) coinfection 
 
IFNβ 
HELICASE CARD CARD 
RIG-I 
      
tr 
ppp  5’
b) SeV-DI –H4 infection 
ppp 5’
Cytoplasm 
 GFP 
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C and V proteins 
ppp  5’tr 
ppp  5’
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Figure 21: Upon coinfection (SeV-GFP(+/-)) or upon SeV-DI-H4 infection, the cellular sensor RIG-I 
presumably recognises dsRNA and 5’triphosphorylated RNAs and leads to IFNβ activation. The viral 
RNA products that are detected by RIG-I upon SeV infection are still to be discovered: the trailer RNAs 
carrying 5’ppp ends remain good candidates. In this study, we also tested whether the overexpression of 
the viral C or V proteins could prevent the induction of IFNβ (via RIG-I) upon both SeV GFP (+/-) and 
DI-H4 infections. 
 
In this study, we demonstrated that SeV-GFP(+/-) and SeV-DI-H4 infections as well as 
transfections of the trailer pppRNAs or dsRNA (polyI/C) induced IFNβ activation in MEFs 
cells in a RIG-I dependent manner (not Mda-5). This suggests that RIG-I presumably detects 
both the 5’triphosphorylated RNAs and dsRNA. Moreover, these data showed that in infected 
or transfected MEF cells, the expression of SeV C protein had a much greater effect in 
counteracting RIG-I dependent IFNβ activation than the SeV V protein; and that the C24-204 
region was sufficient for this function.  
 
 80
JOURNAL OF VIROLOGY, Nov. 2007, p. 12227–12237 Vol. 81, No. 22
0022-538X/07/$08.000 doi:10.1128/JVI.01300-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Activation of the Beta Interferon Promoter by Unnatural Sendai Virus
Infection Requires RIG-I and Is Inhibited by Viral C Proteins
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As infection with wild-type (wt) Sendai virus (SeV) normally activates beta interferon (IFN-) very poorly,
two unnatural SeV infections were used to study virus-induced IFN- activation in mouse embryonic fibro-
blasts: (i) SeV-DI-H4, which is composed mostly of small, copyback defective interfering (DI) genomes and
whose infection overproduces short 5-triphosphorylated trailer RNAs (pppRNAs) and underproduces viral V
and C proteins, and (ii) SeV-GFP(/), a coinfection that produces wt amounts of viral gene products but that
also produces both green fluorescent protein (GFP) mRNA and its complement, which can form double-
stranded RNA (dsRNA) with capped 5 ends. We found that (i) virus-induced signaling to IFN- depended
predominantly on RIG-I (as opposed to mda-5) for both SeV infections, i.e., that RIG-I senses both pppRNAs
and dsRNA without 5-triphosphorylated ends, and (ii) it is the viral C protein (as opposed to V) that is
primarily responsible for countering RIG-I-dependent signaling to IFN-. Nondefective SeV that cannot
specifically express C proteins not only cannot prevent the effects of transfected poly(I-C) or pppRNAs on IFN-
activation but also synergistically enhances these effects. SeV-Vminus infection, in contrast, behaves mostly like
wt SeV and counteracts the effects of transfected poly(I-C) or pppRNAs.
All viruses evade the cellular innate immune system in part
by expressing gene products that interfere with the ability of
the host cell to establish an antiviral state (6). In the case of the
Paramyxovirinae, this anti-host-defense activity is due mostly to
viral C and V proteins (15, 27, 31). The C and V proteins are
encoded by separate alternate open reading frames (ORFs),
which both overlap that of the P protein. V and C are also
referred to as accessory gene products, as not all members of
this virus subfamily express one or the other. More specifically,
rubulavirus and avulavirus express V but do not express C
proteins, and human parainfluenza virus type 1 (PIV1), a res-
pirovirus most closely related to Sendai virus (SeV), expresses
C but does not express a V protein (16, 20).
Paramyxovirus V and C proteins antagonize interferon
(IFN) signaling by various mechanisms, and they also target
the production of type I IFN (15, 31). Beta IFN (IFN-)
production is one of the earliest events in the cellular innate
immune response, which leads to the establishment of an anti-
viral state. IFN- production requires the coordinated activa-
tion of several transcription factors, including NF-B and IRF3
(15, 29). For intracellular RNA virus replication, the signaling
pathway that leads to IRF3 activation starts with mda-5 and
RIG-I, two cytoplasmic DExH/D-box helicases with N-termi-
nal CARD domains. These helicases respond to double-
stranded RNA (dsRNA) and, at least for RIG-I, to 5-triphos-
phorylated single-stranded RNA (ssRNA) (pppRNA), which
are generated in the cytoplasm during RNA virus replication
(9, 11, 25). Upon the detection of these viral RNAs, the CARD
domains of these helicases interact with IPS-1/Cardif/MAVS/
VISA, which is present in the mitochondrial membrane, and
this CARD-CARD interaction is thought to lead to the re-
cruitment and activation of TBK1, IKKε, and other IKK ki-
nases that activate NF-B and IRF3, thereby activating the
IFN- promoter (8). The production of these early IFNs ini-
tiates autocrine and paracrine signal amplifications via the
Jak/Stat pathway to produce a generalized antiviral state and
also assists in the subsequent activation of adaptive immune
responses.
The role of mda-5 in sensing RNA virus infection was un-
covered because mda-5 was found to bind to the PIV5 V
protein and other paramyxovirus V proteins, including SeV V.
These V-protein–mda-5 interactions, moreover, prevented
IFN- activation in response to transfected poly(I-C) (1). On
the other hand, other studies found that RIG-I and not mda-5
acts as the sensor of paramyxovirus infection (13, 28). This
paper provides evidence that for SeV infection of mouse em-
bryonic fibroblasts (MEFs), it is the C protein (and not V) that
is primarily responsible for this effect and that C acts by coun-
tering RIG-I (and not mda-5). Independent expression of C
was found to inhibit RIG-I-dependent signaling to the IFN-
promoter induced by either pppRNAs or dsRNAs. Moreover,
SeV that cannot specifically express C proteins was unable to
counteract poly(I-C)- or pppRNA-induced IFN- activation,
whereas SeV that cannot express V behaved mostly like wild-
type (wt) SeV.
MATERIALS AND METHODS
Cells, viruses, and antibodies. MEFs were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum.
SeV stocks were grown in the allantoic cavitiesof 9-day-old embryonated
chicken eggs for 3 days at 33°C. For nondefective stocks (109 PFU/ml), 0.1 ml of
* Corresponding author. Mailing address: Department of Microbi-
ology and Molecular Medicine, University of Geneva School of Med-
icine, 11 Ave. de Champel, CH1211 Geneva, Switzerland. Phone: 41-
223795657. Fax: 41-223795702. E-mail: Daniel.Kolakofsky@medecine
.unige.ch.
 Published ahead of print on 5 September 2007.
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a 105 dilution (ca. 1,000 PFU) was inoculated per egg. In the case of DI stocks,
0.1 ml of a 103 dilution was used. In all cases, the amount of viral proteins present
in the resulting allantoic fluid was analyzed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and Coomassie blue staining of pelleted virus.
Virus titers were determined by plaquing on LLC-MK2 cells.
SeV-GFP(), which expresses green fluorescent protein (GFP) from a trans-
gene between the M and F genes, and SeV-GFP() or SeV-RFP, which ex-
presses antisense GFP mRNA or red fluorescent protein (RFP) (dsRED) from
similarly located transgenes, were prepared as previously described (31). DI-H4
stocks were described previously (30).
Primary antibodies used included rabbit anti-RFP (AB3216; Chemicon); anti-
actin monoclonal antibody (MAb) (1501; Chemicon); rabbit anti-GFP (632460;
BD biosciences); rabbit anti-SeV-P/C/V (homemade); anti-hemagglutinin (HA)
MAb (16B12; BABCO), anti-Flag MAb (F1804; Sigma), rabbit anti-mda-5 (J.
Tschopp, Lausanne, Switzerland), and rabbit anti-RIG-I (T. Fujita, Kyoto,
Japan).
Plasmids, transient transfections, infections, inductions, luciferase assay, and
fluorescence-activated cell sorter analysis. EBS plasmids (3) expressed viral and
fluorescent proteins and were constructed by standard methods; precise detail
can be obtained from the authors.
NS1 {residues 1 to 77 [NS1(1-77)]} (from Jacques Perrault) and E3L {residues
100 to 190 [E3L(100-190)]} (from Bertram Jacobs), were HA tagged and cloned
into pEBS. Flag-tagged RIG-I, RIG-I-C, or RIG-CARDS (dominant negative)
and mouse mda-5 were obtained from Jurg Tshopp and Klaus Conzelmann.
p-IFN-fl-lucter, which contains the firefly luciferase gene under the control of
the human IFN- promoter, was described previously (14). pTK-rl-lucter, used
as a transfection standard, contains the herpes simplex virus TK promoter region
upstream of the Renilla luciferase gene (Promega).
For transfections, 100,000 cells were plated into six-well plates 20 h before
transfection with 1.5 g of p-IFN-fl-lucter; 0.5 g of pTK-rl-lucter; 0.5 g of
plasmids expressing RIG-I and MDA-5; 1.5 g of plasmids expressing V (whose
C ORF is closed with a stop codon), C1-204 or C1-23-Tom-C24-204 (or C*),
NS1(1-77), wt E3L, mutant E3L(100-190), or RIG- proteins (as indicated); and
TransIT-LT1 transfection reagent (Mirus). At 24 h posttransfection, the cells
were (or were not) infected with various SeV stocks or transfected with 5 g of
poly(I-C) using TransIT-LT1 transfection reagent. Twenty hours later, cells were
harvested and assayed for firefly and Renilla luciferase activity (dual-luciferase
reporter assay system; Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of Renilla luciferase.
Immunoblotting. Cytoplasmic extracts were prepared using 0.5% NP-40
buffer. Equal amounts of total proteins were separated by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis and transferred onto Immobilon-P mem-
branes by semidry transfer. The secondary antibodies used were alkaline phos-
phatase-conjugated goat anti-rabbit (or mouse) immunoglobulin G (Bio-Rad).
The immobilized proteins were detected by light-enhanced chemiluminescence
(Pierce) and analyzed in a Bio-Rad light detector using Quantity One software.
In vitro synthesis of RNA, purification, and transfection. DNA for T7 RNA
polymerase synthesis of model RNA1 was prepared by PCR using the following
partially complementary primers: 5-TAATACGACTCACTATA(ggg/gca)ACA
CACCACAACCAACCCACAAC-3 (forward) (start sites are in lowercase type)
and 5-GAAAGAAAGGTGTGGTGTTGGTGTGGTTGTTGTGGGTTGGT
TGTGG-3 (reverse). In vitro transcription was performed on 100 pmol of
purified PCR product using T7 MEGAshortcript from Ambion according to the
manufacturer’s instructions. For RNA1 containing the unusual OHGCA start
site, RNA was initiated with the dinucleotide 5 OHGpC24 in a reaction without
GTP. For RNA1 containing the usual pppGGG start site, part of the product was
treated with 20 units of calf intestinal phosphatase (Roche) for 30 min at 37°C
followed by proteinase K treatment (15 min at 37°C), phenol extraction, and
ethanol precipitation. The T7 transcripts were purified on NucAway Spin col-
umns from Ambion (to remove unincorporated nucleotides). SeV trailer pppR-
NAs were synthesized similarly by using specific PCR primers.
For RNA transfection, 1 g (1) to 3 g (3) of RNA was transfected into
MEF cells using TransMessenger transfection reagent (QIAGEN).
RT and real-time PCR via TaqMan. Confluent MEFs in 10-cm petri dishes
(107 cells) were infected with 20 PFU/cell of SeV GFP(), SeV GFP(), or both
stocks. At 24 h postinfection (hpi), the cells were collected and lysed in 300 l of
NP-40 lysis buffer. Cytoplasmic extracts were then centrifuged in a 20 to 40%
(wt/wt) CsCl density gradient (16 h at 35,000 rpm at 12°C). The pellet RNAs
were ethanol precipitated and resuspended in 50 l of Tris-EDTA. Fifteen
micrograms of RNA was then mixed with 0.5 g of the forward or the reverse
GFP primer and subjected to a Superscript reverse transcription (RT) reaction,
according to instructions provided by the manufacturer (Gibco), in a total vol-
ume of 50 l. Five microliters of each cDNA was then combined with 12 l
MasterMix (Eurogentec), 20 pmol (each) of forward and reverse primers, and 4.4
pmol of TaqMan probe in a total volume of 25 l. The following primers and
probes (Eurogentec or Microsynth) were used for RT and TaqMan analyses of
the GFP gene: 5-CCGACAACCACTACCTGAGCAC-3 (forward), 5-GAAC
TCCAGCAGGACCATGTG-3 (reverse), and 5-AAAGACCCCAACGAGAA
GCGCGA-3 (probe). Real-time PCR was carried out in duplicates using a 7700
sequence detector (Applied Biosystems).
RESULTS
Three ways to activate IFN-. We have used three ways to
induce the activation of an IFN- promoter expressing a lucif-
erase reporter gene in MEFs (see Fig. 2A). The first is to
simply transfect a synthetic dsRNA, poly(I):poly(C) [poly(I-
C)], into the cells. The second way is to infect the cells with an
SeV stock that contains a well-characterized copyback DI ge-
nome (H4) (30). The third way is to coinfect cells with SeV-
GFP(), which expresses a GFP transgene, and SeV-GFP(),
which expresses mRNA containing the complement of the
GFP ORF, as recently described for vesicular stomatitis virus
(VSV) (24). As shown in Fig. 1A, infection with increasing
amounts of SeV-GFP() alone leads to increasing GFP ex-
pression. Coinfection of 20 PFU/cell of SeV-GFP() with
increasing amounts of SeV-GFP() leads to the gradual de-
crease of GFP expression (top). At 20 PFU/cell of SeV-
GFP(), there are roughly equal amounts of GFP and anti-
GFP mRNAs intracellularly (by strand-specific quantitative
RT-PCR) (Fig. 1B and see Materials and Methods), and there
is a 90% loss of GFP expression (Fig. 1A, top). This loss of
GFP expression cannot be accounted for by the reduced level
of GFP mRNA (Fig. 1B). In contrast, coinfection with increas-
ing amounts of SeV expressing RFP as a neutral control (SeV-
RFP) has a reduced ability to interfere with GFP expression
(Fig. 1A). More importantly, whereas infection with SeV-
GFP() alone or its coinfection with SeV-RFP leads to little
FIG. 1. IFN- activation induced by SeV-GFP(/) infections. (A) Parallel cultures of MEFs were first transfected with pIFN-lucff and
pTK-lucr and then infected with increasing amounts of either SeV-GFP() alone (which expresses a GFP mRNA from a transgene between the
M and F genes) or 20 PFU/cell of SeV-GFP() plus increasing amounts of either SeV-GFP() (which expresses an anti-GFP mRNA from a
transgene in the same location) or SeV-RFP (which expresses an RFP mRNA from a transgene in the same location), as indicated. GFP expression
was monitored by fluorescence-activated cell sorter analysis at 20 hpi. Cell extracts were prepared at 20 hpi, and equal amounts were used to
determine luciferase activities (below). These transfections were carried out three times with independent virus stocks, with similar results.
(B) Cytoplasmic extracts were centrifuged on CsCl density gradients to isolate nonencapsidated (pellet) RNAs. The levels of GFP and anti-GFP
mRNAs in 15 g of CsCl pellet RNA were determined using sense- and antisense-specific primers for RT, followed by quantitative PCR (TaqMan)
(see Materials and Methods). (C) Parallel cultures of MEFs were first transfected with the luciferase reporter plasmids plus either an empty vector,
one expressing wt E3L(100–190), or one expressing mutant E3L(100–190) (E3L-mut.) and then infected with increasing amounts of SeV-GFP()
and SeV-GFP() as indicated. Cell extracts were prepared at 20 hpi, and equal amounts were used to determine luciferase activities. Equal
amounts of cell extracts were also Western blotted using anti-N and anti-HA (below).
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or no activation of IFN- (Fig. 1A), coinfection with SeV-
GFP() clearly activates the IFN- promoter (Fig. 1A, bot-
tom). This IFN- activation is inhibited by the coexpression of
the dsRNA-binding domain of the vaccinia virus E3L protein,
whereas this activation is unaffected by a mutant form of E3L
containing two point mutations that eliminate the binding of
dsRNA (10) (Fig. 1C). Taken together, our results show that
only SeV coinfections that can form GFP dsRNA induce
IFN- activation.
The two SeV infections that activate IFN- differ from each
other in several respects. First, DI-H4 genomes are of the
copyback variety and contain the strong antigenomic replica-
tion promoter at their 3 ends. DI-H4 genomes thus have a
strong competitive advantage in replication over nondefective
(ND) genomes, and this sometimes leads to less viral structural
proteins like N and P being present intracellularly (see, e.g., P
protein in Fig. 3A), but sometimes, this difference is minimal
(see, e.g., Fig. 2A). However, in either case, viral V and C
proteins are almost entirely absent in these DI-H4-infected
cells, whereas V and C are found at wild-type levels in
GFP(/) infections (Fig. 2 and data not shown). Both of
these viral proteins are thought to limit IFN- activation due
to virus infection (15, 31). Second, the DI genome replication
promoters, like those of the ND genomes, are always active in
the presence of viral polymerase, and short 5-triphosphory-
lated trailer RNAs (rather than full-length DI genomes) are
transcribed by a relatively nonprocessive polymerase, espe-
cially when the N protein is limiting. Unlike genome synthesis
that is dependent on ongoing (N) protein synthesis, that of
trailer RNA actually increases when translation is blocked with
cycloheximide (18). SeV trailer RNAs are known to specifically
bind to TIAR, a cellular RNA binding protein of the ELAV
family (4), and to prevent virus-induced apoptosis (7, 12).
DI-H4 infections are expected to overproduce trailer RNAs,
which may stimulate RIG-I (11, 25), similar to measles virus
leader RNA (26). Lastly, DI-H4-infected cells also contain
small amounts of unencapsidated H4 genome RNA that can
self-anneal in a concentration-independent manner to form
dsRNA panhandles with 5-triphosphorylated ends. SeV-GFP
(/)-infected cells, on the other hand, can form dsRNAs
with capped ends.
Relative contributions of mda-5 and RIG-I in sensing SeV
infections in MEFs. mda-5 signaling to IFN- was discovered
because the PIV5 V protein was found to bind this helicase and
thereby prevent poly(I-C)-induced IFN- activation. Further
work showed that the V–mda-5 interaction is a general prop-
erty of paramyxovirus V proteins, including that of SeV (1, 5).
Nevertheless, several groups have now found that SeV infec-
tion is sensed by RIG-I (and not mda-5) (13). To determine
whether RIG-I was also responsible for signaling to the IFN-
promoter in our MEFs, we examined the effect of expressing a
dominant-negative form of RIG-I [RIG-I(CARDs), whose
N-terminal CARD domains are deleted] (Fig. 2A). MEFs were
first transfected with pIFN-lucff, pTK-lucr, and plasmids ex-
pressing either RIG-I(CARDs) or an empty vector as a neg-
ative control. After 24 h, the cells were either transfected with
poly(I-C) or infected with either SeV-DI-H4 or SeV-GFP(/),
and luciferase levels were determined 24 h later. As shown in
Fig. 2A, both SeV infections strongly activated the IFN- pro-
moter, whereas transfected poly(I-C) had a more modest effect
in this experiment. RIG-I(CARDs) coexpression did not af-
fect the levels of P, V, and C proteins found intracellularly
(bottom), but this coexpression reduced IFN- activation to
background levels in all three cases.
To determine whether the loss of IFN- activation by RIG-
I(CARDs) coexpression was due to its ability to also inhibit
mda-5 signaling, e.g., by sequestering cytoplasmic viral RNAs,
we examined whether RIG-I(CARDs) could inhibit mda-5
signaling. As mda-5 and RIG-I can be activated by simple
overexpression, we examined the effect of RIG-I(CARDs)
expression on IFN- activation due to the overexpression of
these two helicases. As shown in Fig. 2B, IFN- activation
clearly occurred upon exogenous mda-5 or RIG-I expression.
Moreover, whereas RIG-I(CARDs) coexpression completely
inhibited activation due to exogenous RIG-I, RIG-I(CARDs)
coexpression had little effect in countering IFN- activation due
to exogenous mda-5. In contrast, the coexpression of a dominant-
negative form of mda-5 completely inhibited IFN- activation
due to mda-5 overexpression (Fig. 2B). Taken together, these
results suggest that IFN- activation in our MEFs in response to
these SeV infections is predominantly, if not exclusively, due to
the action of RIG-I.
The coexpression of either SeV V or C proteins strongly
inhibited IFN- activation due to RIG-I overexpression,
whereas only the V protein strongly inhibited IFN- activation
due to mda-5 overexpression (Fig. 2B). The finding that SeV V
inhibits RIG-I signaling as well as that of mda-5 is consistent
with data from Childs et al. (5), who reported that SeV V was
a possible exception to the rule that all V proteins inhibited
mda-5 but not RIG-I. They reported that SeV V did in fact
modestly inhibit RIG-I (35%), whereas all other V proteins
had no effect.
SeV V and C inhibition of SeV-DI-H4 and SeV-GFP(/)
induced IFN- activation. We next examined the abilities of
FIG. 2. Relative contributions of mda-5 and RIG-I in sensing SeV infections in MEFs. (A) Parallel cultures of MEFs were first transfected with
pIFN-lucff, pTK-lucr, and plasmids expressing dominant-negative RIG-I(CARDs) or an empty vector as a negative control. After 24 h, the cells
were either transfected with poly(I-C) or infected with either SeV-DI-H4 or SeV-GFP(/) (as indicated). Cytoplasmic extracts were prepared
after a further 20 h of incubation and used to determine firefly and Renilla luciferase levels and the relative levels of RIG-I(CARDs) (anti-Flag)
and viral proteins (anti-P/V/C) by Western blotting (bottom). All transfections were carried out in duplicate, and the range of values obtained is
indicated by the error bars. Ctrl., control. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and plasmids expressing
Flag-tagged RIG-I or mda-5 or these helicases plus RIG-I(CARDs), mda-5(CARDs), SeV V (whose overlapping C ORF was closed by a stop
codon), SeV C, or an empty plasmid as a negative control, as indicated. Cytoplasmic extracts were prepared after 40 h of incubation and used to
determine firefly and Renilla luciferase levels. All transfections were carried out in duplicate, and the range of values obtained is indicated by error
bars. The relative levels of the Flag–RIG-I constructs were determined by Western blotting with anti-Flag, those of the Flag–mda-5 constructs were
determined with anti-mda-5, and those of the viral V and C proteins were determined with anti-P/V/C serum (bottom). Vect., vector.
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the SeV V and C proteins to inhibit IFN- activation induced
by SeV-DI-H4 and SeV-GFP(/) infections. As shown in
Fig. 3A, exogenous expression of the SeV V protein did not
affect the level of viral P, V, and C proteins in SeV infections,
but it did reduce IFN- activation due to DI-H4 infection (by
	60%). Remarkably, SeV V overexpression did not inhibit
IFN- activation due to SeV-GFP(/) infection. The coexpres-
sion of exogenous SeV C protein (actually C1–23-Tom-C24–204,
which migrates just slightly slower than the viral P protein) sim-
ilarly did not affect the level of viral P, V, and C proteins in SeV
infections. C overexpression, however, more strongly inhibited
IFN- activation due to either SeV infection [DI-H4-induced
activation was reduced by 	90%, and GFP(/)-induced acti-
vation was reduced by	75%]. Coexpression of the unmodified C
protein produced similar results (Fig. 2B and data not shown).
The ability of the GFP(/) infection to activate IFN-, despite
FIG. 3. SeV V and C inhibition of IFN- activation induced by SeV infections. (A) Parallel cultures of MEFs were transfected with pIFN-lucff,
pTK-lucr, and plasmids expressing the SeV V protein, the SeV C protein (actually C1–23-Tom-C24–204), or unmodified Tom as a negative control.
After 24 h, the cells were infected with either SeV-DI-H4 or SeV-GFP(/) (as indicated). Cytoplasmic extracts were prepared after a further
24 h of incubation and used to determine firefly and Renilla luciferase levels. The relative levels of viral P, V, and C proteins were determined by
Western blotting with anti-P/C/V serum (bottom). All transfections were carried out in duplicate, and the range of values obtained is indicated by
error bars. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and plasmids expressing either Tom, RIG-I(CARDs), IAV
NS1(1–73), C1–23-Tom-C24–204 (C*), or V, as indicated. After 24 h, the cells were infected with increasing amounts of SeV-DI-H4 (1, 2, and
4). Cytoplasmic extracts were prepared after a further 24 h of incubation and used to determine luciferase levels.
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normal levels of expression of the V and C proteins, is presumably
due to the early formation of GFP dsRNA. In this case, the SeV
V protein is considerably less potent than C in preventing the
response to this dsRNA.
As the DI-H4 infections accumulate so few V and C pro-
teins, we compared the abilities of these proteins (expressed
from plasmids) to inhibit IFN- activation relative to RIG-
I(CARDs) and the dsRNA binding domain of the influenza
A virus (IAV) NS1(1–73), another viral protein that inhibits
RIG-I signaling (22, 25). As shown in Fig. 3B, the SeV C
protein was as active as RIG-I(CARDs) in combating an
increasing dose of DI-H4 infection and almost as active as
NS1. Consistent with above-described results (Fig. 3A), the
SeV V protein was less active than C but was still able to inhibit
most of the DI-H4-induced IFN- activation.
The SeV C1–204 protein is composed of two domains: the
N-terminal 23 amino acids (C1–23) which act as a plasma mem-
brane (PM) targeting signal (19) and which is present in the
longer (C/C) but not in the shorter (Y1/Y2) “C” proteins, and
C24–204, or the Y1 protein, which acts as a protein interaction
domain. Whereas C24–204 (or Y1) is naturally expressed during
infection, C1–23 is only found fused to Y1. In order to study the
different contributions of these two domains to C-protein func-
tion, we have used tomato red fluorescent protein (Tom) in
which C1–23 is fused to the N terminus of Tom and C24–204 is
fused to its carboxy terminus as a carrier. The interposition of
Tom between these two domains of C remarkably does not
appear to affect any of the activities of C1–204 (19). MEFs were
transfected with the luciferase reporter plasmids along with
plasmids expressing various Tom constructs as indicated (Fig.
4). After 24 h, half of the cultures were infected with SeV-DI-
H4, and luciferase levels were determined after a further 24 h.
The expression of C1–23-Tom, which carries the wt PM anchor
and is localized at the cell surface, or P8P9-Tom, which carries
a mutant PM anchor and is distributed throughout the cyto-
plasm (19), had little or no effect on the DI-H4-induced IFN-
activation. In contrast, both C1–23-Tom-C24–204 and P8P9-Tom-
C24–204 reduced IFN- activation to near-background levels.
C24–204 alone (Tom-C24–204), moreover, was still quite active in
this respect (Fig. 4). Thus, the C24–204 or Y1 protein interac-
tion domain appears to be responsible for inhibiting RIG-I-
dependent IFN- activation, and this inhibition is largely
independent of whether C24–204 is localized at the PM.
SeV C protein inhibits IFN- activation induced by trans-
fected pppRNA. A general property of nonsegmented nega-
tive-strand RNA viruses is that short, promoter-proximal
pppRNAs (leader and trailer RNAs) are transcribed from
their replication promoters, especially when unassembled N
protein is limiting (17, 18). The ability of SeV infections to
induce IFN is essentially due to the presence of DI genomes
that are present in their egg-grown stocks, especially those of
the copyback variety (30). As mentioned above, copyback DI
genomes have a strong replicative advantage because they con-
tain strong replication promoters at the DI genome and anti-
genome 3 ends. Copyback DI genome replication thus gener-
ates short trailer RNAs that are unmodified at either end and
can be considered as unstable, abortive replication products
(see Discussion).
To examine whether trailer RNAs act as pathogen-associ-
ated molecular patterns (PAMPs), we transfected trailer RNA
made by T7 RNA polymerase in vitro into our MEFs and
monitored the activation of IFN-. As the ability of pppRNAs
to induce IFN- activation is not sequence dependent (11), we
also examined model RNAs that were initiated with GTP but
then treated with phosphatase or those initiated with the dinu-
cleotide GpC rather than pppG (23). The transfections of all
FIG. 4. SeV C24–204 (or Y1) protein inhibits IFN- activation induced by DI-H4 infection. Parallel cultures of MEFs were transfected with
pIFN-lucff, pTK-lucr, and plasmids expressing tomato constructs carrying either the wt (C1–23) or mutant (P8P9) C1–23 fused to their N termini,
with and without C24–204 (or Y1) fused to their carboxy termini, C24–204 fused to the carboxy terminus alone (Tom-C24–204), or unmodified Tom
as a negative control (ctrl.), as indicated. After 24 h, the cells were infected with SeV-DI-H4 (as indicated). Cytoplasmic extracts were prepared
after a further 24 h of incubation and used to determine luciferase levels. The relative levels of the various tomato constructs were determined by
Western blotting with anti-dsRED (bottom). All transfections were carried out in duplicate, and the range of values obtained is indicated by error
bars.
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FIG. 5. pppRNA-induced activation of IFN-. (A) Parallel cultures of MEFs were transfected with pIFN-luc
ff and pTK-lucr, and pRIG-I was
also transfected in some cultures, as indicated. After 24 h, the cells were transfected for 3 h with increasing amounts (1 or 3 g) of either
pppGGG/RNA1, phosphatase-treated GGG/RNA1, pppGCA/RNA1, or OHGCA/RNA1, as indicated. Cytoplasmic extracts were prepared 18 h
post-RNA transfection and used to determine luciferase levels. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and
plasmids expressing Tom, RIG-I(CARDs), IAV NS1(1–73), C1–23-Tom-C24–204 (C*), or V, as indicated. After 24 h, the cells were transfected with
increasing amounts (1 g and 3 g) of pppGGG/RNA1, as indicated. Cytoplasmic extracts were prepared after 3 h of RNA transfection and used
to determine luciferase levels. Rel., relative. (C) Same as above (B), except that the cells were transfected with 3 g of ppptrailer RNA.
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three 5-triphosphorylated ssRNAs clearly led to IFN- acti-
vation, whereas both RNAs that contained 5-hydroxyl ends
had essentially lost their ability to activate IFN- in parallel
transfections (Fig. 5A and C), confirming previously reported
results (11, 25, 26). We then examined the ability of the SeV C
and V proteins to inhibit 5-pppRNA-dependent activation of
IFN- compared to RIG-I(CARDs) and IAV NS1(1–73).
MEFs were first transfected with plasmids expressing various
viral inhibitory proteins or an empty plasmid as a negative
control and then transfected with increasing amounts of
pppRNAs. IFN- activation was monitored after a further 18 h.
As shown in Fig. 5B, expression of the SeV C protein was as
active as RIG-I(CARDs) in inhibiting IFN- activation at all
amounts of pppRNAs transfected although not quite as active
as NS1(1–73). Expression of SeV V was again the least inhib-
itory; in fact, significant inhibition occurred only at the lowest
amount of pppRNA. Thus, short 5-triphosphorylated ssRNAs
such as trailer RNA are potent stimulators of IFN- when
transfected into our MEFs, and expression of the SeV C pro-
tein (but not the SeV V protein) can effectively inhibit this
stimulation (Fig. 5B and C).
Relative importance of C and V in inhibiting RIG-I-depen-
dent signaling to IFN-. Another way to investigate the rela-
tive importance of the C and V proteins in inhibiting RIG-I-
dependent signaling to IFN- is to compare the relative
abilities of SeV infections that cannot specifically express the C
or V proteins to affect pppRNA- or poly(I-C)-induced IFN-
activation. MEFs were therefore first infected with 20 PFU/ml
of either wt SeV, SeV-Vminus (containing a stop codon in the V
ORF just downstream of the mRNA editing site, which pro-
duces a W-like protein instead of V), or SeV-Cminus (contain-
ing three stop codons in the C ORF downstream of the Y2
initiation codon). The infected cells were then transfected (at
24 hpi) with pIFN--luc plus either pppRNA, poly(I-C), or no
RNA and then harvested after 18 h to determine reporter gene
activity. As shown in Fig. 6, these three SeVs replicate to
clearly different levels in our highly IFN-competent MEFs
(even though they replicate similarly in BSR T7, 293T, and
Vero cells), highlighting the essential functions that these ac-
cessory proteins play in countering the innate immune re-
sponse. Nevertheless, in the absence of transfected RNA, only
SeV-Cminus infection activates IFN- to any extent or increases
RIG-I levels; RIG-I is an IFN-stimulated gene, and its level
reflects that of the antiviral state (Fig. 6, bottom). Transfec-
tions of either pppRNA or poly(I-C) strongly activated the
reporter gene and increased RIG-I levels. Prior infection with
either SeV wt or SeV-Vminus reduced transfected RNA stim-
ulation of the reporter gene and prevented the increase in
RIG-I levels (Fig. 6). SeV-Vminus was only slightly less effective
than wt SeV in this respect. In sharp contrast, prior infection
with SeV-Cminus not only did not prevent the increase in RIG-I
levels but also acted synergistically with either pppRNA or
poly(I-C) transfection to increase reporter gene activity by
increasing the level of RIG-I. These results reinforce the view
FIG. 6. RNA-induced activation of IFN- in cells infected with SeV that cannot express either V or C. Parallel cultures of MEFs were either
mock infected or infected with 20 PFU/ml of wt SeV, SeV-Vminus, or SeV-Cminus, as indicated. After 24 h, the cells were transfected with luciferase
reporter plasmids and either pppGGG/RNA1, poly(I-C), or no RNA (untreated). Cytoplasmic extracts were prepared after 18 h of RNA
transfection, used to determine luciferase levels (above), and Western blotted to determine the levels of P, V, and C proteins as well as endogenous
RIG-I and actin as a loading control. rSeV, recombinant SeV.
VOL. 81, 2007 ACTIVATION OF IFN- PROMOTER BY SeV INFECTION 12235
 at Bibliotheque Faculte M
edecine G
eneve on Novem
ber 9, 2007 
jvi.asm.org
D
ow
nloaded from
 
that it is primarily the SeV C protein (and not V) that inhibits
pppRNA- and dsRNA-induced signaling to the IFN- pro-
moter via RIG-I during SeV infection.
DISCUSSION
SeV has been one of the most extensively used model viruses
to investigate IFN induction in infected cells. Most of this work
has used the commercially available Cantell strain of SeV,
whose ability to induce IFN, like that of other SeV strains, is
due to the presence of DI genomes in egg-grown stocks. Non-
defective SeVs that are plaque purified from these stocks,
including that of the Cantell strain, do not induce IFN unless
cellular RIG-I levels are artificially increased (21, 30). For
nondefective SeV infection, the expression of the C and V
proteins is apparently sufficient to prevent IFN- activation
under normal conditions. Measles virus infection, in con-
trast, can apparently induce IFN in the absence of DI ge-
nomes, and evidence that this induction is due to the syn-
thesis of leader pppRNAs has recently been provided (26).
Leader and trailer RNAs, which are unmodified at either
end, are unstable in infected cells unless they are encapsi-
dated with the N protein (presumably after their synthesis as
free RNAs) (2). Free leader and trailer RNAs are more
easily detected in VSV infections, which synthesize larger
amounts of viral RNAs over a shorter period of time. For
nondefective VSV infections, eight times as many trailer
RNAs/antigenome template are found as leader RNAs/ge-
nome template, consistent with the relative strengths of
their respective replication promoters. For VSV copyback
DI infections, there are 40 times as many trailer RNAs/
template (nondefective antigenome plus DI genome) as
leader RNAs/genome template, presumably reflecting the
increased strength of the copyback DI replication promot-
ers. The VSV polymerase clearly has a strong preference for
initiating RNA synthesis at the 3 ends of copyback DI
genomes over both ND genomes and antigenomes (17).
We previously noted that not all SeV stocks that contain DI
genomes strongly induce IFN; this ability appears to be re-
stricted to stocks containing relatively small copyback DI ge-
nomes (the smaller the DI genomes, the more moles of ends
are present for a given weight). The commercially available
Cantell strain contains a copyback DI genome of only 546
nucleotides in length, the smallest SeV DI genome described
to date (30). SeV copyback DI-H4 genomes (1,410 nucleo-
tides) have the same strong replicative advantage as their VSV
counterparts because they also contain strong replication pro-
moters at both their genome and antigenome 3 ends. Thus,
SeV copyback DI infections presumably synthesize consider-
ably more pppRNAs than standard virus infections. We also
previously noted that when cytoplasmic extracts of DI-H4-
infected cells are centrifuged on CsCl density gradients, small
amounts of DI genome RNA are found in the pellet fraction
(30). This indicates that this RNA is not encapsidated with the
N protein and therefore forms dsRNA panhandles in a con-
centration-independent manner. Thus, copyback DI-H4 infec-
tions apparently produce considerably more of both known
PAMPs of RNA virus infection than do standard virus infec-
tions. Coupled with their strongly reduced accumulation of the
viral C and V proteins, it is easy to see why these copyback DI
infections are such potent inducers of IFN-.
All paramyxoviruses express either C or V proteins, and
many viruses express both. In viruses that express only C or V,
we presume that either viral protein alone counteracts the
innate immune response of the host to aid virus replication.
The C and V proteins, which bear no sequence similarity, likely
target different key elements of the host response. Viruses that
express both C and V presumably have more diverse ways of
countering innate immunity. In support of this notion, SeV
infections that cannot specifically express either the C or V
protein contain increased levels of IFN- and interleukin-8
mRNAs relative to wt SeV infections (31), and the indepen-
dent expression of the C or V protein will inhibit poly(I-C)- or
Newcastle disease virus-dependent activation of IRF-3 (15).
Previous work has identified mda-5 as being a key target of
paramyxovirus V proteins in countering the innate immune
response (1). This paper provides evidence that for SeV infec-
tion of MEFs, it is the C protein (and not V) that is primarily
responsible for this effect and that C acts by countering RIG-
I-dependent signaling to IFN-. For example, the independent
expression of either C or V inhibited IFN- activation due to
RIG-I overexpression (Fig. 2B). Also, both proteins inhibited
IFN- activation due to DI-H4 infection, although C was al-
ways more effective here than V (Fig. 3). However, only C
expression effectively inhibited IFN- activation due to
GFP(/) infection (Fig. 3) or transfected poly(I-C) or pp-
pRNAs (Fig. 5). Perhaps the strongest indication that the C
proteins are primarily responsible for countering the innate
immune response comes from experiments with SeV that can-
not specifically express the C or V proteins. SeV-Cminus infec-
tion not only cannot prevent the effects of transfected
poly(I-C) or pppRNAs on IFN- activation but also synergis-
tically enhances these effects. SeV-Vminus infection, in contrast,
behaves mostly like wt SeV infection and counteracts the ef-
fects of transfected poly(I-C) or pppRNAs (Fig. 6).
Finally, we note that poly(I-C) (made with polynucleotide
phosphorylase that generates 5 diphosphate ends and which is
transfected into cells) and the presumed GFP dsRNA (that is
directly generated in the cytoplasm via the viral transcriptase
and which contains capped 5 ends) both activate IFN- via
RIG-I in MEFs. Thus, the ability of dsRNA to induce RIG-I
signaling does not depend on the manner in which it is intro-
duced into this cell compartment, nor is it peculiar to the
presence of 5-diphosphorylated ends that are not normally
found in cells and could theoretically act as PAMPs. Moreover,
in either case, the activation of IFN- by these dsRNAs is
inhibited by the SeV C protein and not V, presumably because
this signaling passes through RIG-I and not mda-5. It appears
that our MEFs contain insufficient amounts of mda-5 to sense
SeV infection, as these MEFs respond well to the expression of
plasmid-derived mda-5 (Fig. 2B). This conclusion is also con-
sistent with our finding that three different rubulavirus V pro-
teins that are known to counteract poly(I-C)-induced mda-5
signaling were unable to inhibit IFN- activation in response to
SeV-DI-H4 infection (data not shown). We expect that the
SeV V protein will be more important in countering the innate
immune response in other cells in which mda-5 functions as a
PAMP recognition receptor.
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Additional Data 
The implication of SeV nucleocapsid in the induction of the IFN-β 
The success of the innate cellular defense to viral infection is dependent on the capacity of the 
host to detect the presence of the invading pathogen. Upon infection, many cellular sensors 
recognise different components of the virus and initiate in turn signal transduction cascades 
(such as IRF-3) producing in the end cytokines, including IFNs. The RNA helicase RIG-1 has 
been recently discovered to recognise viral RNA. RNA recognition leads to IRF-3 and NF-kB 
activation and finally to the induction of type I IFNs and the antiviral state of the cell. To 
circumvent the detection of their own RNA genome, the mononegalevirales possess the 
nucleocapsid (NCs) that surrounds completely the RNA viral genomes (and antigenomes). It 
is likely that their nucleocapsid never disassemble during genome expression. This protection 
seems to be quite strong considerating that the RNA genomes (within the nucleocapsid) are 
resistant to nuclease attack at any salt concentration and that the NC is very stable, as it 
withstands the high salt and gravity forces of cesium chloride density gradient centrifugation 
(Lamb and Kolakofsky, 1996). Further more, the N proteins are believed to be “sticky”, in the 
way that they are tightly bound to the viral RNA genomes and can also encapsidate free RNA 
independently of whether it comes from the virus or the cell. 
It has been shown in 2002 that MeV nucleocapsid (NC) protein was the major component of 
IRF-3 activation and triggered the induction of IFN (Tenoever et al., 2002). The ability to 
activate IRF-3 during the course of infection has also been observed in other single stranded, 
enveloped RNA viruses such as RSV, NDV, VSV and SeV (Casola et al., 2001; Servant et al., 
2001; Sundstrom et al., 2001). This suggests that the IRF-3 cascade could be involved in the 
viral NC detection. Since NCs are the first viral elements that enter the cell, it is logical to 
make the hypothesis that, like MeV, SeV NCs act as PAMPs and consequently induce 
IFNβ activation upon SeV infection. 
 
1)  SeV N protein expressed alone does not activate IFNβ. When N is expressed alone 
(in the absence of the viral P protein which forms a complex with N and prevent 
“illegitimate” non-specific binding to cellular RNA), it is often found in high number 
and aggregates together with non genome RNAs, which represent a bogus NCs. To 
analyze the direct effect of the SeV N protein alone, MEF cells were first transfected 
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with a plasmid containing a luciferase reporter gene under the control of the IFNβ 
promoter and 24h later with a plasmid expressing SeV N protein (Fig. A). We have 
examined the ability of the N protein to induce IFNβ activation after transfection and 
compared the level of IFNβ activation with those of the copyback DI-H4 infection that 
we used as a positive control. As shown in figure A, the expression of N protein alone 
does not induce IFNβ activation. By contrast, DI-H4 infection activates stongly the 
activation of the IFNβ in this experiment. These results show that under these 
conditions, SeV viral N protein does not induce IFNβ activation.  
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Figure A: Transfected SeV N proteins do not induce IFNβ activation. 
Parallel cultures of MEFs were first transfected with pIFNβ-lucff and pTK-lucr. After 24h, the cells were 
either infected with SeV-DI-H4, or transfected with plasmids expressing SeV N protein (pEBS_N). 
Cytoplasmic extracts were prepared after 20h of incubation, and used to determine firefly and renilla 
luciferase levels. 
 
2) Transfected encapsidated SeV (NCs) genomes induce IFNβ activation. To further 
investigate the role of the NCs, 24 hours SeV infected cells were collected and the 
NCs purified by CsCl centrifugation (cf. M&M). Two doses of purified SeV NCs (or 
PolyI/C) were transfected into MEF cells and tested for their ability to activate IFNβ 
by using the reporter plasmid in which the IFNβ promoter expresses a luciferase 
reporter gene. Surprisingly, we observed that transfected purified NCs induce strongly 
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IFNβ activation and that the transfection of 10μl of purified NCs (corresponding to 
250000 infected cells) is almost as efficient as a DI-H4 infection. Moreover, we can 
see that NCs transfection is more competent than the synthetic dsRNA (poly I/C) 
treatment in activating IFNβ. These results suggest that induction of IFNβ requires the 
presence of the NCs complex (fig. B). 
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Figure B: Transfected NCs induce IFNβ activation. 
Parallel cultures of MEFs were first transfected with pIFNβ-lucff and pTK-lucr. After 24h, the cells were 
either infected with SeV-DI-H4, or transfected either with poly I/C (5ug) or purified SeV NCs (5-10ul) 
isolated by CsCl density gradients centrifugation (cf.M&M). Cell extracts were prepared after further 20h 
of incubation, and equal amounts were used to determine luciferase activities.  
 
3) SeV C and V proteins expression decreases the IFNβ activation upon NCs 
transfection. Since SeV C and V proteins are responsible of counteracting the host 
innate immune response and because we have shown in paper three that IFNβ 
activation upon DI-H4 infection was in part due to a downregulation of the viral C and 
V proteins, we decided to over-express the V or C proteins in NCs-transfected MEF 
cells. We observed that IFNβ activation was strongly reduced by C expression (4 
folds), and more modestly by V expression (2 folds) (Fig C). Thus, the SeV V and C 
proteins inhibit IFNβ activation induced by NCs transfection.  
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Figure C: Over-expression of viral C and V proteins inhibits IFNβ activation induced by SeV NCs 
transfection. Parallel cultures of MEFs were transfected with pIFNβ-lucff and pTK-lucr and plasmids 
expressing the SeV V protein, or the SeV C protein. 24h post-transfection, the cells were transfected with 
purified SeV NCs (5ul). Cytoplasmic extracts were prepared after further 20h of incubation, and used to 
determine luciferase levels. 
 
4) NCs from either SeV or DI-H4 infections induce IFNβ at the same level. Because 
DI-H4 infection induces more strongly IFNβ activation compared to a ND SeV 
infection, we decided to compare NCs coming from both infections and their ability to 
induce IFNβ activation. Prior to transfection, the purified NCs were charged on a gel 
and stained with Commassie Blue in order to compare the amount of N proteins from 
each infection (SeV or DI-H4) (Fig D.). Because DI-H4 genome is 10 times smaller 
than the ND genome (and thus contains 10 times more moles of ends), we asked 
whether DI-H4 NCs could induce more IFNβ than a SeV NCs. Two different 
concentrations of NCs were transfected (for both types of infection) into MEF cells 
and IFNβ activation was monitored using the reporter plasmid carrying the IFNβ 
promoter expressing the luciferase gene (Fig D). We observed that the level of IFNβ 
activation is the same in both the SeV and the DI-H4 NCs transfections. These data 
suggest that the IFNβ activation is not dependent on the number of moles of genome. 
Furthermore, because the number of mole correlates with the number of 5’ 
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triphosphorylated extremities of the genome, we can suggest that the IFNβ activation 
upon NCs transfection is not dependent on the number of 5’ppp ends of each genome. 
To confirm this idea, we decided to remove the eventual triphosphates at the ends of 
the genomes by treating the purified NCs with phosphatase (CIP) (cf.M&M). The NCs 
were then transfected in MEF cells and the IFNβ activation was analyzed. 
Interestingly, transfected NCs previously treated with CIP had no effect on the level of 
IFNβ activation. This data suggest that 5’tri-phophorylated ends of the genomes 
presumably do not act as a viral inducer of the IFNβ upon NCs transfection (Fig. E).  
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Figure D: Transfections of purified NCs from SeV or DI-H4 infections induce IFNβ at the same level.  
Parallel cultures of MEFs were first transfected with pIFNβ-lucff and pTK-lucr. After 24h, the cells were 
transfected with the same amount of NCs (2.5-5ul) purified from either SeV or DI-H4 infections. 
Cytoplasmic extracts were prepared after 20h of incubation, and used to determine luciferase levels. The 
amount of viral N proteins after two CsCl gradient centrifugations was determined by SDS-PAGE and 
Coomassie-blue staining and is represented in the upper panel. 
 
5) RNase treatment shuts down the induction of IFNβ. In order to rule out the 
possible RNA contamination of our purified NCs, we decided to treat the viral NCs 
with the RNases T and A. After RNase treatment, the cells were transfected as usual 
and challenged for the IFNβ activation. Unexpectedly, we can observe no more IFNβ 
activation, suggesting that RNA products are presumably the ones responsible for the 
strong induction of IFNβ upon NCs transfection (Fig. E). 
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Figure E: Effect of transfected NCs on the IFNβ activation after CIP and RNase treatment 
Parallel cultures of MEFs were transfected with pIFNβ-lucff and pTK-lucr. 24h post-transfection, the cells 
were transfected with purified SeV NCs (5ul) or with SeV NCs that were previously treated with CIP or 
RNAse. Cytoplasmic extracts were prepared after further 20h of incubation, and used to determine 
luciferase levels. The amount of viral N proteins after two CsCl gradient centrifugations was determined 
by SDS-PAGE and Coomassie-blue staining and is represented in the upper panel. 
 
 
CONCLUSION 
We first wanted to determine whether viral NCs themselves could act as PAMPs. We found 
that bona fide NCs (as opposed to N protein aggregates that form upon N expression in the 
absence of viral infection) did indeed appear to activate IFNβ. This activation could be 
inhibited by the viral C and V proteins, and did not appear to be influenced by the number of 
5’ppp ends present in the preparation; and this for two reasons: first, the transfections of the 
NCs from both the ND and DI-H4 did not show any difference in the level of IFNβ activation 
and that phosphatase treatment had also no effect. Unexpectedly, we treated the NCs with 
RNase as a control for the phosphatase treatment, and found that the IFNβ activation was shut 
down. These results suggest that it is (cellular or viral) RNA trapped in the NCs that is 
responsible for the IFNβ activation and not the NC itself.  
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MATERIALS AND METHODS 
 
Cells and viruses 
Mouse embryo fibroblast cells (MEFs) were grown in Dulbecco's modified Eagle's medium 
supplemented with 10% fetal calf serum.  
SeV stocks were grown in the allantoic cavities of 9-days-old embryonated chicken eggs for 3 
days at 33 °C. For nondefective stocks (109 pfu/ml), 0.1 ml of a 105 dilution (ca. 1000 pfu) 
was inoculated per egg. In the case of DI stocks, 0.1 ml of a 103 dilution was used. In all 
cases, the amount of viral proteins present in the resulting allantoic fluid was analyzed by 
SDS-PAGE and Coomassie-blue staining of pelleted virus. Virus titers were determined by 
plaquing on LLC-MK2 cells. 
 
Plasmids, transient transfections, infections, luciferase assay  
EBS plasmids expressing viral proteins were constructed by standard methods (Bontron et al., 
1997); the precise detail can be obtained from the authors.  
pβ-IFN-fl-lucter, which contains the firefly luciferase gene under the control of the human 
IFNβ promoter, is described in (King and Goodbourn, 1994). pTK-rl-lucter, used as a 
transfection standard, contains the herpes simplex virus TK promoter region upstream of the 
renilla luciferase gene (Promega).  
For transfections, 100,000 cells were plated in six-well plates 20 h before transfection with 
1.5 μg of pβ-IFN-fl-lucter, 0.5 μg of pTK-rl-lucter,1.5 μg of plasmids (EBS) expressing N. At 
24 h post-transfection, the cells were (or not) infected with DI-H4 stocks or transfected with 5 
μg of poly-I/C or with 5-10ul of purified SeV or DI-H4 NCs. (cf. M&M Purification and 
analysis of nucleocapsid RNAs) using TransMessenger transfection reagent (QIAGEN).  
20hrs later, cells were harvested and assayed for firefly and renilla luciferase activity (dual-
luciferase reporter assay system; Promega). Relative expression levels were calculated by 
dividing the firefly luciferase values by those of renilla luciferase. 
 
Purification of nucleocapsid RNAs and RNase/phosphatase treatments 
Confluent MEFs in 10 cm  Petri dishes (107 cells) were infected with 20 pfu/cell of SeV Z or 
SeV-DI-H4. 24hpi, the cells were collected and lysed in 300 ul of NP40 lysis buffer. 
Cytoplasmic extracts were then centrifuged in a 20–40% (w/w) CsCl density gradient 
(16h/35,000 rpm/12°C) for purification. The bands containing the encapsidated RNAs 
resulting from replication (SeV Z or SeV-DI-H4 genomes) were extracted, pelleted in TNE 
 99
1X (45min/35000 rpm/4°C) and resuspended in 40ul TE 0.1% SDS, 10% glycerol. This step 
was repeated twice in the case of the infections.  
Encapsidated RNAs from the SeV infection were treated (or not) with 60U of calf intestine 
alkaline phosphatase (CIP) in a buffer (10X) containing 5M Tris-HCl, 1mM EDTA (Roche), 
or with 50U RNase T1 (Roche) and 1ug RNase A (Roche) for 30min at 37°C. CIP and 
RNAse treatments were performed between the two CsCl density gradients. 
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General Discussion 
The ability of the host cell to fight viral infection requires recognition of the invading viral 
pathogen as such and subsequent induction of signaling cascades that lead to the production 
of innate and adaptive antiviral responses. IFNβ plays a crucial role in priming neighbouring 
cells for possible infection and is also involved (with other IFN-stimulated genes) in 
recruiting cells of the host immune system to the site of infection, providing a way to 
eliminate infected cells. In the present study, we investigated the mechanisms used by the host 
cell to recognize SeV infection, and those used by SeV to counteract the cellular innate 
immune system.  
By using different SeV stocks carrying mutations either in the promoter region or in the C 
proteins, we demonstrated that the presence of the leader RNA transcript (or the 
overexpression of the trailer) as well as the expression of the viral C and V proteins have an 
important role in counteracting the IFNβ activation and the expression of the chemokine IL-8 
(c.f. Paper 1). As opposed to the V protein and the leader RNA, a number of investigations 
have been made on the SeV C protein. As mentioned in the first paper, this particular protein 
is in charge of many functions during infection: (i) it stimulates viral RNA synthesis early in 
infection (Latorre et al., 1998a); (ii) it inhibits viral RNA synthesis late in infection by binding 
to the viral polymerase (Cadd et al., 1996b); (iii) it has a role in the virus particle budding, 
which is facilitated by its binding to Alix, and in virion assembly, possibly by interaction with 
the matrix (M) protein (Mottet et al., 1996; Sakaguchi et al., 2005); (iv) The C protein 
interacts with Stat1 in two ways: counteracting IFN signaling and inducing Stat1 instability 
(Garcin et al., 2003). (v) Finally, the C protein inhibits the IRF-3-dependent activation of 
IFNβ as well as the activation of IL-8 expression (Strahle et al., 2003). These multiple 
functions of SeV C protein during infection fit well with its property to interact with various 
viral and cellular proteins, such as Stat1, Alix and Rig-I (unpublished). However, these 
interactions remain to be closely analyzed. Additionally, the reason why IL-8 expression has 
been only recently discovered could be explained by the fact that standard SeV induces very 
little IL-8. Indeed IL-8 is only expressed upon infection of SeV bearing mutations in the C 
and V proteins, and in the leader region. Moreover, it has been already reported that SeV and 
MeV infections induce an other CC-chemokine RANTES via the activation of IRF-3 (Genin 
et al., 2000; Tenoever et al., 2002). These data confirm the results suggesting that SeV targets 
the inflammatory and adaptive immune responses (IL-6 and IL-8) as well as the IFN-induced 
intracellular antiviral state (IFNβ and STAT1). 
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SeV is commonly used by many laboratories for its capacity to strongly induce IFN. This 
ability was long known to be associated with the presence of DI genomes in the SeV stock. 
The third paper provides evidence that the strong induction of IFNβ activation upon SeV 
infection (SeV stock containing DI genomes) is mainly due to the presence of copyback DI 
genomes. Moreover, the level of IFNβ activation was found to be proportional to that of DI 
genome replication. Apparently, the ability of DI-H4 to induce IFNβ is not only related to its 
strong interference with the helper, which leads to lower levels of V and C proteins 
intracellularly but also to the relative content of copyback DI genomes, which can presumably 
form dsRNA. (cf. paper 2). 
It is important to emphasize the difference between a standard SeV-WT infection from an 
infection of SeV that contains DI genomes. In the case of a SeV-WT infection, the RNA 
genomes and antigenomes are tightly assembled into NCs, meaning that they are never free to 
anneal (like other NNV). Furthermore, Weber et al. have shown recently that no detectable 
amounts of dsRNA produced by NNV have been found in infected cells (Weber et al., 2006). 
This result can be explained by the fact that the amount of dsRNA produced by NNV are 
below their detection limit, since one molecule of dsRNA per cell can be effective in 
triggering an antiviral response. If it is the case, we can imagine two different ways for SeV-
WT (devoided of DI genomes) to produce dsRNA: 1) During SeV replication, the polymerase 
ignores occasionally the stop signal at the end of the trailer template, which results in the 
extension of the trailer beyond the trailer/L gene junction. This event will produce a long 
trailer whose extended 3’sequences can anneal to those of the L gene (Vidal and Kolakofsky, 
1989). 2) dsRNA can also be the result of a readthrough by the transcriptase of the L gene-end 
site until the end of the genome (an event that can happen at 5% of the time at all gene 
junctions). In this case the genome 5’end can anneal to the trailer RNAs (Le et al., 2002). 
Finally, if we consider that there is a small amount of dsRNA that is generated in SeV 
infection, it is evident that the presence of dsRNA will be dampen by the SeV C and V 
proteins expressed during ND genome replication and that the expression of IFNβ will 
consequently be blocked. 
In the case of copyback DI infections, it is a different story. Because DI-H4 contains two 
antigenomic promoters located at both the genomes and antigenomes ends, it has strong 
replicative advantage over the standard virus. Consequently, a huge amount of DI genomes is 
rapidly generated and the level of viral proteins (including the level of the nucleocapsid 
protein) is also strongly attenuated. This rapid generation of DI genomes and the low level of 
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NC proteins could explain why the genomes and antigenomes may not assemble into 
nucleocapsids and would consequently form dsRNA. If DI-H4 genomes and antigenomes are 
not encapsidated during infection, two forms of dsRNA can be found (in addition to those 
mentioned for a SeV infection). First, the extremities of the DI genome (complementary on 
110 nucleotides) can self anneal in a concentration independent manner and form dsRNA, 
resulting in the shape of panhandles. Secondly, the genome and the antigenome can anneal 
together, which remains unlikely since this would require the melting of intramolecular 
secondary structure.  
Recent evidence suggests that NNV infections could activate the innate immune 
response by producing viral signatures other than dsRNA, namely 5’tri-phosphorylated 
single-stranded RNA transcripts (5’pppRNAs). This discovery suggests that dsRNA may not 
always be implicated in the IFNβ induction upon viral infection and that there is probably 
more than one factor able to induce this primary cellular induction. Two cytoplasmic 
helicases, namely RIG-I and Mda-5, have been recently found to respond to dsRNA and, at 
least for RIG-I, to 5’pppRNAs. These RNAs are generated in the cytoplasm during RNA 
virus replication. Upon detection of specific viral RNAs RIG-I and Mda-5 interact with Cardif 
which is present in the mitochondrial membrane, and this interaction is thought to lead to the 
recruitment and activation of the TBK1, IKKε and other IKK kinases that activate NF-kB and 
IRF3, thereby activating the IFNβ promoter. 
In the third paper, we investigated different potential inducers of IFNβ, including the 
synthetic dsRNA (polyI/C) and 5’pppRNAs and the involvement of RIG-I in these inductions. 
We showed evidences that i) transfection of poly-I/C and ii) a SeV coinfection that can 
produce GFP dsRNA, as well as iii) transfections of small 5’pppRNAs can all induce IFNβ. 
In all cases, the IFNβ induction was dependent on RIG-I. Not all 5’pppRNAs generated by 
SeV can act as PAMPs: 1) SeV mRNAs carry 5’ ppp ends, but because they are capped, these 
mRNAs cannot be potential targets. 2) SeV genomes and antigenomes also carry 
triphosphorylated 5’ends, but because the RNA is tightly and entirely encapsidated, it cannot 
be seen. 3) Finally, leader and trailer RNA transcript are the most susceptible to induce IFNβ, 
because they are short unencapsidated 5’pppRNAs that are independent on on-going (N) 
protein synthesis. For this reason, we suspect that, in the case of DI-H4 infection, there is a 
real overproduction of pppRNAs (trailer) resulting in the induction of the IFNβ activation. 
Alternatively, other viral structures may take the role of RNA as a danger signal for the host 
cell. Indeed, it was previously shown that the NCs from VSV and MeV are capable of 
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triggering IFN induction. It was interesting to observe in our experiments that NCs purified 
from SeV infection could strongly induce IFNβ. However, RNase treatment revealed that it 
was probably not the NCs that were responsible for this activation, but more likely RNA 
products that have contaminated the CsCl banded NCs. Because the NC is the first viral 
element that enters the cell, one can imagine that viruses have evolved to avoid its detection. 
Thus, it is reasonable to think that NCs do not act as PAMPs. Concerning MeV, it was shown 
recently that the NCs were not responsible for the IFNβ activation after all and that it was the 
leader transcript of MeV that was responsible for the activation of IFNβ via the RIG-I 
pathway (Helin et al., 2001; Plumet et al., 2007). This again comforts the idea that SeV leader 
and trailer RNAs are more likely to be the main PAMPs responsible for triggering the 
antiviral responses upon SeV infection. 
Regarding the C and V proteins, we presented evidence that for SeV infection of 
MEFs, it is the C protein (and not V) that is primarily responsible for this effect, and that C 
acts by countering RIG-I dependent signaling to IFNβ. For example, independent expression 
of either the C or the V proteins inhibited IFNβ activation due to RIG-I over-expression. In 
addition to this, both proteins inhibited IFNβ activation due to DI-H4 infection, although C 
was always more effective than V (in our experiments). However, only C expression 
effectively inhibited IFNβ activation due to GFP(+/-) infection, or transfected poly-I/C or 
pppRNAs (cf paper 3).  
These new findings, suggesting that the 5’pppRNA is a PAMP specific to the NNV 
infections, lead us to reconsider the way the cell could detect the presence of viruses. 
However, no proof has been found concerning the role of 5’pppRNA products in the 
activation of IFNβ in SeV infection. Further analyses of the precise RNAs involved in the 
IFNβ activation need to be done. Additionally, more investigations are necessary to determine 
how these PAMPs are detected and the mechanisms that drive cellular responses. Finally, 
learning more about the protein targets of SeV proteins also appear important in order to 
understand the details of the IFN suppressive activities of SeV and virus infection in general. 
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We have used cDNA arrays to compare the activation of various cellular genes in response to infection with
Sendai viruses (SeV) that contain specific mutations. Three groups of cellular genes activated by mutant SeV
infection, but not by wild-type SeV, were identified in this way. While some of these genes are well known inter-
feron (IFN)-stimulated genes, others, such as those for interleukin-6 (IL-6) and IL-8, are not directly induced
by IFN. The gene for beta IFN (IFN-), which is critical for initiating an antiviral response, was also specifi-
cally activated in mutant SeV infections. The SeV-induced activation of IFN- was found to depend on IFN reg-
ulatory factor 3, and the activation of all three cellular genes was independent of IFN signaling. Mutations that
disrupt four distinct elements in the SeV genome (the leader RNA, two regions of the C protein, and the V
protein) all lead to enhanced levels of IFN- mRNA, and at least three of these viral genes also appear to be
involved in preventing activation of IL-8. Our results suggest that SeV targets the inflammatory and adaptive
immune responses as well as the IFN-induced intracellular antiviral state by using a multifaceted approach.
Alpha/beta interferons (IFN-/) are cytokines that act in a
pleiotropic manner to limit viral replication and spread (2, 57).
In fibroblasts (e.g., the bronchial epithelial target of many
paramyxoviruses), the product of the single IFN- gene is
directly induced by viral infection, and IFN- feeds back onto
cells in an autocrine manner to induce multiple IFN- genes
and in a paracrine manner to prime neighboring cells for their
possible infection (60). Since most viruses induce IFN- to
some extent, intracellular double-stranded RNA (dsRNA)
generated from the viral genome is traditionally assumed to be
the common signature of virus replication that sets the IFN
system in motion (22, 32). dsRNA is thought to induce the
formation of an enhanceosome at the IFN- promoter that
includes IFN regulatory factor 3 (IRF-3) and NF-B (among
other transcription factors) (65). IFNs induce a cellular state
that is nonconducive for viral replication by signaling through
their cell surface receptor, leading to the phosphorylation of
cytoplasmic STAT proteins and their nuclear translocation.
IFN-/ responses are regulated primarily via IFN-stimulated
gene (ISG) factor 3, a heterotrimeric transcription factor com-
posed of STAT1, STAT2, and IRF-9 (p48). ISG factor 3 binds
to a DNA element (IFN-stimulated response element) in the
promoters of ISGs and activates their expression (7).
The extravasation of neutrophils, eosinophils, basophils, and
mononuclear cells is the salient feature of the innate response
to microorganisms in the lung. Localized and systemic pro- and
anti-inflammatory cytokines thus also play an important role in
the outcome of viral infection and pathogenicity of this organ
(58). The CC chemokine interleukin-8 (IL-8) is secreted from
epithelial surfaces in a polar fashion during infection with
pathogenic bacteria such as Salmonella enterica serovar Typhi-
murium and sets up a subepithelial chemotactic gradient di-
recting neutrophils and other immune cells to the site of in-
fection (27). In polarized epithelial monolayers, S. enterica
serovar Typhimurium-induced IL-8 expression is controlled via
the activation of the mitogen-activated protein kinase cascade
and IB kinase, followed by NF-B translocation to the nu-
cleus and production of IL-8 mRNA. IL-8 secretion by primary
human monocytes in response to dengue virus infection is also
tightly linked to NF-B activation (3). Sendai virus (SeV) in-
fection of human embryonic kidney 293 cells induces the
expression of the CXC chemokine RANTES in an IRF-3-
and NF-B-dependent manner (23, 41). NF-B, like IRF-3,
is found in the cytoplasm of unstimulated cells, retained in a
complex with the inhibitory IB proteins. Upon stimulation
with many inducers, including dsRNA and virus infection, IB
is rapidly phosphorylated and degraded, resulting in NF-B
release and translocation to the nucleus (30, 33).
Given the importance of the host innate immune response to
virus infection, viruses have, during their coevolution with
cells, developed strategies to regulate cytokine synthesis and
action. SeV, a model paramyxovirus and respiratory pathogen
of mice, is known to use its C protein to evade the host inter-
feron response by at least two mechanisms. (i) C binds STAT1,
preventing its activation in response to IFN, and the carboxyl
part of the C protein (i.e., residues 24 to 204, or the Y proteins)
is sufficient for this activity. A phenylalanine at position 170 of
C is also critical for blocking STAT1 activation (18, 59). (ii) C
also targets STAT1 for degradation, and the amino-terminal
residues of the C proteins (residues 1 to 23, which are absent
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in the Y proteins) are essential for this activity (reference 17
and references therein).
This paper reports that SeVs carrying specific mutations in
the C gene, in contrast to wild-type SeV (SeV-wt), activate
IL-8 and IFN- expression as well as that of several ISGs. Our
results suggest that the products of virtually all of the viral
accessory genes (C and V proteins and leader RNA) act to
prevent the expression of these cellular genes that are central
to the overall host antiviral response.
MATERIALS AND METHODS
Cells and viruses. 2C4 cells (39), 2fTGH cells (48), and their derived cell lines
U3A (45) and U5A and U5AIFNAR (43) were obtained from IM Kerr (Im-
perial Cancer Research Fund, London, United Kingdom) and grown in Dulbec-
co’s modified Eagle’s medium supplemented with 10% fetal bovine serum in the
presence of the relevant maintenance drug (hygromycin at 250 g/ml or G418 at
400 g/ml). The generation of recombinant SeV (rSeV) expressing alternate C
and V (and P) proteins is described elsewhere (8, 19, 37, 38). All SeV stocks were
grown in the allantoic cavities of 10-day-old embryonated chicken eggs. Virus
present in the allantoic fluid was analyzed by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis and Coomassie blue staining after virus pel-
leting. Virus titers were determined by plaquing on LLC-MK2 cells.
Virus infections. Cells were infected at a multiplicity of infection of 20 in
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum. After
an absorption period of 1 to 2 h, the inoculum was removed and replaced with
fresh medium.
Plasmids, transient transfections, and luciferase assay. IRF-3 (54), IRF-3N
(41), and IRF-3-ribozyme (67) were obtained from John Hiscott and Paula Pitha.
pDsRed2, expressing red fluorescent protein (RFP), was from Clontech. The
reporter plasmid with the firefly luciferase gene under the control of the human
IFN- promoter was described by King and Goodbourn (35) and is referred to
here as p-IFN-fl-lucter. pTK-rl-lucter, used as a transfection standard, contains
the herpes simplex virus thymidine kinase promoter region upstream of the
Renilla luciferase gene (Promega). For transfections, 100,000 cells were plated in
six-well plates 20 h before transfection with 1 g of p-IFN-fl-lucter, 0.3 g of
pTK-rl-lucter, 1 g of IRF-3-expressing plasmid, and 6.9 l of Fugene (Roche)
according to the manufacturer’s instructions. At 24 h posttransfection, the cells
were (or were not) infected with SeV recombinants or treated with 50 g of
poly(I)-poly(C) (Sigma, St. Louis, Mo.) per ml. Twenty hours later, cells were
harvested and assayed for firefly and Renilla luciferase activities (dual-luciferase
reporter assay system; Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of Renilla luciferase.
RNA extraction and quantification. Total RNA was extracted with Trizol
reagent (Invitrogen), and two dilutions were electrophoresed on agarose-HCHO
gels. The gels were stained with ethidium bromide, and the intensities of the 18S
and 28S rRNA bands were quantified by using the ChemiDoc System (Bio-Rad)
and One-D-scan software. All samples were diluted to a final concentration of
1 g/l so that their subsequent transcription into DNA, if not quantitative,
would be little influenced by this parameter.
RT and real-time PCR via TaqMan. Ten microliters of total RNA was mixed
with 0.5 g of random hexamer primer (Promega) and subjected to a reverse
transcription (RT) reaction with Superscript enzyme (Gibco), as described by the
manufacturer, in a total volume of 50 l. Two microliters of each cDNA was then
combined with 1 l of internal control (either 20 ribosomal 18S or human
glyceraldehyde-3-phosphate dehydrogenase [GAPDH] [Applied Biosystems]),
11 l of MasterMix (Eurogentec), 20 pmol (each) of forward and reverse prim-
ers, and 4.4 pmol of TaqMan probe in a total volume of 22 l. The following
primers and probes (Eurogentec or Microsynth) were used: for the IFN- gene,
5-CAGCAATTTTCAGTGTCAGAAGCT-5 (forward), 5-TCATCCTGTCCT
TGAGGCAGT-3 (reverse), and 5-CTGTGGCAATTGAATGGGAGGCTTG
A-3 (probe); for the IL-8 gene, 5-CGGTGGCTCTCTTGGCAG-3 (forward),
5-TTAGCACTCCTTGGCAAAACT-3 (reverse), and 5-CTTCCTGATTTCT
GCAGCTCTGTGTGAAGGT-3 (probe); for the IL-6 gene, 5-TCCAGGAG
CCCAGCTATGAA-3 (forward), 5-CCCAGGGAGAAGGCAACTG-3 (re-
verse), and 5-TCCTTCTCCACAAGCGCCTTCGG-3 (probe); for the 6-16
gene, 5-CCTGCTGCTCTTCACTTGCA-3 (forward), 5-AGCCGCTGTCCG
AGCTC-3 (reverse), and 5-TGGAGGCAGGTAAGAAAAAGTGCTGCTCG
G-3 (probe); for the N gene of SeVZ, 5-GCAATAACGGTGTCGATCACG-3
(forward), 5-GATCCTAGATTCCTCCTACCCCA-3 (reverse), and 5-CGA
AGATGACGATACCGCAGCAGTAGC-3 (probe); and for the N gene of
SeVM, 5-CGAAGAGGATGATGCCGC-3 (forward), 5-GGGTCATGTAT
CCTAAATCCTCGT-3 (reverse), and 5-CAGCAGCTGGGATGGGAGGAA
T-3 (probe). Real-time PCR was carried out in a 7700 sequence detector
(Applied Biosystems, Foster City, Calif.).
Generation of customized cDNA arrays. Macroarrays were prepared as de-
scribed previously (55). 5 IMAGE clones 0.5 to 0.8 kb in length were chosen and
obtained from the Human Genome Mapping Project (Hinxton, United King-
dom), plated onto L agar plates and grown overnight at 37°C. Single colonies
were picked and propagated overnight in Luria-Bertani medium containing 50
g of ampicillin per ml. Bacterial lysates were generated by 1:10 dilution in
distilled water. From these lysates, inserts were amplified by PCR as described
above. After purification (QIAquick PCR purification kit; Qiagen, Crawley,
United Kingdom), PCR products were sequenced (ABI Prism; Applied Biosys-
tems). PCR-amplified cDNAs were transferred into 96-well plates and spotted
manually onto dry nylon membranes (Hybond N; Amersham Pharmacia, Little
Chalfont, United Kingdom) in triplicates by using 96-pin replicators (Nalge
Nunc, Naperville, Ill.; V&P Scientific, San Diego, Calif.). Membranes were air
dried, denatured by alkaline treatment, and then neutralized. The membranes
were again air dried and UV cross-linked prior to the experiment.
Generation of labeled cDNA, hybridization, washing of membranes and anal-
ysis. Radiolabeled cDNA was generated from 10 g of total RNA by RT with
400 U of reverse transcriptase (Superscript II; Gibco) in the presence of 30 Ci
of [-33P]dCTP. After RT, residual RNA was hydrolyzed by alkaline treatment
at 70°C for 20 min. For removal of unincorporated nucleotides, the cDNA was
purified by using G-50 columns (Amersham Pharmacia) according to the instruc-
tions of the manufacturer. Before hybridization to the arrays, the labeled cDNA
was mixed with 50 g of COT-DNA (Gibco) and 10 g of poly(A) DNA (Sigma),
denatured at 95°C for 5 min, and hybridized for 1 h to minimize nonspecific
binding. The cDNA was then added directly to the membranes, which had been
prehybridized in 20 ml of hybridization buffer for at least 30 min. The membranes
were hybridized for 16 h at 65°C in hybridization bottles (Amersham Pharmacia)
in a rotary hybridization oven. After hybridization, the hybridization buffer was
discarded and replaced by 150 ml of washing buffer. The membranes were
washed once in 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–
0.1% SDS, twice in 0.2 SSC–0.1% SDS, and once in 0.1 SSC–0.1% SDS for
20 min each at 65°C. The membranes were then exposed to phoshorimage
screens for 48 h and scanned with a phosphorimager (Storm; Molecular Dynam-
ics, Little Chalfont, United Kingdom). For analysis, images were analyzed with
ImageQuant (Molecular Dynamics). Further data analysis was performed with
Excel (Microsoft).
IL-8 assay. Levels of IL-8 in supernatants and in cell lysates were determined
by a sandwich enzyme-linked immunosorbent assay with paired monoclonal
antibodies (Pierce) as described by the manufacturer. The IL-8 concentrations
were normalized by using total protein levels in the lysate.
RESULTS
In our experiments we have used two strains (or lineages) of
SeV whose history is relevant to studies of virulence. The
natural host of SeV has not been clearly identified, and this
virus is sometimes referred to as murine parainfluenza virus
type I because it efficiently infects mice, causes disease, and
spreads readily to uninfected animals. However, there is no
virologic or serologic evidence of SeV in wild mouse popula-
tions (29). There are two known lineages of SeV, Z/H/Fushimi
and Ohita M/Hamanatsu (12, 31, 53, 62). The nucleotide se-
quences within each lineage are 99% identical, and they are
89% identical between lineages. Z/H/Fushimi comes from vi-
ruses isolated in the early 1950s after an epidemic of pneumo-
nitis of newborn infants in Sendai, Japan (29, 56). These SeVs
have been passaged extensively in eggs in various labs since the
1950s, and they are moderately virulent for mice (50% lethal
dose [LD50] 	 10
3 to 104 PFU). All of the SeVZ strains used
in this study (including the wt) are recombinants.
Ohita M (SeVM) and Hamanatsu, in contrast, are highly
virulent (LD50, 
10
2), low-egg-passage (nonrecombinant) vi-
ruses isolated from two completely separate, very severe epi-
demics of animal houses in Japan. This lineage is presumably
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closer to the virus in its natural (unknown) host, and it is known
that SeV passage in eggs attenuates its virulence in mice. SeVM
grew poorly in cell culture, and a clear-plaque variant emerged
that was avirulent (LD50, 10
5) and contained only two amino
acid substitutions, CF170S and LE2050A (31). When placed in the
rSeVZ background, the CF170S mutation was found to account
for most or all of the loss of virulence (15). This virus is
referred to here as SeVM-CF170S. SeVM-CF170S appeared to
initiate the infection of mice normally, but the infection was
limited to the first day. This was the first evidence that the C
gene, like the SeV V gene (34), was involved in countering host
innate defenses. Although SeVZ-wt is attenuated relative to
SeVM-wt in laboratory mice, rSeVZ-wt still replicates as effi-
ciently in the monkey and chimpanzee models of human re-
spiratory disease as human parainfluenza virus type 1 (56), the
virus which is most closely related to SeV and which is endemic
in children.
We have used a cDNA array designed to study the human
cell response to IFN-/ (55) to monitor the effects of various
SeV infections on host mRNA levels. Around 150 genes of
interest were selected from the UniGene database. These
genes comprise known ISGs and genes of intrinsic interest
which might or might not be induced by IFNs in different cell
systems. They include genes involved in cell proliferation, im-
mune responses, and the responses to a variety of cytokines
(see Table 1 of reference 55). We compared matched sets of
SeV carrying two different mutations in the C gene (SeVM-
CF170S and SeVZ-C10-15), whose products interact with
STAT1 in different ways (to interfere with IFN signaling and to
induce STAT1 instability, respectively) (Fig. 1D). We also used
matched sets of SeV carrying mutations in the viral replication
promoters (SeVZ-GP1-42 and -GP31-42) that prevent apopto-
sis and lead to persistent infections (the numbers refer to the
nucleotides of the genomic promoter that have been replaced
with the equivalent sequences of the antigenomic promoter)
(16, 20). Promoter mutations are thought to act via mutant
leader RNAs that are abundantly transcribed from the geno-
mic replication promoter and which bind to cellular RNA-
binding proteins that regulate mRNA fate (28).
Upon infection with SeVM-wt or SeVZ-wt, many of these
mRNA levels remain unchanged (Fig. 1A to C). This lack of
response is presumably due in part to active SeV countermea-
sures that neutralize the cell’s antiviral response (24). Upon
infection with the mutant viruses, the mRNA levels of 15 of the
150 genes examined were elevated, and three patterns of gene
activation were seen (all values are triplicates, and a twofold
difference is very significant [55]). One series of genes (group
1, nine genes) (Fig. 1A) is activated by SeV-CF170S infection
alone; these mRNA levels are unchanged in SeV-C10-15 and
SeV-GP1/31-42 infections. The CF170S substitution inactivates
the ability of all four C proteins (C, C, Y1, and Y2) to stably
bind STAT1 and to interdict IFN signaling (18, 59). According
to this view, any of the four C proteins may function to prevent
these mRNA levels from increasing during SeV infection (Fig.
1D) (14). The IL-6 gene is the sole representative of group 2;
it is activated by SeV-C10-15 as well as SeV-CF170S, but not
by the promoter mutants or the wt viruses (Fig. 1B). According
to this view, a second function of the C gene, specific to the
NH2-terminal 23 amino acids present only in the longer C
proteins, is also required for SeV to prevent IL-6 activation.
The third group, consisting of five genes, is activated by SeV-
C10-15 and SeV-GP1-42 infections as well as SeV-CF170S, but
not by SeV-GP31-42 or SeV-wt infections (Fig. 1C). Appar-
ently, a third function provided specifically by the first 30 nu-
cleotides (nt) of the genomic promoter (or leader RNA) is also
required to prevent activation of genes such as that of IL-8
(Fig. 1C). This third function is not the ability of mutant leader
RNA to bind TIAR, a host RNA-binding protein important for
virus-induced apoptosis, as this occurs with SeV-GP31-42 as
well (28). In summary, comparative analysis of host gene acti-
vation with SeV with specific mutations has identified three
groups of cellular genes that respond differently to SeV infec-
tion.
Real-time RT-PCR estimations of mRNA levels. IFN signal-
ing through the JAK/STAT pathway activates many ISGs (such
as 6-16, PKR, etc.) that collectively contribute to the cellular
antiviral response. SeVs that interdict IFN signaling would
therefore also prevent the activation of these ISGs. While
many of the genes activated by the mutant SeVs are well
known ISGs, IL-6 and IL-8 are known to be non-ISGs; treat-
ment of 2fTGH cells with 1,000 IU of IFN- does not increase
IL-6 or IL-8 mRNA levels over those of the untreated control
(55). We therefore continued our study of selected host genes
activated by SeV by real-time RT-PCR (TaqMan), a method
that is more quantitative than DNA arrays. We first examined
IL-8 (a chemokine) and IFN-, an early host response protein
whose gene was absent in the DNA array. 2C4 cells (a 2fTGH-
derived cell line) were infected with 20 PFU of the various
SeVs per cell, and the levels of various host mRNAs were
determined, including that of GADPH as an internal control
(see Materials and Methods). All four SeVs (SeVM-wt, CF170S,
SeVZ-wt, and C10-15) grow relatively well in 2C4 cells, as
indicated by their accumulated N mRNAs (Fig. 2 and 3) or N
proteins (data not shown); however, the SeVM-wt infections
accumulated ca. 2-fold less N mRNA than the three other SeV
infections (Fig. 2C). The relative levels of virus replication are
presumably important in stimulating the host response, and
SeVM-wt infections might therefore be expected to activate
IL-8 and IFN- less strongly than the other SeVs for this
reason alone. We found that IL-8 and IFN- mRNA levels
were elevated 20-fold in SeVM-CF170S versus SeVM-C-wt
infections. A strong difference was also found between SeVZ-
C10-15 and SeVZ-C-wt infections, where N mRNAs had ac-
cumulated identically (Fig. 2). Moreover, IL-8 and IFN-
mRNA levels were also elevated in other SeVM-CF170S versus
SeVM-C-wt infections of 2C4 cells, where N mRNAs had ac-
cumulated identically (Fig. 3). Thus, specific mutations in two
different regions of the SeV C proteins lead to increased acti-
vation of IL-8 and IFN-. In all cases, IL-8 and IFN- mRNA
levels were more strongly increased by SeVM-CF170S than by
SeVZ-C10-15.
We also examined the effects of various SeV infections of
cells transfected with plasmids expressing IRF-3 (or RFP as a
neutral control), and in some cases the cells were also treated
with 50 g of poly(I)-poly(C) (dsRNA) per ml. Elevated IRF-3
levels should enhance the antiviral response of the cells to SeV
infection, and the combined treatment is thought to approxi-
mate a virus infection in itself and should potentiate the anti-
viral response. This appears to be so, as the levels of IL-6, IL-8,
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FIG. 1. Comparison of host mRNA levels in 2fTGH cells infected with various SeVs. (A to C) Parallel cultures of 2fTGH cells were infected
with 20 PFU of the various SeVs per cell. Total cytoplasmic RNA was prepared with Trizol at 24 hpi, and equal amounts (10 g) were used as
a template for oligo(dT)-primed [33P]cDNA synthesis. The [33P]cDNA was annealed to triplicate DNAs arrayed on nylon membranes, and the
[33P]cDNA bound was quantitated in a PhosphorImager. The graphs show the fold increase in each mRNA relative to the mock control. (D)
Schematic representation of the viral mutations and their effects on host gene activation. The C proteins are shown as two telescoping boxes
representing the longer (C and C) and shorter (Y1 and Y2) C proteins, whose activities during infection, and the mutations investigated, are
indicated. The promoter mutation GP42 is thought to exert its effect via mutant leader (Le) RNA. The presumed requirement for the various wt
genetic elements to prevent host gene activation is shown. The names of the mutant SeVs used are also indicated. Instab., instability; sig., signaling.
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and IFN- mRNAs induced by SeV infection in general in-
creased with increasing proresponse treatment (i.e., RFP,
IRF-3, and IRF-3 plus dsRNA) (Fig. 3). IRF-3 overexpression
(Fig. 3A to C, IRF-3 versus RFP) enhanced IFN- and IL-6
activation by SeV but did not enhance that of IL-8. The addi-
tional dsRNA treatment had little effect on further enhancing
IFN- and IL-6 mRNA levels but strongly enhanced IL-8
mRNA levels. These differences in the enhancement of IL-6
and -8 and IFN- activation upon treatment with IRF-3 with or
without dsRNA presumably reflect different activation path-
ways in response to SeV infection. It is possible that IL-8
activation requires both IRF-3 and dsRNA, whereas IRF-3 is
sufficient for IL-6 and IFN- activation.
SeV activation of IL-6, IL-8, and IFN- is independent of
IFN signaling. 2fTGH human fibrosarcoma cells were chosen
for these experiments because sublines defective in specific
components of the IFN signaling system have been generated
from these cells by X irradiation (48). U5A cells, for example,
are defective in the IFN-/ receptor 2 chain, which is essential
for IFN-/ signaling, and these cells have been restored to
IFN sensitivity by complementation with the IFNAR2 gene
(U5AIFNAR2 cells) (43). Even though IL-6 and -8 are not
activated upon simple IFN treatment of uninfected cells, IFN
secreted during SeV infection may act differently, as additional
signaling pathways are being induced by the virus infection.
Moreover, CF170S (in contrast to C10-15) does not prevent
IFN signaling, and it is important to know whether this phe-
notype is responsible for the activation of IL-6 and -8. We
therefore examined the various SeV infections of U5A as well
U5AIFNAR2 cells to determine whether activation of IL-6
and IFN- by SeV-CF170S and SeV-C10-15 required IFN
signaling. We also examined the activation of the 6-16 gene, a
known ISG, as a positive control (10). As shown in Fig. 4, both
SeV-CF170S and SeV-C10-15 activated IL-6, IL-8, and IFN-
in U5A cells relative to SeV-wt infection. The IFNAR2-com-
plemented cell line yielded similar results, except that the
activation of these genes was paradoxically reduced in U5A
IFNAR2 cells relative to U5A cells. In contrast to the case for
IL-6, IL-8, and IFN-, little or no activation of 6-16 occurred
in SeV-C mutant-infected U5A cells, whereas a modest acti-
vation was evident in U5AIFNAR2 cells. Moreover, 6-16 was
the only mRNA whose levels in U5AIFNAR2 cells exceeded
those in U5A cells. The activation of IL-6, IL-8, and IFN-
during SeV infection, in contrast to that of 6-16, is thus largely
independent of IFN signaling.
STAT1-defective U3A cells. The SeV C proteins interact
with STAT1 in two ways (Fig. 1D). C and STAT1 form a stable
complex in vitro and during SeV infection, and this complex is
associated with a loss of IFN signaling. These events are
blocked by the CF170S mutation but not by C10-15. The
shorter Y proteins are also active in this respect. The longer C
proteins alone also induce STAT1 instability, and in contrast to
their effects on IFN signaling, this effect does not require F170
(Fig. 1D). To examine whether SeV-C mutant-induced activa-
tion of IL-6, IL-8, and IFN- requires STAT1, U3A cells,
which are known to be defective for STAT1, were examined
(45). However, we were unable to examine the companion
U3ASTAT1 cells, as these cells were found to have lost
STAT1 expression. Moreover, attempts to recomplement U3A
cells with STAT1 failed (data not shown).
The results of the U3A cell infections are shown in Fig. 5. As
before, IL-6 and -8 and IFN- mRNA levels were all clearly
increased in SeV-CF170S infections relative to SeV-wt infec-
tions. However, in contrast to the case for U5A and 2fTGH
cells, SeV-C10-15 infections did not contain enhanced
mRNA levels relative to SeV-wt infections. Given that STAT1
is probably not the only gene that has been lost in U3A cells
that have been X irradiated (which randomly destroys chro-
mosomal DNA), we can conclude only that enhanced mRNA
levels due to SeV-C10-15 infection require STAT1 and/or
FIG. 1—Continued.
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another, unknown gene, whereas activation due to SeV-CF170S
requires neither STAT1 nor any other gene destroyed in U3A
cells.
IL-8 gene activation and IL-8 secretion. IL-8 is not known to
act intracellularly. We therefore examined whether the SeV-
induced IL-8 gene activation in U5A/U5AIFNAR2 cells also
led to increased IL-8 protein synthesis and secretion. When
IL-8 protein levels in cytoplasmic extracts of the various SeV-
infected cells were examined, they were found to roughly mir-
ror the mRNA levels (Fig. 4E). However, when the culture
supernatants were examined, a somewhat different result was
found (Fig. 4F). Whereas the increased IL-8 mRNA level of
SeV-C10-15-infected U5A cells was accompanied by strongly
increased IL-8 secretion, that of U5AIFNAR2 cells led to
only a modest increase in IL-8 secretion. Moreover, the in-
FIG. 2. Effects of SeV C gene mutations on IFN- and IL-8 mRNA
levels during infection. Parallel cultures of 2C4 cells were infected (or
not) in triplicate for 24 h with 20 PFU of the various SeVs per cell.
Total cytoplasmic RNA was prepared from each culture, and the same
amount of RNA (ca. 1 g) was transcribed into cDNA with random
hexadeoxynucleotides and murine leukemia virus reverse transcrip-
tase. The relative amounts of IFN- and IL-8 gene sequences, relative
to that of GADPH as an internal control, were determined by real-
time PCR (see Materials and Methods). The average levels of the
mRNAs and their deviations in the triplicate infections are shown. The
relative SeV N mRNA levels of the SeVZ-C-wt and -C10-15 infec-
tions were also determined (SeVZ and SeVM are 10% different in
sequence, and their detection requires different primers and probes).
FIG. 3. Effects of IRF-3 and dsRNA treatment on SeV-induced
host gene activation. Parallel cultures of 2C4 cells were transfected
with pRFP or pIRF-3. The cultures were then infected (or not) with 20
PFU of the various SeVs per cell at 20 h posttransfection, and some of
the cultures were also treated with 50 g of poly(I)-poly(C) per ml.
The cells were harvested at 24 hpi. The relative amounts of IFN-,
IL-6, and IL-8 gene sequences present were determined as described
for Fig. 2.
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creased IL-8 mRNA levels in either SeV-CF170S-infected cell
line did not lead to clearly increased IL-8 secretion.
IL-8 expression can be controlled at both the transcriptional
and posttranscriptional levels. In polarized epithelial monolay-
ers, S. enterica serovar Typhimurium-induced IL-8 secretion
requires not only the activation of NF-B and production of
IL-8 mRNA but also the activation of the small, Rho family
GTPases Cdc42 and Rac1, which regulate endocytic protein
traffic from the Golgi network to the basolateral surface of the
cell. In the absence of Cdc42 or Rac1 function, IL-8 mRNA
levels increase in response to bacterial infection but IL-8 is not
secreted (3), similar to the case for our SeV-CF170S-infected
FIG. 4. SeV infection of cells defective for the IFN receptor and their complemented pseudo-wt derivatives. (A to D) Parallel cultures of U5A
or U5AIFNAR2 cells were infected (or not) in duplicate with 20 PFU of the various SeVs per cell for 24 h. The relative amounts of IFN-, IL-6,
IL-8, and 6-16 mRNAs present were determined as described for Fig. 2. (E and F) Equal samples of the culture supernatants (F) or cytoplasmic
extracts of the cultures (E) were analyzed for IL-8 protein levels by enzyme-linked immunosorbent assay.
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U5A cells. The requirement for Cdc42 and Rac1 activation,
moreover, is cell type dependent (9). The CF170S and C10-15
mutations thus appear to affect IL-8 secretion differently.
SeV prevents IFN- gene activation in several ways. The
manner in which IFN- transcription is induced by virus infec-
tion is well studied, and the activation of IRF-3 is central to this
process. IRF-3 is expressed constitutively and is found in the
cytoplasm in an inactive, unphosphorylated state. Upon virus
infection or dsRNA treatment of cells, IRF-3 is phosphory-
lated by an unknown kinase and translocates to the nucleus,
where, together with other transcription factors such as NF-B
(which is itself also directly activated by virus infection or
dsRNA), it activates IFN- transcription (41, 65, 68). Phos-
phorylation of IRF-3 after viral infection is the first step in the
activation of a gene program that includes a positive feedback
loop of IFN-/ and IRF family members (60). The results
described above suggest that the SeV C gene encodes func-
tions that prevent virus-induced IFN- transcription (directly
or indirectly). During the course of this work, it was reported
that the SeV V protein, as well as the V proteins of the
rubulaviruses SV5 and hPIV2, also prevented IFN- transcrip-
tion (26, 50, 64).
Given that SeV appears to use two viral genes (C and V) to
neutralize IFN- expression, we have examined a broader
panel of mutant rSeV infections for their relative activation of
the IFN- promoter compared to that of dsRNA treatment.
Besides SeV-CF170S and C10-15, we examined two promoter
mutants, SeV-AGP55, in which the first 55 nt of the antigeno-
mic promoter is replaced with the equivalent leader sequences
of the genomic promoter (38). SeV-AGP55 transcribes leader
RNA from both promoters (and no trailer RNA). The con-
verse SeV-GP48 has the first 48 nt of the genomic promoter
replaced with the equivalent trailer sequences, and SeV-GP48
transcribes basically trailer RNA from both promoters (and no
leader RNA; GP48 and GP1-42 are identical in this respect
[data not shown]) (19, 20). Finally, we examined SeV-V/
W, which contains a stop codon at the beginning of the V
open reading frame (ORF), such that edited V mRNAs are
translated into W-like proteins, and specifically no V protein is
expressed (8).
2fTGH cells were transfected with a reporter plasmid in
which luciferase is controlled by the IFN- promoter (pIFN-
luciferase). To determine whether virus-induced IFN- tran-
scription required IRF-3 activation, the cells were cotransfect-
ed with either a dominant-negative mutant of IRF-3 (IRF-3N),
an anti-IRF-3 ribozyme, or an empty control plasmid (see
Materials and Methods). The transfected cultures were then
infected (or not) with the various SeVs (or treated with
dsRNA) 24 h later and were harvested at 20 h postinfection
(hpi). As shown in Fig. 6, with the notable exception of SeV-
AGP55, all of the mutant SeV infections induced the reporter
more strongly than SeV-wt and as well as dsRNA treatment. In
all cases, the coexpression of IRF-3N or an anti-IRF-3 ri-
bozyme prevented the SeV-induced expression of the reporter.
Thus, mutations in two regions of the C protein that carry out
different functions, as well as the loss of leader RNA expres-
sion or the expression of the V protein, all lead to IFN-
promoter activation in an IRF-3-dependent manner. Overex-
pression of the W protein cannot compensate for the lack of V
protein, so the highly conserved Cys-rich carboxyl domain of V
is specifically required. Only the loss of trailer RNA expression
(SeV-AGP55) did not result in IFN- activation.
Leader and trailer RNAs, the promoter-proximal products
of viral RNA synthesis, are AU rich and are thought to bind to
cellular RNA-binding proteins that bind AU-rich elements
(28). In contrast to leader RNA, trailer RNA is expressed
relatively late in infection (upon antigenome accumulation)
and would not be expected to counteract immediate-early re-
sponse genes. However, many of the other viral products that
do not have a dedicated essential role in the replication ma-
FIG. 5. SeV infection of cells defective for STAT1. Parallel cul-
tures of U3A cells were infected (or not) in duplicate with 20 PFU of
the various SeVs per cell for 24 h. The relative amounts of IFN-, IL-6,
and IL-8 mRNAs present were determined as described for Fig. 2.
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chinery per se (C and V proteins and leader RNA) appear to
be pressed into service to coordinately prevent IFN- activa-
tion.
DISCUSSION
We have used cDNA arrays to compare the activation of
various cellular genes in response to infection with SeVs that
contain mutations in their C proteins or leader regions. Three
groups of cellular genes were identified in this way (Fig. 1). Of
the mutant SeV examined by DNA arrays, only the leader(31-
42) mutation failed to activate any of the cellular genes relative
to SeV-wt, and consistent with this failure, SeV-GP31-42 was
the only one of the four mutant SeVs not to have lost virulence
in mice (M. Itoh, unpublished data). The CF170S mutation is
associated with a ca. 5-log-unit increase in LD50 (31), and this
mutation appears to be the most important in cell culture
infections as well as in mice (15). This mutation activates IL-6,
IL-8, and IFN- more strongly than C10-15, and only this
mutation activates all three groups of cellular genes that re-
spond to SeV infection.
The IFN- gene is both a primary response gene and an
ISG, and it plays a central role in initiating the IFN-induced
antiviral response. This is the first report that the SeV C pro-
teins and leader RNA counteract the expression of this key
primary response gene, and it confirms that the report of Poole
et al. (50) that the product of our hemagglutinin-tagged V gene
is active in this respect. As expected, activation of IFN- re-
quired activation of IRF-3 (Fig. 6) and was independent of IFN
signaling (Fig. 4), but the details of how this occurs remain to
be elucidated. We have also provided evidence that the SeV C
proteins and leader RNA counteract the expression of the
chemokine IL-8. Infections by other viruses, e.g., respiratory
syncytial virus (RSV) (44), dengue virus (3), hepatitis C virus
(49), and human immunodeficiency virus type 1 (46, 52), are
known to induce IL-8 secretion, as do infections by bacteria
and parasites, including Mycobacterium tuberculosis (66). In a
related vein, cytomegalovirus, a large DNA virus, encodes a
chemokine receptor that may facilitate virus replication (13),
and human herpesvirus 8/Kaposi’s sarcoma virus carries four
ORFs whose products are related to chemokines (42). Viral
modulation of chemokine expression presumably represents
one aspect of the continuous battle between viral parasites and
antiviral, inflammatory, and immune responses of the host.
SeV infection has been reported to induce the CXC chemo-
kine RANTES via the activation of IRF-3 and NF-B (23, 40).
IL-8 may not have been noticed in these earlier studies, be-
cause SeV-wt induces very little IL-8 (Fig. 2). Our results
suggest that SeV targets the inflammatory and adaptive im-
mune responses (IL-6 and IL-8) as well as the IFN-induced
intracellular antiviral state (IFN- and STAT1). As IFN- and
IL-8 transcription both depend on NF-B activation, SeV may
target this key transcription factor as well.
The leader(1-42), C10-15, CF170S, and V/W mutations
appear to disrupt four distinct elements in the SeV program to
counteract the cellular antiviral response. The facts that they
all lead to enhanced levels of IFN- mRNA and that at least
three of them increase IL-8 mRNA levels suggest that SeV
employs a multifaceted approach to inhibit viral clearance by
inflammatory cells as well as to prevent the IFN-induced an-
tiviral state, sometimes using the same viral macromolecules
due to its limited coding capacity. The best-studied example of
paramyxovirus-induced activation of IL-8 is that of RSV (21,
69). The IL-8 promoter in A549 cells can be induced by RSV
infection in at least three distinct pathways: via tumor necrosis
factor alpha (which requires only an intact NF-B binding
site), directly by intracellular RSV replication (which also re-
quires other transcription factor binding sites) (5), and via the
interaction of the viral F protein with Toll-like receptor 4 (in
which IRF-3 plays an important role) (36). Measles virus H
protein interaction with Toll-like receptor 2 also activates IL-8
(1). If all three parallel cellular pathways for IL-8 expression
operate during SeV infection of 2fTGH cells, several different
SeV products will be required to effectively prevent IL-8 acti-
vation (Fig. 1D).
Rubulaviruses do not express C proteins, but their V pro-
teins have recently been found to prevent IFN- expression by
preventing the activation of IRF-3 and NF-B, as well as in-
FIG. 6. Effect of SeV infection on IFN- promoter reporter gene
expression. Parallel cultures of 2fTGH cells were transfected with a
mixture of pINF-fl-lucter and pTK-rl-lucter along with pIRF-3-N,
pAnti-IRF-3-ribozyme, or an empty plasmid (Ctrl), as indicated in
Materials and Methods. Duplicate cultures were infected (or not) with
20 PFU of the various SeVs per cell or treated with dsRNA and
harvested at 20 hpi. The relative activities of the fl- and rl-luciferases
were determined. Error bars indicate standard deviations.
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ducing the degradation of STAT1 or STAT2 (26, 50). The
Rubulavirus V proteins thus also counteract more than one
arm of the innate antiviral response. The versatility of these
viral gene products continues to surprise us. The SeV C pro-
teins have been more intensively studied than SeV V protein
or leader RNA. Like the influenza A virus NS1 protein (6, 63)
and hepatitis C virus NS5A protein (49), the SeV C proteins
are pleiotropic polypeptides that have multiple activities dur-
ing infection, presumably due to their interaction with various
viral and cellular proteins. Their multiple functions, deci-
phered in large part via C gene mutations, include (i) stimu-
lation of viral RNA synthesis early in infection (SeV-C/C
infections exhibit a 10-h delay in the accumulation of viral
products) (37); (ii) inhibition of viral RNA synthesis in a pro-
moter-specific manner late in infection, by interacting with the
P4-L vRdRP (this selective inhibition may promote the switch
from mRNA synthesis to genome replication and increase the
fidelity of vRdRP promoter recognition) (4, 61); (iii) a role in
virion assembly, possibly by interaction with the matrix (M)
protein (SeV-4C particles are poorly infectious and amor-
phic) (25); (iv) interaction with STAT1 in two separate ways, to
inhibit IFN signaling and to induce STAT1 instability (17); and
(v) inhibition of the IRF-3-dependent activation of IFN- and
the activation of IL-8 expression in an IFN signaling-indepen-
dent manner (this work).
How C interacts specifically with all of its viral and cellular
partners remains an enigma and is reminiscent of acidic acti-
vation domains of transcription factors that interact with mul-
tiple partners. Acidic activation domains are “natively disor-
dered” (11, 51), and this property apparently allows them to
bind different surfaces with high specificity (multiple induced
fits) and limited stability. The NH2-terminal portion of the
measles virus P protein that contains the overlapping C protein
ORF is, in fact, a recent example of such natively disordered
proteins, in accordance with the prediction of algorithms that
detect unstructured regions (47). By using the same algorithms
(PONDR), the SeV C protein is strongly predicted to be na-
tively disordered, and this property is shared with the common
NH2-terminal portions of rubulavirus V, I, and P proteins (17,
26). The C10-15 deletion, moreover, is in a region of C with
the highest prediction of disorder. It will be of interest to
examine whether purified SeV C proteins are indeed natively
disordered.
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ADDENDUM IN PROOF
Fujii et al. (Y. Fujii, T. Sakaguchi, K. Kiyotani, C. Huang, N.
Fukuhara, Y. Egi, and T. Yoshida, J. Virol. 76:8540–8547,
2002) have shown that mutations in the leader region specifi-
cally attenuate virus virulence in mice.
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The ability of some Sendai virus stocks to strongly activate IFNβ has long been known to be associated with defective-interfering (DI)
genomes. We have compared SeV stocks containing various copyback and internal deletion DI genomes (and those containing only nondefective
(ND) genomes) for their ability to activate reporter genes driven by the IFNβ promoter. We found that this property was primarily due to the
presence of copyback DI genomes and correlated with their ability to self-anneal and form dsRNA. The level of IFNβ activation was found to be
proportional to that of DI genome replication and to the ratio of DI to ND genomes during infection. Over-expression of the viral Vand C proteins
was as effective in blocking the copyback DI-induced activation of the IFNβ promoter as it was in reducing poly-I/C-induced activation, providing
evidence that these DI infections activate IFNβ via dsRNA. Infection with an SeV stock that is highly contaminated with copyback DI genomes is
thus a very particular way of potently activating IFNβ, presumably by providing plentiful dsRNA under conditions of reduced expression of viral
products which block the host antiviral response.
© 2006 Elsevier Inc. All rights reserved.Keywords: Sendai virus; Defective-Interfering genome; Interferon beta; Innate immunityOur understanding of how animal cells recognize and mount
an innate antiviral response to intracellular RNA virus
replication has recently made great progress. Two DexD/H
box helicases with CARD domains, RIG-I and Mda5/Helicard,
were found to participate in the detection of cytoplasmic
dsRNA (Andrejeva et al., 2004; Yoneyama et al., 2004). dsRNA
is thought to be a common product of RNAvirus infections that
acts as a pathogen-associated molecular pattern (PAMP)
responsible for initiating the innate antiviral response. RIG-I
and Mda5 initiate antiviral responses by coordinately activating
several transcription factors, including NF-κB and IRF-3, that
bind to the IFNβ promoter forming an enhanceosome that
activates this primary host-response gene (McWhirter et al.,
2005). Upon binding dsRNA, the CARD domains of these
helicases are thought to be freed for interaction with the
synonymous domain of MAVS/VISA/cardif/IPS-1, a mitochon-
drial protein which in turn is required for recruiting the kinases
that activate these transcription factors (Xu et al., 2005; Meylan⁎ Corresponding author.
E-mail address: Daniel.Kolakofsky@Medecine.unige.ch (D. Kolakofsky).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.03.022et al., 2005; Seth et al., 2005; Kawai et al., 2005). Autocrine
interaction of secreted IFNβ with its cell surface receptor then
closes the “innate immunity loop”, leading to increased IFN-
stimulated gene (ISG) products, such as other IFNs and the
intracellular effectors of the antiviral state (Sen, 2001).
The role of Mda5 in dsRNA signaling to IFNβ was
uncovered because Mda5 binds to the paramyxovirus SV5 V
protein (Andrejeva et al., 2004). This interaction, and that of
other paramyxovirus V proteins, blocks dsRNA signaling, and
this property of V maps to the highly conserved cys-rich domain
at their C-termini (Poole et al., 2002; Andrejeva et al., 2004). V
proteins of different paramyxoviruses, however, are very
different at their N-terminal portions, which accounts for their
otherwise very different properties (Lamb and Kolakofsky,
2001). Rubulavirus V proteins (e.g., SV5, PIV2) are associated
with intracellular and virion nucleocapsids (NCs) and are
important in promoting virus growth. PIV2 which cannot
express the entire V protein is highly debilitated even in the most
permissive cell culture (Nishio et al., 2005). Respirovirus (e.g.,
Sendai virus (SeV)) V proteins, in contrast, are nonstructural
proteins, are not associated with NCs and their expression
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although V expression is not required for replication in cell
culture, SeVVexpression is essential for virulence in mice (Kato
et al., 1997; Delenda et al., 1998). This requirement is
presumably due to its ability to block dsRNA-induced activation
of the IFNβ promoter (Poole et al., 2002) as infection with SeV
that cannot specifically express the V protein strongly activates
IFNβ (Strahle et al., 2003). Finally, in contrast to rubulaviruses,
respirovirus VmRNAs express a nested set of C proteins from an
overlapping ORF, and these C proteins also block the innate
antiviral response, in several ways (e.g., by blocking IFN
signaling) (Gotoh et al., 1999; Garcin et al., 1999).
It is noteworthy that infection with wild-type SeV or SV5
does not normally activate IFNβ. In contrast, infections with
SV5 VΔC (which produces a C-terminally truncated V protein)
or infections with SeV with mutations in either the leader
region, two regions of the C protein or the V protein all lead to
enhanced levels of IFNβ mRNA (He et al., 2002; Strahle et al.,
2003). In the case of SeV, these viral genes also appear to be
involved in preventing activation of inflammatory cytokines
such as IL-8. For SeV, all the viral products that are not known
to play essential roles in the replication process itself (the Vand
C proteins, and leader and trailer RNAs) appear to function in
countering the innate antiviral response. In the context of a
normal, wild-type infection of cells in culture, the effect of these
various viral anti-host-response products is apparently sufficient
to prevent, or severely limit, IFNβ activation.
The IFNβ promoter is normally activated in cells treated
with dsRNA (poly I:poly C, or poly-I/C) or infected with virus.
Sendai virus infection is often used in this respect, and virus
stocks which strongly activate IFNβ are also available
commercially. However, it has long been known that the
remarkable ability of some SeV stocks to induce IFN secretion
in macrophage and other cell lines is related to the presence of
defective-interfering (DI) particles (Johnston, 1981; Poole et al.,
2002), but the nature of the IFN-inducing agent in these stocks
was not examined. Moreover, for VSV, another mononegavirus,
DI particles containing “snap-back” DI genomes (see below)
were found to be very potent inducers of IFN, even in the
absence of co-infecting nondefective (ND) helper virus (Marcus
and Sekellick, 1977; Sekellick and Marcus, 1982). DI particles
contain deleted viral genomes which are generated spontane-
ously as by-products of ND genome replication. DI genomes
have, sine qua non, gained the ability to successfully compete
with their helper ND genomes for the viral replication substrates
provided by the latter; hence, they are also “interfering”
(Perrault, 1981; Lazzarini et al., 1981). Because of their
replicative advantage over ND genomes, DI genomes invariably
accumulate in SeV stocks that are repeatedly passed in eggs,
unless steps to prevent this accumulation are taken.
Nonsegmented negative-strand RNA viruses (NNV) DI
genomes can be of two types, internal deletion or copyback
(Fig. 1). The replicative advantage of internal deletion DI
genomes over ND genomes is not well understood (Garcin et
al., 1994), but that of copyback DI genomes is well studied.
Copyback DI genomes have always replaced the weaker
genomic replication promoter at the 3′ ends of their minusstrands with the stronger antigenomic promoter, and thus both
DI genomes and antigenomes initiate from the same strong
antigenomic promoter. Paramyxovirus replication promoters are
contained within the 3′ terminal 91–96 nt of the genomic RNA
(narrow boxes, Fig. 1), and all natural copyback DI genomes
have copied back 91 nt or more while carrying out this promoter
exchange (see Fig. 1). Although these RNAs contain termini
that are perfectly complementary for ca. 100 nt, DI genomes are
normally present within nucleocapsids (NCs), where their RNA
ends are not free to anneal. However, when SDS is used to
gently dissociate the N protein from RNA, copyback DI
genomes (and antigenomes) rapidly form ssRNA circles with
dsRNA panhandles, as seen in the EM and on biochemical
analysis (Kolakofsky, 1976). Several copyback DI genomes
from independent virus stocks were characterized initially. They
all contained complementary termini of ca. 100 nt in length, and
as expected, the rate at which they circularized on SDS
treatment was inversely proportional to their length.
Similar copyback DI genomes with limited terminal
complementarity are common for VSV. However, VSV, unlike
SeV, also generates an extreme form of copyback DI genome
whose sequences are complementary over their entire length of
ca. 2 kb (snapback DIs) and which form long dsRNA “hairpins”
(of ca. 1000 bp) rather than ss circles upon SDS treatment
(Lazzarini et al., 1981; Perrault, 1981). It is these VSV snapback
DI genomes, like DI 011, that were reported to strongly induce
IFN by themselves, in aged chick embryo fibroblasts (CEFs)
and mouse L cells (Marcus and Gaccione, 1989; Marcus and
Sekellick, 1977). These reports have remained controversial,
however, because this IFN induction was independent of co-
infecting helper virus, whereas Youngner and colleagues found
that it correlated with contaminating ND virus in L cells. These
latter workers, moreover, were unable to find a correlation
between the snapback content of their DIs and IFN induction
(Frey et al., 1979). Sekellick and Marcus also reported that
snapback DI induction of IFN was unaffected by heat treatment
that would inactivate its RNA polymerase, or UV treatment that
would prevent its genome from being copied, and concluded
that this IFN induction was due to a pre-existing molecule that
did not require any synthetic events for its formation (Sekellick
and Marcus, 1982; Marcus and Gaccione, 1989). Disassembly
of DI 011 NCs intracellularly would then appear to be the only
explanation for dsRNA formation. However, as the infection of
a single DI 011 particle per CEF was sufficient to induce a
quantum (maximum) yield of IFN, the manner in which the DI
011 NC is presumably disassembled so efficiently in vivo (to
permit dsRNA formation) remains an enigma as NCs are
generally very stable in vivo.
Given the growing appreciation that dsRNAmay be a common
product of RNAvirus infection that participates in the induction of
the innate antiviral response, we have reexamined the requirement
of SeV DI genomes for the activation of the IFNβ promoter.
Results
Three SeV stocks containing DI genomes (Figs. 1, 2a), as
well as a stock containing only ND genomes, were examined for
Fig. 1. A schematic view of SeV RNA synthesis and DI genomes. The ND (−) genome is shown above, with its 3′ end genomic replication promoter (on the left) and
the complement of the antigenomic replication promoter (at the 5′ end), both contained within the terminal 96 nt, shown as thin boxes. The central protein coding
region, from the beginning of the N ORF to the end of the L ORF, is shown as thicker boxes; these regions are not drawn to scale. Only the N/P junction is shown, the
remaining genes are lumped together as a P/V/C … L. The (+) RNAs transcribed from the ND genome (le RNA and the 6 mRNAs) are shown below the ND genome.
The sole transcript of the ND-antigenome, tr RNA, is shown above. The lines below the ND genome indicate the progress of the replicase when generating internal
deletion (E307) or copyback (H4/ChR1) DI genomes. The structure of the DI (−) genomes is shown below; the dark shading on the left indicates the extent of the
terminal complementarity, which is also indicated in brackets on the left. The inverted triangle indicates the yfp sequence used to tag H4. The arrows below the DI
genomes show the PCR amplification strategy used to clone the DI RNA of the Charles River SeV stock.
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IFNβ promoter. The DI-H4 stock is composed predominantly
of a natural 1410 nt long copyback DI genome, whose termini
are perfectly complementary for 110 nt (Calain et al., 1992).
The DI-S104 stock, like H4, was generated by passage in eggs,
but this stock is composed of 5 major DI species. Only the
smallest DI of this stock has been cloned as DNA and found to
be an internal deletion DI of 1794 nt (called E307) (Engelhorn
et al., 1993). Their termini are complementary for only 12 nt,
like those of ND genomes. However, Northern analysis with a
leader/N gene probe, which anneals specifically to internal
deletion DI genomes, shows that this stock contains 3 internal
deletion as well as 2 copyback DI genomes (the latter of ca.
2500 and 3500 nt in length) (Fig. 2a). DI-GP55, in contrast to
the others, was produced and rescued by recombinant means
(Garcin et al., 1995) and is identical to E307 except that it
contains the 55 nt trailer region at the (−) DI genome 3′ end, in
place of the leader region. DI-GP55 is thus a copyback DI
genome whose termini are complementary for 55 nt (Fig. 1). As
mentioned above, copyback DI genomes with more extensive
terminal complementarity, such VSV DI 011, have not been
reported for SeV, and we have no stable SeV stocks that contain
only internal deletion DI genomes.
Infection of 293T cells with all 3 DI stocks was found to
activate the IFNβ reporter, but to very different extents (Fig. 2c).H4 was the most potent, followed by GP55, and S104 was the
least potent. In contrast, infection with ND genomes alone barely
activated the reporter gene, even though the ND infection
accumulated as much or more viral proteins than the DI
infections (Fig. 2b). In these and other experiments, there is often
an inverse correlation between the accumulation of viral proteins
and the extent of IFNβ activation, as might be expected if
activation is due to the presence of DI genomes. More
importantly, plaque purification of the H4 stock yields a virus
preparation that does not contain DI genomes and which does
not activate the IFNβ promoter during infection (ND-H4, Fig.
3). The ability of the DI-H4 stock to activate IFNβ is thus not due
to mutations within the ND genome, which could have arisen
because of the presence of the DI genomes.
IFNβ activation requires modification of IRF-3, which is
hyper-phosphorylated in response to viral infection, or dsRNA
(Fitzgerald et al., 2003; Sharma et al., 2003). Activated IRF-3
dimerizes andmigrates to the nucleus where it binds to the PRD I
and III elements of the IFNβ promoter, as part of an
enhanceosome (Maniatis et al., 1998). The activation of the
IFNβ promoter by SeV DI infection appears to require IRF-3
since this activation is largely ablated by co-expression of a
dominant-negative form of IRF-3 (data not shown). When the
extent of IRF-3 dimerization was examined, a significant
fraction of the IRF-3 was found as dimers (on non-denaturing
Fig. 2. Only DI infections activate IFNβ in 293T cells. (a) Northern blot of encapsidated (CsCl banded) RNAs from the various infections as indicated, using a (+)
riboprobe from the end of the L gene (which detects all DI genomes) or a (+) riboprobe from the leader/N gene region, which detects only internal deletion DI genomes.
The DI-H4 and GP-55 genomes do not anneal with the leader/N gene probe. (b) A Western blot of equal amounts of cell extracts (total proteins) of the various
infections, using anti-P and anti-N antibodies. (c) 293T cells were transfected with a luciferase reporter plasmid under the control of the IFNβ promoter (and control
plasmid) for 24 h then infected (or not) with the various SeV stocks for 20 h. Cell extracts were prepared, and levels of the renilla and firefly luciferases were
determined. The cumulative results of 3 experiments are shown. (d) Two different amounts (1× and 5×) of total cell proteins from extracts of the various infections were
separated on nondenaturing gels andWestern blotted with anti-IRF-3. (e) Equal amounts of cell extracts of the various infections (total proteins) were separated on SDS
gels andWestern blotted with anti-IRF-3. The right-hand lane shows uninfected cells that express transfected IRF-3 5D. The 5 isoforms, numbered 1 to 5, are indicated.
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formation was roughly in proportion to the degree of IFNβ
activation (Fig. 2d). In contrast, there was no evidence of dimers
in the ND extract.We also examined the electrophoretic mobility
of IRF-3 on SDS-PAGE as this mobility is sensitive to IRF-3
phosphorylation status (Hiscott et al., 2003; Hasegawa et al.,
1992; Yoneyama et al., 2002). We could distinguish 5
electrophoretic forms of IRF-3 in our extracts (Fig. 2e). Mock-
infected extracts predominantly contained forms 2 and 3.
Infection with ND SeV led to the strong appearance of faster
form 5, without loss of 2 and 3. In contrast, infection with DI-H4
and GP55 led to the appearance of the slightly slower form 4,
reduction in the intensity of forms 2 and 3, and the appearance of
the slowest form 1, which co-migrates with phospho-mimetic
IRF-3 5D that is constitutively active (Lin et al., 1999). IRF-3 isthus being modified in response to the ND infection, but these
modifications do not lead to dimerization or the activation of the
IFNβ promoter. The presence of DI genomes during infection
somehow causes IRF-3 to be modified differently, leading to its
dimerization and IFNβ promoter activation.
DI-H4-induced activation of IFNβ is proportional to DI
genome replication
The relative amounts of DI and ND genomes in cell extracts
can be examined by Northern blotting (Figs. 2 and 3), but this
analysis is linear only over a relatively narrow range and often
unequally estimates RNAs that vary significantly in length
(>10-fold in this case). RT/PCR is better suited to this task, but
this method cannot differentiate between DI-H4 and ND
Fig. 4. Evolution of the DI-H4+yfp stock on passage in eggs. (a) The DI-
H4+yfp genome was prepared from DNA by reverse genetics (Methods and
materials) and rescued by superinfecting the BSR T7 culture with ND SeV
(Methods and materials). The culture supernatant was inoculated into eggs, and
the resulting allantoic fluid was diluted 1 to 500 for reinoculation, for a total of 20
times. The stocks from each passage level were assayed for their ability to
activate a GFP gene under the control of the IFNβ promoter. Only the results
from passage levels 8 and 16 to 20 are shown, along with DI-H4 as positive
control and mock-infected as a negative control. (b) Total RNA was prepared
from cells infected with passage levels 8 and 16 to 20 and examined by RT/PCR
for their levels of ND genome (N gene) and DI genome (YFP) relative to that of
GADPH mRNAs. Total RNA from a mock-infected culture served as the
negative control. (c) Equal amounts of extracts from cells infected with passage
levels 8 and 16 to 19 were examined by Western blotting with anti-N and anti-P/
V/C and anti-actin as a loading control.
Fig. 3. Allantoic fluid stocks prepared from plaque-purified SeV do not activate
IFNβ. The DI-H4 and ChR stocks were titered on LLC-MK2 cells in the
absence of serum. Single plaques from the highest positive dilution (10−7) were
picked, and 3/10 of each plaque was inoculated into hen's eggs that were
incubated at 33 °C for 3 days. The allantoic fluid stocks resulting from the
plaque-purified virus (ca. 109 pfu/ml) were compared with the original stocks
containing the same amount of viral proteins (as determined by Coomassie blue
staining of SDS gels) for their ability to activate pIFNβ-GFP in 293T cells. A
Northern blot of encapsidated (CsCl banded) RNAs from equal amounts of ND-,
H4-, and ChR1-infected cells, using a (+) riboprobe from the end of the L gene,
is shown in the insert.
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amplification. However, the dsRNA panhandles of circular DI
genome RNAs are exceedingly stable and cannot be invaded by
primers extended by RTase even at elevated temperatures. To
circumvent these technical problems, we prepared a tagged
version of the DI-H4 genome containing a 162 nt insertion
from the YFP gene (Fig. 1), such that the DI and ND genomes
could be independently and accurately estimated by RT/PCR,
over a large range of values. A second reason for preparing DI-
H4+yfp is that, although our H4 stocks are composed
predominantly of the 1410 nt long species cloned as DNA,
overexposure of Northern blots shows that several other RNAs
are present in much lower amounts and which have not
otherwise been characterized. As we do not know whether all
the DI genomes in the H4 stock contribute equally to inducing
IFNβ activation or whether activation is due to a particular (and
perhaps uncharacterized) species, we cannot be sure that IFNβ
activation is in fact due to the 1410 nt copyback DI genome.
Recapitulation of these results with a tagged copy of the DI-H4
genome would settle this issue as well.
DI-H4+yfp genomes were recovered from DNA in BSR T7
cells that were subsequently co-infected with ND SeV. Stocks
containing this DI genome were then generated by multiple
passages in embyonated chicken eggs (Methods and materials),
and each passage was tested for its ability to activate a GFP
reporter gene under the control of the IFNβ promoter (pIFNβ-
GFP) upon infection of 293T cells. Although some IFNβ
activation above background appeared by passage 3, this
activation increased slowly and erratically at first and eventually
reached activation levels approximately half those of the
reference H4 stock by passage 20 (Fig. 4a), During the later
passages (16 to 20), the level of intracellular ND genomes
steadily decreased (Fig. 4b), leading to a reduction in the levels
of viral proteins (Fig. 4c), whereas the levels of DI-H4+yfpgenomes steadily increased (Fig. 4b). The ability of SeV DI
stocks to induce IFNβ activation thus correlates with the
relative levels of DI genomes during infection. As DI and ND
genome NCs are relatively stable structures, these levels reflect
the rates that DI and ND genomes are synthesized during
infection with the various passage levels. The evolution of the
DI-H4+yfp stock towards IFNβ activation (during relatively
undiluted passage in eggs) thus correlates with the level of DI
genome synthesis during infection. The remarkable ability of
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predominant 1410-nt-long copyback DI genome.
Examination of the UV inactivation kinetics of DI-induced
IFNβ activation, as compared to the UV inactivation kinetics of
ND and DI genome replication, can provide broad information
on the nature of this IFNβ activation. DI-H4+yfp (P(passage)
17, insert, Fig. 5) was irradiated with 256 nm UV light for
various times (0.5 to 8 min) and used to infect 293T cells
containing pIFNβ-GFP. Intracellular RNA was isolated at
20 hpi, and the levels of ND genome RNA and DI-H4+yfp
genome RNAwere measured by RT/PCR. GFP expression was
monitored by FACS (Fig. 5a). DI-H4+yfp (1572 nt) is 1/10 the
length of the ND genome (15,384 nt) and thus proportionately
less sensitive to UV inactivation. This difference in the loss of
ND and DI genome levels is most apparent at the shortest times
of UV irradiation and is lost at the higher doses, presumably
because DI genome replication ultimately depends on ND
genomes to provide all the replication substrates (N, P and L
proteins). The reduction of GFP expression levels uponFig. 5. UV inactivation kinetics of DI-H4+yfp infections. (a) The allantoic fluid
of DI-H4+yfp passage level 17 was irradiated with 254 nm light (110 μW/cm2)
from 0.5 to 8min and then used to infect 293Tcells that had been transfected with
pIFNβ-GFP. Total RNA was prepared at 24 hpi, and the levels of DI-H4+yfp
genome and ND genome were determined by RT/PCR. GFP expression levels
were monitored by FACS. The results are shown relative to RNA from cells
infected with non-irradiated allantoic fluid. The cumulative results of 2
experiments are shown. The error bars, always <20%, are not shown for clarity.
(b) A Northern blot of encapsidated RNAs fromND, DI-H4 and DI-H4+yfp P17
infections, using a (+) probe from the end of the L gene.increasing UV irradiation parallels that of ND and DI genomes
and most closely follows the loss of the DI genomes at the
lowest doses of UV. More importantly, as the reduction of GFP
expression levels closely follows that of DI genomes over a
range of 2 logs, IFNβ activation is clearly proportional to the
level of copyback DI genome replication (in 293T cells) for a
given stock as well.
The manner in which SeV DI genomes presumably generate
dsRNA that induces IFN is thus quite different from that of
VSV DI 011. SeV DI genomes not only require co-infection
with ND helper virus, IFN induction here (293T cells) is strictly
proportional to the level of DI genome replication, in contrast to
VSV snapback DI IFN induction (in aged CEFs) where viral
RNA synthesis is not required.
The SeV stock of Charles Rivers Laboratory
As mentioned above, SeV stocks (Cantell strain) whose
infection of cultured cells strongly activates IFNβ, are available
from Charles River Laboratory. A fresh allantoic fluid stock of
this virus preparation was found to activate IFNβ to levels
similar to those of DI-H4 (Fig. 3), and this stock was found to
contain a very small DI genome (of ∼600 nt) by Northern
analysis (insert, Fig. 3). When the ND virus of this preparation
was plaque purified on LLC-MK2 cells, allantoic fluid stocks
prepared from the purified virus had lost the ability to activate
IFNβ (ND-ChR1, Fig. 3). Thus, similar to DI-H4, the ability of
the Charles River virus preparation to activate IFNβ appears to
be due to the presence of the DI genome(s), and not to mutations
within its ND genome.
To determine the nature of this DI genome, we cloned the
DI genome as DNA, as illustrated in Fig. 1 (small horizontal
arrows are primers). We used one set of primers to amplify
the common right end of all DIs (arrows under GP55, Fig. 1)
and 3 sets of primers that were specific to the left end of
either internal deletion (arrows under E307, Fig. 1) or
copyback DIs (arrows under H4, Fig. 1). The common right
end primer set and the 3 copyback-specific left-end primer
sets all yielded a PCR product of the expected size, whereas
the 3 internal-deletion-specific left-end primers failed to
produce visible DNA (not shown). When these amplified
DNA fragments were sequenced, DI-ChR1 was deduced to be
a simple copyback DI genome of 546 nt (453 nt are co-linear
with the 5′ end of the ND (−) genome), with terminal
complementarity over 93 nt. To our knowledge, this is the
smallest natural SeV DI genome described to date, and this
property may be related to its ability to activate IFNβ so
strongly.
The SeV V and/or C proteins inhibit DI-H4-induced IFNβ
activation
Although our 293T cells produce IFN in response to DI-
H4 infection, they do not respond to added IFN. 293T cells
are thus useful in studying IFNβ activation in isolation
because the activation is not also driven by positive feedback
via ISGs. However, to study the broader aspects of the
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IFN in response to infection and respond as well to the
secreted IFN. When 2fTGH cells containing a pIFNβ-luc
reporter are treated with poly-I/C (either added to the
medium or via transfection (*)) or IFNα, poly-I/C* and H4
infection strongly activate IFNβ promoter, whereas IFNα has
no effect and poly-I/C treatment has little effect (IFNβ is not
an ISG, and TLR3 may be poorly expressed in these
fibroblasts). Moreover, whereas poly-I/C* and IFNα clearly
increased ISG levels (STAT1, RIG-I, ISG15 and ISG56), H4
infection failed to increase these ISG levels above the
untreated control. The SeV V protein blocks poly-I/C-
induced IFNβ activation (Poole et al., 2002) and presumably
should also block that induced by DI-H4 infection. We
reasoned that, if DI-H4 infections generated abnormally large
amounts of dsRNA, the amount of V expressed from the ND
genome during DI infections might be insufficient to block
dsRNA signaling via RIG-I and Mda5. We therefore over-
expressed the V and C proteins by plasmid transfection in
2fTGH cells containing pIFNβ-luc and re-examined the
effects of the various treatments. As shown in Fig. 6a, over-
expression of the V and C proteins was as effective in
blocking the DI-H4-induced activation of the IFNβ promoter
as it was in reducing the poly-I/C*-induced activation. This
result is consistent with the notion that DI-H4 infection
induces IFNβ activation, at least in part, via dsRNA. Over-
expression of the V and C proteins also partially blocked the
poly-I/C*- and IFNα-induced increase in ISG levels,
including that of RIG-I.
To examine whether DI-H4 infection was indeed able to
block IFN signaling, we similarly treated 2fTGH cells
containing a pIRSE-luc reporter and examined the effects on
the reporter gene and ISG protein levels (Fig. 6b). In contrast
to IFNα and poly-I/C* treatment which activated this
promoter and increased ISG levels, DI-H4 infection did not
activate the ISRE reporter over the untreated control, and the
levels of STAT1, RIG-I, ISG15 and ISG56 were not increasedFig. 6. (a) The effect of poly I/C, DI-H4 infection and IFNα treatment on IFNβ
and ISGs in 2fTGH cells, in the presence and absence of the SeV V and C
proteins. 2fTGH cells were transfected with a luciferase reporter plasmid under
the control of the IFNβ promoter (and the TK-renilla control plasmid) and pSeV-
V/C that expresses V and C proteins from the same mRNA (or and empty
plasmid) for 24 h. Parallel cultures were then either treated with 100 μg/ml of
poly I/C in MEM (poly-I/C), transfected with 1 μg of poly I/C (poly I/C*),
infected with DI-H4 or treated with 1000 IU of IFNα. Cell extracts were
prepared 20 h later, and the levels of the renilla and firefly luciferase activities
were determined. The cumulative results of 2 experiments are shown. Equal
amounts of total protein of each extract were also examined for their levels of
STAT1 (and actin), RIG-I, SeV P, V and C proteins and ISG-15 and ISG-56 by
Western blotting with specific antibodies (Methods and materials). (b) The effect
of poly I/C, DI-H4 infection and IFNα treatment on ISGs in 2fTGH cells.
2fTGH cells were transfected with a luciferase reporter plasmid under the
control of an ISRE promoter (and the TK-renilla control plasmid) for 24 h.
Parallel cultures were then treated as in panel A. Cell extracts were prepared 20 h
later, and the levels of the renilla and firefly luciferase activities were
determined. The cumulative results of 2 experiments are shown. Equal amounts
of total protein of each extract were also examined for their levels of STAT1 (and
actin), RIG-I and ISG-15 and ISG-56 by Western blotting.in these extracts. Thus, there appears to be sufficient viral
proteins expressed during DI-H4 infection to block IFN
signaling.
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dsRNA is thought to be a common product or PAMP of RNA
virus infections that initiates the innate antiviral response, in part
by activating IFNβ. However, the source of this dsRNA is
presumably different for different viruses. (+) RNA virus
genomes contain highly conserved 2° and 3° structures at their
5′ and 3′ ends that are essential for virus replication (Simmonds
et al., 2004), and these highly structured RNA regions by
themselves can initiate signaling to IFNβ upon binding to RIG-I
(Sumpter et al., 2005). In contrast, NNV genomes are not known
to contain conserved 2° structures, and, moreover, NNV
genomes function in RNA synthesis not as free RNAs but as
assembled NCs, in which the genome RNA cannot normally
anneal (Lamb and Kolakofsky, 2001). One possible source of
dsRNA during NDSeVreplication is the occasional extension of
the trailer RNA beyond the trailer/L gene junction (see Fig. 1),
producing run-on trailer RNAswhose 3′ sequences can anneal to
those of the L mRNA (Vidal and Kolakofsky, 1989). In a similar
vein, the transcriptase which synthesizes the L mRNA
presumably reads through the L gene-end site at a frequency
of ca. 5% (similar to other gene junctions; Le Mercier et al.,
2002) and terminates at the genome 5′ end, thus providing read-
through L transcripts that can anneal to trailer RNAs. Although
the NNV replication strategy appears to minimize dsRNA
potential during intracellular replication, this strategy presum-
ably cannot exclude the generation of small amounts of dsRNA.
It is reasonable that the levels of V and C expressed during ND
genome replication are designed to counteract the small amounts
of dsRNA generated. If so, the presence of significant amounts
of copyback DI genomes during intracellular replication will
certainly change the nature of the SeV infection.
The most important new finding of this study is that not all
SeV stocks that are heavily contaminated by DI genomes are
equally able to activate IFNβ. The H4, GP55 and S104 stocks all
contain the H strain ND genome as helper and can be directly
compared. S104 infections accumulate more viral products than
H4 infections as the S104 DI genomes appear to interfere less
with their helper virus replication than those of H4 (Fig. 2b). At
the same time, S104 infections activated IFNβ 10 to 20-fold less
strongly than H4 infections in multiple experiments (Fig. 2a and
data not shown). Besides the different extents to which S104 and
H4 DI genomes interfere with ND genome expression and thus
affect the intracellular concentration of the viral VandC proteins,
H4 stocks are composed exclusively of copyback DI genomes,
whereas S104 stocks are composed predominantly (>70%) of
internal deletion DI genomes. Moreover, the two copyback DI
genomes in this stock are both longer than DI-H4. DI-GP55 is
also longer than DI-H4, its termini are complementary for only
half the length as H4 (55 nt), and DI-GP55 interferes with ND
genome expression less than DI-H4. Taken together, these data
suggest that the ability of SeV DI stocks to activate IFNβ is
related both to (i) their ability to interfere with helper genome
expression, which leads to lower levels of Vand C intracellularly,
and (ii) their relative content of copyback DI genomes. The size
of the DI genome may also play a role in this latter respect.
However, it will be necessary to examine these properties of SeVDI genomes more directly, e.g., by extending the terminal
complementarity of DI-GP55 to 110 nt, or by altering the length
of DI-H4+yfp, to be more certain of these conclusions.
Copyback DI genomes may be stronger activators of IFNβ
than internal deletion DI genomes because they have a stronger
potential to form dsRNA. Copyback DI genomes are composed
of equal amounts of genomes and antigenomes (rather than a
10-fold excess of genomes), and their termini can self-anneal
intramolecularly as well. The question then remains of how this
dsRNA potential is expressed as the synthesis of DI genomes,
like that of ND genomes, is thought to be coupled to their
assembly into NCs. The vast majority of these NCs, once
formed, are very stable in vivo and band in CsCl density
gradients as fully assembled NCs. However, it is not rare to find
small amounts of DI-H4 genomes and antigenomes in extracts
of infected cells which pellet through these gradients as free
RNAs (<5%, unpublished). It is not clear whether these non-
assembled DI genomes were normally made as NCs which
subsequently disassembled or were actually made de novo
without concurrent assembly with N protein, as reported for
some conditions of VSV DI genome replication in vitro
(Chanda et al., 1980). Independent of how non-assembled DI-
H4 genomes are presumably generated in vivo, their formation
appears to be proportional to their synthesis (Fig. 4). Their
presence would represent a vast increase in the dsRNA potential
of SeV DI vs. ND infections, under conditions where there is
less V protein available to dampen dsRNA signaling to IFNβ
(Fig. 4c). The relatively short lengths of the H4 and ChR1 DI
genomes may play a role in how frequently their non-assembled
RNAs are formed in vivo, but this needs to be investigated.
There is one further aspect of SeV copyback DI infections that
should be mentioned to explain their ability to induce IFN so
efficiently, coupled with the remarkable fact that these DI
genomes with dsRNA potential are actually selected for on
passage in eggs (e.g., Fig. 4) (Le Mercier et al., 2002). We have
previously prepared ambisense ND SeV in which an additional
mRNA was expressed from the 3′ end of the antigenome. In
contrast to copyback DI genomes, genomes and antigenomes of
the ambisense SeV contain the weaker genomic promoter. These
ambisense SeV grew poorly in IFN-sensitive cultures and were
relatively IFN-sensitive. They were also highly unstable on
passage in eggs and reverted to virus that grows well even in IFN-
pretreated cells that restrict vesicular stomatitis virus replication,
i.e., the wild-type SeV phenotype. Since this reversion was
always associated with a point mutation in the ambi-mRNA start
site that severely limited its expression, we concluded that the
selection ofmutants unable to express ambi-mRNAon passage in
chicken eggs was presumably due to increased levels of dsRNA
during infection (vRdRp read-through of the ambi-mRNA stop
site creates a capped transcript that can potentially extend the
entire length of the antigenome, whereas extension of the
uncapped trailer RNA (wt SeV) is limited by the poor processivity
of its vRdRp). If ND ambisense SeV with dsRNA potential are
strongly selected against in eggs, then how are DI genomes with
dsRNA potential positively selected under the same conditions?
There are two possible explanations for this conundrum.
Firstly, the dsRNA potential of ambisense SeV is not associated
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ambi-mRNA promoter will largely eliminate this potential. The
ND genomes of SeV stocks containing copyback DI genomes,
in contrast, cannot escape their DI genomes by simple mutation,
and the dsRNA potential of copyback DI genomes is always
associated with a strong selective advantage as copyback DI
genomes outcompete their ND genomes for the replication
substrates provided by the latter. Secondly, and perhaps more
importantly, copyback DI infections are relatively non-cyto-
pathic and often end as persistent infections (Roux et al., 1991).
This is in part due to the ectopic expression of trailer RNA (in
place of leader RNA) from the copyback DI (−) genome (Garcin
et al., 1998) (Fig. 1). Trailer RNA is known to interact with
TIAR, a protein with many links to apoptosis, and this
interaction is important in suppressing SeV-induced PCD
(Iseni et al., 2002). The relative absence of leader RNAs during
copyback DI infections may also contribute to this DI
phenotype as mutations in the SeV leader region are associated
with virulence in mice (Fujii et al., 2002), and the normal
expression of leader RNA appears to be required to prevent
IFNβ activation (Strahle et al., 2003). The ability of copyback
DI infections to delay, and in many cases completely prevent
PCD, may compensate for the negative consequences of
increased dsRNA during infection, which presumably selects
against SeV that express ambi-mRNAs.
In summary, infection with an SeV stock that is highly
contaminated with copyback DI genomes is a potent way of
activating IFNβ. These DI infections presumably provide
plentiful dsRNA, under conditions of reduced expression of
viral products which block the host response to dsRNA, and
with minimal cytopathic effects that lead to persistent infection.
In contrast, infection with an SeV stock that is not contaminated
with copyback DI genomes does not activate IFNβ and is
highly cytopathic. These are two very different virus infections,
and they should not be confused when SeV stocks of unknown
composition are used to activate IFNβ.
Methods and materials
Cells, viruses, and antibodies
BSR-T7 cells were grown in BHK-21 Medium (Glasgow
MEM, Gibco) supplemented with 5% fetal calf serum (FCS) in
the presence of the relevant maintenance drug (G418 at 400 μg/
ml). 2fTGH cells and 293T cells were grown in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf
serum (FCS).
SeV stocks were grown in the allantoic cavities of 9-day-old
embryonated chicken eggs for 3 days at 33 °C. For ND stocks
(109 pfu/ml), 0.1 ml of a 105 dilution (ca. 1000 pfu) was
inoculated per egg. In the case of DI stocks, 0.1 ml of a 102 to
104 dilution was used. In all cases, the amount of viral proteins
present in the resulting allantoic fluid was analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and
Coomassie blue staining of pelleted virus. Virus titers were
determined by plaquing on LLC-MK2 cells. Anti-IRF-3 (Santa
Cruz), anti-actin (Chemicon), anti-Stat1 (C-terminus) (Trans-duction Laboratories), anti-N-877 and anti-PCV, anti-ISG-15
and anti-ISG-56 were provided by Dr. Ganes Sen from The
Cleveland Clinic Institute. Anti-Rig-I was provided by Tadaatsu
Imaizumi from Hirosaki University School of Medicine.
Plasmids, transient transfections, luciferase assay and FACS
pβ-IFN-fl-lucter, which contains the firefly luciferase gene
under the control of the human IFNβ promoter, is described in
King and Goodbourn (1994). The IFNα/β-responsive reporter
plasmid, p(9–27)4tkD(239)lucter, referred to here as pISRE-fl-
lucter, contains four tandem repeats of the IFN-inducible gene
9–27 ISRE fused to the firefly luciferase gene (Didcock et al.,
1999). pTK-rl-lucter used as a transfection standard contains the
herpes simplex virus TK promoter region upstream of the renilla
luciferase gene (Promega). pIRF-3ΔN, which expresses a
dominant negative form of IRF-3, and pIRF-3 5D, which is
constitutively active, were obtained from John Hiscott and
Paula Pitha (Lin et al., 1998).
For transfections, 100,000 cells were plated in six-well plates
20 h before transfection with 1 μg of pβ-IFN-fl-lucter or pISRE-
fl-lucter, 0.3 μg of pTK-rl-lucter, with or without 1 μg of IRF-
3ΔN, or 1 μg of EBS plasmid expressing SeV-V protein (Nishio
et al., 2005), and Fugene (Roche) according to the manufac-
turer's instructions. At 24 h post-transfection, the cells were (or
were not) infected with various Sendai virus stocks or treated
with 100 μg of poly(I)–poly(C) (Sigma, St. Louis, MO) per ml or
transfected with 1 μg of poly(I)–poly(C) using Fugene. Twenty
hours later, cells were harvested and assayed for firefly and
renilla luciferase activity (dual-luciferase reporter assay system;
Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of renilla
luciferase. pIFNβ-GFP, which expresses GFP under the control
of the IFNβ promoter, was constructed by cloning the IFNβ
promoter region from pIFNβ-fl-lucter into pEGFP-N3 (BD
Biosciences Clontech), between the AseI and HindIII sites. For
transfections, 100,000 cells were plated in six-well plates 20 h
before transfection with 1 μg of pIFNβ-GFP and CaPO4
(Stratagene) according to the manufacturer's instructions. At
24 h post-transfection, the cells were (or were not) infected with
Sendai virus or different DI stocks. Twenty hours later, cells were
harvested and assayed for GFP expression by FACS analysis.
Preparation of DI-H4+yfp
100,000 BSR-T7 cells were plated in six-well plates 20 h
before transfection with a mix containing 0.75 μg of pTM1-L,
1.5 μg of pTM1-N, 1.5 μg of pTM1-P/Cstop (which does not
express C proteins), 1 μg of the various pDI constructs and
Fugene. Six hours later, the transfection mix was discarded and
replaced with 2 ml of Glasgow MEM supplemented with 5%
FCS. Twenty four hours post-transfection, the cells were
infected with ND SeV. Forty eight hours post-infection, the
cells were scraped into their medium and injected directly into
the allantoic cavity of 9-day embryonated chicken eggs. Three
days later, the allantoic fluids were harvested and injected
undiluted into eggs. For further passages, the virus stocks were
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500 before injection. The presence of viruses in the resulting
stock was determined by pelleting allantoic fluids (100 μl)
through a TNE (10 mM Tris–HCl [pH 8.0], 100 mM NaCl,
1 mM EDTA)–25% glycerol cushion for 20 min at 14,000 rpm
in an Eppendorf 5417C centrifuge. Virus pellets were
resuspended in sample buffer, and the proteins were separated
by sodium dodecyl sulfate–10% PAGE and stained with
Coomassie brilliant blue, alongside an ND stock of known titer.
Analysis of encapsidated RNAs
Confluent 293T cells in 9 cm ∅ Petri dishes (2 × 107 cells)
were infected with 10 pfu/cell of ND stocks, and an equivalent
amount of viral protein for DI stocks. Two days post-infection,
the cells were collected, and the intracellular viral nucleocapsids
(NC) were purified by 20–40% (w/w) CsCl density gradient
centrifugation and pelleted. After treatment with SDS and
proteinase K, the nucleocapsid RNAs were phenol-extracted
and ethanol-precipitated. The resulting RNAs were character-
ized by Taqman analysis using specifics oligonucleotides and
Taqman probes and by Northern blotting using a biotinylated
riboprobe generated in vitro by T7 RNA polymerase transcrip-
tion of plus strands complementary to nucleotides 13,397–
14,850 of the (−) ND genome.
Reverse transcription and real-time PCR via Taqman
Total RNA was extracted using Trizol (Invitrogen). Twenty
micrograms of total RNA was mixed with 0.5 μg Random
Hexamers (Promega) and subjected to a Superscript reverse
transcription (RT) reaction as described by the manufacturer
(Gibco) in a total volume of 50 μl. Two microliters of each
cDNA was then combined with 1 μl of internal control
Human GAPDH (Applied Biosystems), 11 μl MasterMix
(Eurogentec), 20 pmol (each) of forward and reverse primers
and 4.4 pmol of Taqman probe in a total volume of 22 μl.
The following primers and probes (Eurogentec or Microsynth)
were used: N gene: 5′-GCAATAACGGTGTCGATCACG-3′
(Fwd); 5′-TGCCTGAGCCGATCGG-3′ (Rev); 5′-CGAAGAT-
GACGATACCGCAGCAGTAGC-3′ (Probe). YFP gene:
5′-CCGACAACCACTACCTGAGCTA-3′ (Fwd); 5′-GAACTC-
CAGCAGGACCATGTG-3′ (Rev); 5′-AAAGACCCCAACGA-
GAAGCGCGA-3′ (Probe). Real-time PCR was carried out in the
7700 Sequence Detector (Applied Biosystems).
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As infection with wild-type (wt) Sendai virus (SeV) normally activates beta interferon (IFN-) very poorly,
two unnatural SeV infections were used to study virus-induced IFN- activation in mouse embryonic fibro-
blasts: (i) SeV-DI-H4, which is composed mostly of small, copyback defective interfering (DI) genomes and
whose infection overproduces short 5-triphosphorylated trailer RNAs (pppRNAs) and underproduces viral V
and C proteins, and (ii) SeV-GFP(/), a coinfection that produces wt amounts of viral gene products but that
also produces both green fluorescent protein (GFP) mRNA and its complement, which can form double-
stranded RNA (dsRNA) with capped 5 ends. We found that (i) virus-induced signaling to IFN- depended
predominantly on RIG-I (as opposed to mda-5) for both SeV infections, i.e., that RIG-I senses both pppRNAs
and dsRNA without 5-triphosphorylated ends, and (ii) it is the viral C protein (as opposed to V) that is
primarily responsible for countering RIG-I-dependent signaling to IFN-. Nondefective SeV that cannot
specifically express C proteins not only cannot prevent the effects of transfected poly(I-C) or pppRNAs on IFN-
activation but also synergistically enhances these effects. SeV-Vminus infection, in contrast, behaves mostly like
wt SeV and counteracts the effects of transfected poly(I-C) or pppRNAs.
All viruses evade the cellular innate immune system in part
by expressing gene products that interfere with the ability of
the host cell to establish an antiviral state (6). In the case of the
Paramyxovirinae, this anti-host-defense activity is due mostly to
viral C and V proteins (15, 27, 31). The C and V proteins are
encoded by separate alternate open reading frames (ORFs),
which both overlap that of the P protein. V and C are also
referred to as accessory gene products, as not all members of
this virus subfamily express one or the other. More specifically,
rubulavirus and avulavirus express V but do not express C
proteins, and human parainfluenza virus type 1 (PIV1), a res-
pirovirus most closely related to Sendai virus (SeV), expresses
C but does not express a V protein (16, 20).
Paramyxovirus V and C proteins antagonize interferon
(IFN) signaling by various mechanisms, and they also target
the production of type I IFN (15, 31). Beta IFN (IFN-)
production is one of the earliest events in the cellular innate
immune response, which leads to the establishment of an anti-
viral state. IFN- production requires the coordinated activa-
tion of several transcription factors, including NF-B and IRF3
(15, 29). For intracellular RNA virus replication, the signaling
pathway that leads to IRF3 activation starts with mda-5 and
RIG-I, two cytoplasmic DExH/D-box helicases with N-termi-
nal CARD domains. These helicases respond to double-
stranded RNA (dsRNA) and, at least for RIG-I, to 5-triphos-
phorylated single-stranded RNA (ssRNA) (pppRNA), which
are generated in the cytoplasm during RNA virus replication
(9, 11, 25). Upon the detection of these viral RNAs, the CARD
domains of these helicases interact with IPS-1/Cardif/MAVS/
VISA, which is present in the mitochondrial membrane, and
this CARD-CARD interaction is thought to lead to the re-
cruitment and activation of TBK1, IKKε, and other IKK ki-
nases that activate NF-B and IRF3, thereby activating the
IFN- promoter (8). The production of these early IFNs ini-
tiates autocrine and paracrine signal amplifications via the
Jak/Stat pathway to produce a generalized antiviral state and
also assists in the subsequent activation of adaptive immune
responses.
The role of mda-5 in sensing RNA virus infection was un-
covered because mda-5 was found to bind to the PIV5 V
protein and other paramyxovirus V proteins, including SeV V.
These V-protein–mda-5 interactions, moreover, prevented
IFN- activation in response to transfected poly(I-C) (1). On
the other hand, other studies found that RIG-I and not mda-5
acts as the sensor of paramyxovirus infection (13, 28). This
paper provides evidence that for SeV infection of mouse em-
bryonic fibroblasts (MEFs), it is the C protein (and not V) that
is primarily responsible for this effect and that C acts by coun-
tering RIG-I (and not mda-5). Independent expression of C
was found to inhibit RIG-I-dependent signaling to the IFN-
promoter induced by either pppRNAs or dsRNAs. Moreover,
SeV that cannot specifically express C proteins was unable to
counteract poly(I-C)- or pppRNA-induced IFN- activation,
whereas SeV that cannot express V behaved mostly like wild-
type (wt) SeV.
MATERIALS AND METHODS
Cells, viruses, and antibodies. MEFs were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum.
SeV stocks were grown in the allantoic cavitiesof 9-day-old embryonated
chicken eggs for 3 days at 33°C. For nondefective stocks (109 PFU/ml), 0.1 ml of
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a 105 dilution (ca. 1,000 PFU) was inoculated per egg. In the case of DI stocks,
0.1 ml of a 103 dilution was used. In all cases, the amount of viral proteins present
in the resulting allantoic fluid was analyzed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and Coomassie blue staining of pelleted virus.
Virus titers were determined by plaquing on LLC-MK2 cells.
SeV-GFP(), which expresses green fluorescent protein (GFP) from a trans-
gene between the M and F genes, and SeV-GFP() or SeV-RFP, which ex-
presses antisense GFP mRNA or red fluorescent protein (RFP) (dsRED) from
similarly located transgenes, were prepared as previously described (31). DI-H4
stocks were described previously (30).
Primary antibodies used included rabbit anti-RFP (AB3216; Chemicon); anti-
actin monoclonal antibody (MAb) (1501; Chemicon); rabbit anti-GFP (632460;
BD biosciences); rabbit anti-SeV-P/C/V (homemade); anti-hemagglutinin (HA)
MAb (16B12; BABCO), anti-Flag MAb (F1804; Sigma), rabbit anti-mda-5 (J.
Tschopp, Lausanne, Switzerland), and rabbit anti-RIG-I (T. Fujita, Kyoto,
Japan).
Plasmids, transient transfections, infections, inductions, luciferase assay, and
fluorescence-activated cell sorter analysis. EBS plasmids (3) expressed viral and
fluorescent proteins and were constructed by standard methods; precise detail
can be obtained from the authors.
NS1 {residues 1 to 77 [NS1(1-77)]} (from Jacques Perrault) and E3L {residues
100 to 190 [E3L(100-190)]} (from Bertram Jacobs), were HA tagged and cloned
into pEBS. Flag-tagged RIG-I, RIG-I-C, or RIG-CARDS (dominant negative)
and mouse mda-5 were obtained from Jurg Tshopp and Klaus Conzelmann.
p-IFN-fl-lucter, which contains the firefly luciferase gene under the control of
the human IFN- promoter, was described previously (14). pTK-rl-lucter, used
as a transfection standard, contains the herpes simplex virus TK promoter region
upstream of the Renilla luciferase gene (Promega).
For transfections, 100,000 cells were plated into six-well plates 20 h before
transfection with 1.5 g of p-IFN-fl-lucter; 0.5 g of pTK-rl-lucter; 0.5 g of
plasmids expressing RIG-I and MDA-5; 1.5 g of plasmids expressing V (whose
C ORF is closed with a stop codon), C1-204 or C1-23-Tom-C24-204 (or C*),
NS1(1-77), wt E3L, mutant E3L(100-190), or RIG- proteins (as indicated); and
TransIT-LT1 transfection reagent (Mirus). At 24 h posttransfection, the cells
were (or were not) infected with various SeV stocks or transfected with 5 g of
poly(I-C) using TransIT-LT1 transfection reagent. Twenty hours later, cells were
harvested and assayed for firefly and Renilla luciferase activity (dual-luciferase
reporter assay system; Promega). Relative expression levels were calculated by
dividing the firefly luciferase values by those of Renilla luciferase.
Immunoblotting. Cytoplasmic extracts were prepared using 0.5% NP-40
buffer. Equal amounts of total proteins were separated by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis and transferred onto Immobilon-P mem-
branes by semidry transfer. The secondary antibodies used were alkaline phos-
phatase-conjugated goat anti-rabbit (or mouse) immunoglobulin G (Bio-Rad).
The immobilized proteins were detected by light-enhanced chemiluminescence
(Pierce) and analyzed in a Bio-Rad light detector using Quantity One software.
In vitro synthesis of RNA, purification, and transfection. DNA for T7 RNA
polymerase synthesis of model RNA1 was prepared by PCR using the following
partially complementary primers: 5-TAATACGACTCACTATA(ggg/gca)ACA
CACCACAACCAACCCACAAC-3 (forward) (start sites are in lowercase type)
and 5-GAAAGAAAGGTGTGGTGTTGGTGTGGTTGTTGTGGGTTGGT
TGTGG-3 (reverse). In vitro transcription was performed on 100 pmol of
purified PCR product using T7 MEGAshortcript from Ambion according to the
manufacturer’s instructions. For RNA1 containing the unusual OHGCA start
site, RNA was initiated with the dinucleotide 5 OHGpC24 in a reaction without
GTP. For RNA1 containing the usual pppGGG start site, part of the product was
treated with 20 units of calf intestinal phosphatase (Roche) for 30 min at 37°C
followed by proteinase K treatment (15 min at 37°C), phenol extraction, and
ethanol precipitation. The T7 transcripts were purified on NucAway Spin col-
umns from Ambion (to remove unincorporated nucleotides). SeV trailer pppR-
NAs were synthesized similarly by using specific PCR primers.
For RNA transfection, 1 g (1) to 3 g (3) of RNA was transfected into
MEF cells using TransMessenger transfection reagent (QIAGEN).
RT and real-time PCR via TaqMan. Confluent MEFs in 10-cm petri dishes
(107 cells) were infected with 20 PFU/cell of SeV GFP(), SeV GFP(), or both
stocks. At 24 h postinfection (hpi), the cells were collected and lysed in 300 l of
NP-40 lysis buffer. Cytoplasmic extracts were then centrifuged in a 20 to 40%
(wt/wt) CsCl density gradient (16 h at 35,000 rpm at 12°C). The pellet RNAs
were ethanol precipitated and resuspended in 50 l of Tris-EDTA. Fifteen
micrograms of RNA was then mixed with 0.5 g of the forward or the reverse
GFP primer and subjected to a Superscript reverse transcription (RT) reaction,
according to instructions provided by the manufacturer (Gibco), in a total vol-
ume of 50 l. Five microliters of each cDNA was then combined with 12 l
MasterMix (Eurogentec), 20 pmol (each) of forward and reverse primers, and 4.4
pmol of TaqMan probe in a total volume of 25 l. The following primers and
probes (Eurogentec or Microsynth) were used for RT and TaqMan analyses of
the GFP gene: 5-CCGACAACCACTACCTGAGCAC-3 (forward), 5-GAAC
TCCAGCAGGACCATGTG-3 (reverse), and 5-AAAGACCCCAACGAGAA
GCGCGA-3 (probe). Real-time PCR was carried out in duplicates using a 7700
sequence detector (Applied Biosystems).
RESULTS
Three ways to activate IFN-. We have used three ways to
induce the activation of an IFN- promoter expressing a lucif-
erase reporter gene in MEFs (see Fig. 2A). The first is to
simply transfect a synthetic dsRNA, poly(I):poly(C) [poly(I-
C)], into the cells. The second way is to infect the cells with an
SeV stock that contains a well-characterized copyback DI ge-
nome (H4) (30). The third way is to coinfect cells with SeV-
GFP(), which expresses a GFP transgene, and SeV-GFP(),
which expresses mRNA containing the complement of the
GFP ORF, as recently described for vesicular stomatitis virus
(VSV) (24). As shown in Fig. 1A, infection with increasing
amounts of SeV-GFP() alone leads to increasing GFP ex-
pression. Coinfection of 20 PFU/cell of SeV-GFP() with
increasing amounts of SeV-GFP() leads to the gradual de-
crease of GFP expression (top). At 20 PFU/cell of SeV-
GFP(), there are roughly equal amounts of GFP and anti-
GFP mRNAs intracellularly (by strand-specific quantitative
RT-PCR) (Fig. 1B and see Materials and Methods), and there
is a 90% loss of GFP expression (Fig. 1A, top). This loss of
GFP expression cannot be accounted for by the reduced level
of GFP mRNA (Fig. 1B). In contrast, coinfection with increas-
ing amounts of SeV expressing RFP as a neutral control (SeV-
RFP) has a reduced ability to interfere with GFP expression
(Fig. 1A). More importantly, whereas infection with SeV-
GFP() alone or its coinfection with SeV-RFP leads to little
FIG. 1. IFN- activation induced by SeV-GFP(/) infections. (A) Parallel cultures of MEFs were first transfected with pIFN-lucff and
pTK-lucr and then infected with increasing amounts of either SeV-GFP() alone (which expresses a GFP mRNA from a transgene between the
M and F genes) or 20 PFU/cell of SeV-GFP() plus increasing amounts of either SeV-GFP() (which expresses an anti-GFP mRNA from a
transgene in the same location) or SeV-RFP (which expresses an RFP mRNA from a transgene in the same location), as indicated. GFP expression
was monitored by fluorescence-activated cell sorter analysis at 20 hpi. Cell extracts were prepared at 20 hpi, and equal amounts were used to
determine luciferase activities (below). These transfections were carried out three times with independent virus stocks, with similar results.
(B) Cytoplasmic extracts were centrifuged on CsCl density gradients to isolate nonencapsidated (pellet) RNAs. The levels of GFP and anti-GFP
mRNAs in 15 g of CsCl pellet RNA were determined using sense- and antisense-specific primers for RT, followed by quantitative PCR (TaqMan)
(see Materials and Methods). (C) Parallel cultures of MEFs were first transfected with the luciferase reporter plasmids plus either an empty vector,
one expressing wt E3L(100–190), or one expressing mutant E3L(100–190) (E3L-mut.) and then infected with increasing amounts of SeV-GFP()
and SeV-GFP() as indicated. Cell extracts were prepared at 20 hpi, and equal amounts were used to determine luciferase activities. Equal
amounts of cell extracts were also Western blotted using anti-N and anti-HA (below).
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or no activation of IFN- (Fig. 1A), coinfection with SeV-
GFP() clearly activates the IFN- promoter (Fig. 1A, bot-
tom). This IFN- activation is inhibited by the coexpression of
the dsRNA-binding domain of the vaccinia virus E3L protein,
whereas this activation is unaffected by a mutant form of E3L
containing two point mutations that eliminate the binding of
dsRNA (10) (Fig. 1C). Taken together, our results show that
only SeV coinfections that can form GFP dsRNA induce
IFN- activation.
The two SeV infections that activate IFN- differ from each
other in several respects. First, DI-H4 genomes are of the
copyback variety and contain the strong antigenomic replica-
tion promoter at their 3 ends. DI-H4 genomes thus have a
strong competitive advantage in replication over nondefective
(ND) genomes, and this sometimes leads to less viral structural
proteins like N and P being present intracellularly (see, e.g., P
protein in Fig. 3A), but sometimes, this difference is minimal
(see, e.g., Fig. 2A). However, in either case, viral V and C
proteins are almost entirely absent in these DI-H4-infected
cells, whereas V and C are found at wild-type levels in
GFP(/) infections (Fig. 2 and data not shown). Both of
these viral proteins are thought to limit IFN- activation due
to virus infection (15, 31). Second, the DI genome replication
promoters, like those of the ND genomes, are always active in
the presence of viral polymerase, and short 5-triphosphory-
lated trailer RNAs (rather than full-length DI genomes) are
transcribed by a relatively nonprocessive polymerase, espe-
cially when the N protein is limiting. Unlike genome synthesis
that is dependent on ongoing (N) protein synthesis, that of
trailer RNA actually increases when translation is blocked with
cycloheximide (18). SeV trailer RNAs are known to specifically
bind to TIAR, a cellular RNA binding protein of the ELAV
family (4), and to prevent virus-induced apoptosis (7, 12).
DI-H4 infections are expected to overproduce trailer RNAs,
which may stimulate RIG-I (11, 25), similar to measles virus
leader RNA (26). Lastly, DI-H4-infected cells also contain
small amounts of unencapsidated H4 genome RNA that can
self-anneal in a concentration-independent manner to form
dsRNA panhandles with 5-triphosphorylated ends. SeV-GFP
(/)-infected cells, on the other hand, can form dsRNAs
with capped ends.
Relative contributions of mda-5 and RIG-I in sensing SeV
infections in MEFs. mda-5 signaling to IFN- was discovered
because the PIV5 V protein was found to bind this helicase and
thereby prevent poly(I-C)-induced IFN- activation. Further
work showed that the V–mda-5 interaction is a general prop-
erty of paramyxovirus V proteins, including that of SeV (1, 5).
Nevertheless, several groups have now found that SeV infec-
tion is sensed by RIG-I (and not mda-5) (13). To determine
whether RIG-I was also responsible for signaling to the IFN-
promoter in our MEFs, we examined the effect of expressing a
dominant-negative form of RIG-I [RIG-I(CARDs), whose
N-terminal CARD domains are deleted] (Fig. 2A). MEFs were
first transfected with pIFN-lucff, pTK-lucr, and plasmids ex-
pressing either RIG-I(CARDs) or an empty vector as a neg-
ative control. After 24 h, the cells were either transfected with
poly(I-C) or infected with either SeV-DI-H4 or SeV-GFP(/),
and luciferase levels were determined 24 h later. As shown in
Fig. 2A, both SeV infections strongly activated the IFN- pro-
moter, whereas transfected poly(I-C) had a more modest effect
in this experiment. RIG-I(CARDs) coexpression did not af-
fect the levels of P, V, and C proteins found intracellularly
(bottom), but this coexpression reduced IFN- activation to
background levels in all three cases.
To determine whether the loss of IFN- activation by RIG-
I(CARDs) coexpression was due to its ability to also inhibit
mda-5 signaling, e.g., by sequestering cytoplasmic viral RNAs,
we examined whether RIG-I(CARDs) could inhibit mda-5
signaling. As mda-5 and RIG-I can be activated by simple
overexpression, we examined the effect of RIG-I(CARDs)
expression on IFN- activation due to the overexpression of
these two helicases. As shown in Fig. 2B, IFN- activation
clearly occurred upon exogenous mda-5 or RIG-I expression.
Moreover, whereas RIG-I(CARDs) coexpression completely
inhibited activation due to exogenous RIG-I, RIG-I(CARDs)
coexpression had little effect in countering IFN- activation due
to exogenous mda-5. In contrast, the coexpression of a dominant-
negative form of mda-5 completely inhibited IFN- activation
due to mda-5 overexpression (Fig. 2B). Taken together, these
results suggest that IFN- activation in our MEFs in response to
these SeV infections is predominantly, if not exclusively, due to
the action of RIG-I.
The coexpression of either SeV V or C proteins strongly
inhibited IFN- activation due to RIG-I overexpression,
whereas only the V protein strongly inhibited IFN- activation
due to mda-5 overexpression (Fig. 2B). The finding that SeV V
inhibits RIG-I signaling as well as that of mda-5 is consistent
with data from Childs et al. (5), who reported that SeV V was
a possible exception to the rule that all V proteins inhibited
mda-5 but not RIG-I. They reported that SeV V did in fact
modestly inhibit RIG-I (35%), whereas all other V proteins
had no effect.
SeV V and C inhibition of SeV-DI-H4 and SeV-GFP(/)
induced IFN- activation. We next examined the abilities of
FIG. 2. Relative contributions of mda-5 and RIG-I in sensing SeV infections in MEFs. (A) Parallel cultures of MEFs were first transfected with
pIFN-lucff, pTK-lucr, and plasmids expressing dominant-negative RIG-I(CARDs) or an empty vector as a negative control. After 24 h, the cells
were either transfected with poly(I-C) or infected with either SeV-DI-H4 or SeV-GFP(/) (as indicated). Cytoplasmic extracts were prepared
after a further 20 h of incubation and used to determine firefly and Renilla luciferase levels and the relative levels of RIG-I(CARDs) (anti-Flag)
and viral proteins (anti-P/V/C) by Western blotting (bottom). All transfections were carried out in duplicate, and the range of values obtained is
indicated by the error bars. Ctrl., control. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and plasmids expressing
Flag-tagged RIG-I or mda-5 or these helicases plus RIG-I(CARDs), mda-5(CARDs), SeV V (whose overlapping C ORF was closed by a stop
codon), SeV C, or an empty plasmid as a negative control, as indicated. Cytoplasmic extracts were prepared after 40 h of incubation and used to
determine firefly and Renilla luciferase levels. All transfections were carried out in duplicate, and the range of values obtained is indicated by error
bars. The relative levels of the Flag–RIG-I constructs were determined by Western blotting with anti-Flag, those of the Flag–mda-5 constructs were
determined with anti-mda-5, and those of the viral V and C proteins were determined with anti-P/V/C serum (bottom). Vect., vector.
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the SeV V and C proteins to inhibit IFN- activation induced
by SeV-DI-H4 and SeV-GFP(/) infections. As shown in
Fig. 3A, exogenous expression of the SeV V protein did not
affect the level of viral P, V, and C proteins in SeV infections,
but it did reduce IFN- activation due to DI-H4 infection (by
	60%). Remarkably, SeV V overexpression did not inhibit
IFN- activation due to SeV-GFP(/) infection. The coexpres-
sion of exogenous SeV C protein (actually C1–23-Tom-C24–204,
which migrates just slightly slower than the viral P protein) sim-
ilarly did not affect the level of viral P, V, and C proteins in SeV
infections. C overexpression, however, more strongly inhibited
IFN- activation due to either SeV infection [DI-H4-induced
activation was reduced by 	90%, and GFP(/)-induced acti-
vation was reduced by	75%]. Coexpression of the unmodified C
protein produced similar results (Fig. 2B and data not shown).
The ability of the GFP(/) infection to activate IFN-, despite
FIG. 3. SeV V and C inhibition of IFN- activation induced by SeV infections. (A) Parallel cultures of MEFs were transfected with pIFN-lucff,
pTK-lucr, and plasmids expressing the SeV V protein, the SeV C protein (actually C1–23-Tom-C24–204), or unmodified Tom as a negative control.
After 24 h, the cells were infected with either SeV-DI-H4 or SeV-GFP(/) (as indicated). Cytoplasmic extracts were prepared after a further
24 h of incubation and used to determine firefly and Renilla luciferase levels. The relative levels of viral P, V, and C proteins were determined by
Western blotting with anti-P/C/V serum (bottom). All transfections were carried out in duplicate, and the range of values obtained is indicated by
error bars. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and plasmids expressing either Tom, RIG-I(CARDs), IAV
NS1(1–73), C1–23-Tom-C24–204 (C*), or V, as indicated. After 24 h, the cells were infected with increasing amounts of SeV-DI-H4 (1, 2, and
4). Cytoplasmic extracts were prepared after a further 24 h of incubation and used to determine luciferase levels.
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normal levels of expression of the V and C proteins, is presumably
due to the early formation of GFP dsRNA. In this case, the SeV
V protein is considerably less potent than C in preventing the
response to this dsRNA.
As the DI-H4 infections accumulate so few V and C pro-
teins, we compared the abilities of these proteins (expressed
from plasmids) to inhibit IFN- activation relative to RIG-
I(CARDs) and the dsRNA binding domain of the influenza
A virus (IAV) NS1(1–73), another viral protein that inhibits
RIG-I signaling (22, 25). As shown in Fig. 3B, the SeV C
protein was as active as RIG-I(CARDs) in combating an
increasing dose of DI-H4 infection and almost as active as
NS1. Consistent with above-described results (Fig. 3A), the
SeV V protein was less active than C but was still able to inhibit
most of the DI-H4-induced IFN- activation.
The SeV C1–204 protein is composed of two domains: the
N-terminal 23 amino acids (C1–23) which act as a plasma mem-
brane (PM) targeting signal (19) and which is present in the
longer (C/C) but not in the shorter (Y1/Y2) “C” proteins, and
C24–204, or the Y1 protein, which acts as a protein interaction
domain. Whereas C24–204 (or Y1) is naturally expressed during
infection, C1–23 is only found fused to Y1. In order to study the
different contributions of these two domains to C-protein func-
tion, we have used tomato red fluorescent protein (Tom) in
which C1–23 is fused to the N terminus of Tom and C24–204 is
fused to its carboxy terminus as a carrier. The interposition of
Tom between these two domains of C remarkably does not
appear to affect any of the activities of C1–204 (19). MEFs were
transfected with the luciferase reporter plasmids along with
plasmids expressing various Tom constructs as indicated (Fig.
4). After 24 h, half of the cultures were infected with SeV-DI-
H4, and luciferase levels were determined after a further 24 h.
The expression of C1–23-Tom, which carries the wt PM anchor
and is localized at the cell surface, or P8P9-Tom, which carries
a mutant PM anchor and is distributed throughout the cyto-
plasm (19), had little or no effect on the DI-H4-induced IFN-
activation. In contrast, both C1–23-Tom-C24–204 and P8P9-Tom-
C24–204 reduced IFN- activation to near-background levels.
C24–204 alone (Tom-C24–204), moreover, was still quite active in
this respect (Fig. 4). Thus, the C24–204 or Y1 protein interac-
tion domain appears to be responsible for inhibiting RIG-I-
dependent IFN- activation, and this inhibition is largely
independent of whether C24–204 is localized at the PM.
SeV C protein inhibits IFN- activation induced by trans-
fected pppRNA. A general property of nonsegmented nega-
tive-strand RNA viruses is that short, promoter-proximal
pppRNAs (leader and trailer RNAs) are transcribed from
their replication promoters, especially when unassembled N
protein is limiting (17, 18). The ability of SeV infections to
induce IFN is essentially due to the presence of DI genomes
that are present in their egg-grown stocks, especially those of
the copyback variety (30). As mentioned above, copyback DI
genomes have a strong replicative advantage because they con-
tain strong replication promoters at the DI genome and anti-
genome 3 ends. Copyback DI genome replication thus gener-
ates short trailer RNAs that are unmodified at either end and
can be considered as unstable, abortive replication products
(see Discussion).
To examine whether trailer RNAs act as pathogen-associ-
ated molecular patterns (PAMPs), we transfected trailer RNA
made by T7 RNA polymerase in vitro into our MEFs and
monitored the activation of IFN-. As the ability of pppRNAs
to induce IFN- activation is not sequence dependent (11), we
also examined model RNAs that were initiated with GTP but
then treated with phosphatase or those initiated with the dinu-
cleotide GpC rather than pppG (23). The transfections of all
FIG. 4. SeV C24–204 (or Y1) protein inhibits IFN- activation induced by DI-H4 infection. Parallel cultures of MEFs were transfected with
pIFN-lucff, pTK-lucr, and plasmids expressing tomato constructs carrying either the wt (C1–23) or mutant (P8P9) C1–23 fused to their N termini,
with and without C24–204 (or Y1) fused to their carboxy termini, C24–204 fused to the carboxy terminus alone (Tom-C24–204), or unmodified Tom
as a negative control (ctrl.), as indicated. After 24 h, the cells were infected with SeV-DI-H4 (as indicated). Cytoplasmic extracts were prepared
after a further 24 h of incubation and used to determine luciferase levels. The relative levels of the various tomato constructs were determined by
Western blotting with anti-dsRED (bottom). All transfections were carried out in duplicate, and the range of values obtained is indicated by error
bars.
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FIG. 5. pppRNA-induced activation of IFN-. (A) Parallel cultures of MEFs were transfected with pIFN-luc
ff and pTK-lucr, and pRIG-I was
also transfected in some cultures, as indicated. After 24 h, the cells were transfected for 3 h with increasing amounts (1 or 3 g) of either
pppGGG/RNA1, phosphatase-treated GGG/RNA1, pppGCA/RNA1, or OHGCA/RNA1, as indicated. Cytoplasmic extracts were prepared 18 h
post-RNA transfection and used to determine luciferase levels. (B) Parallel cultures of MEFs were transfected with pIFN-lucff, pTK-lucr, and
plasmids expressing Tom, RIG-I(CARDs), IAV NS1(1–73), C1–23-Tom-C24–204 (C*), or V, as indicated. After 24 h, the cells were transfected with
increasing amounts (1 g and 3 g) of pppGGG/RNA1, as indicated. Cytoplasmic extracts were prepared after 3 h of RNA transfection and used
to determine luciferase levels. Rel., relative. (C) Same as above (B), except that the cells were transfected with 3 g of ppptrailer RNA.
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three 5-triphosphorylated ssRNAs clearly led to IFN- acti-
vation, whereas both RNAs that contained 5-hydroxyl ends
had essentially lost their ability to activate IFN- in parallel
transfections (Fig. 5A and C), confirming previously reported
results (11, 25, 26). We then examined the ability of the SeV C
and V proteins to inhibit 5-pppRNA-dependent activation of
IFN- compared to RIG-I(CARDs) and IAV NS1(1–73).
MEFs were first transfected with plasmids expressing various
viral inhibitory proteins or an empty plasmid as a negative
control and then transfected with increasing amounts of
pppRNAs. IFN- activation was monitored after a further 18 h.
As shown in Fig. 5B, expression of the SeV C protein was as
active as RIG-I(CARDs) in inhibiting IFN- activation at all
amounts of pppRNAs transfected although not quite as active
as NS1(1–73). Expression of SeV V was again the least inhib-
itory; in fact, significant inhibition occurred only at the lowest
amount of pppRNA. Thus, short 5-triphosphorylated ssRNAs
such as trailer RNA are potent stimulators of IFN- when
transfected into our MEFs, and expression of the SeV C pro-
tein (but not the SeV V protein) can effectively inhibit this
stimulation (Fig. 5B and C).
Relative importance of C and V in inhibiting RIG-I-depen-
dent signaling to IFN-. Another way to investigate the rela-
tive importance of the C and V proteins in inhibiting RIG-I-
dependent signaling to IFN- is to compare the relative
abilities of SeV infections that cannot specifically express the C
or V proteins to affect pppRNA- or poly(I-C)-induced IFN-
activation. MEFs were therefore first infected with 20 PFU/ml
of either wt SeV, SeV-Vminus (containing a stop codon in the V
ORF just downstream of the mRNA editing site, which pro-
duces a W-like protein instead of V), or SeV-Cminus (contain-
ing three stop codons in the C ORF downstream of the Y2
initiation codon). The infected cells were then transfected (at
24 hpi) with pIFN--luc plus either pppRNA, poly(I-C), or no
RNA and then harvested after 18 h to determine reporter gene
activity. As shown in Fig. 6, these three SeVs replicate to
clearly different levels in our highly IFN-competent MEFs
(even though they replicate similarly in BSR T7, 293T, and
Vero cells), highlighting the essential functions that these ac-
cessory proteins play in countering the innate immune re-
sponse. Nevertheless, in the absence of transfected RNA, only
SeV-Cminus infection activates IFN- to any extent or increases
RIG-I levels; RIG-I is an IFN-stimulated gene, and its level
reflects that of the antiviral state (Fig. 6, bottom). Transfec-
tions of either pppRNA or poly(I-C) strongly activated the
reporter gene and increased RIG-I levels. Prior infection with
either SeV wt or SeV-Vminus reduced transfected RNA stim-
ulation of the reporter gene and prevented the increase in
RIG-I levels (Fig. 6). SeV-Vminus was only slightly less effective
than wt SeV in this respect. In sharp contrast, prior infection
with SeV-Cminus not only did not prevent the increase in RIG-I
levels but also acted synergistically with either pppRNA or
poly(I-C) transfection to increase reporter gene activity by
increasing the level of RIG-I. These results reinforce the view
FIG. 6. RNA-induced activation of IFN- in cells infected with SeV that cannot express either V or C. Parallel cultures of MEFs were either
mock infected or infected with 20 PFU/ml of wt SeV, SeV-Vminus, or SeV-Cminus, as indicated. After 24 h, the cells were transfected with luciferase
reporter plasmids and either pppGGG/RNA1, poly(I-C), or no RNA (untreated). Cytoplasmic extracts were prepared after 18 h of RNA
transfection, used to determine luciferase levels (above), and Western blotted to determine the levels of P, V, and C proteins as well as endogenous
RIG-I and actin as a loading control. rSeV, recombinant SeV.
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that it is primarily the SeV C protein (and not V) that inhibits
pppRNA- and dsRNA-induced signaling to the IFN- pro-
moter via RIG-I during SeV infection.
DISCUSSION
SeV has been one of the most extensively used model viruses
to investigate IFN induction in infected cells. Most of this work
has used the commercially available Cantell strain of SeV,
whose ability to induce IFN, like that of other SeV strains, is
due to the presence of DI genomes in egg-grown stocks. Non-
defective SeVs that are plaque purified from these stocks,
including that of the Cantell strain, do not induce IFN unless
cellular RIG-I levels are artificially increased (21, 30). For
nondefective SeV infection, the expression of the C and V
proteins is apparently sufficient to prevent IFN- activation
under normal conditions. Measles virus infection, in con-
trast, can apparently induce IFN in the absence of DI ge-
nomes, and evidence that this induction is due to the syn-
thesis of leader pppRNAs has recently been provided (26).
Leader and trailer RNAs, which are unmodified at either
end, are unstable in infected cells unless they are encapsi-
dated with the N protein (presumably after their synthesis as
free RNAs) (2). Free leader and trailer RNAs are more
easily detected in VSV infections, which synthesize larger
amounts of viral RNAs over a shorter period of time. For
nondefective VSV infections, eight times as many trailer
RNAs/antigenome template are found as leader RNAs/ge-
nome template, consistent with the relative strengths of
their respective replication promoters. For VSV copyback
DI infections, there are 40 times as many trailer RNAs/
template (nondefective antigenome plus DI genome) as
leader RNAs/genome template, presumably reflecting the
increased strength of the copyback DI replication promot-
ers. The VSV polymerase clearly has a strong preference for
initiating RNA synthesis at the 3 ends of copyback DI
genomes over both ND genomes and antigenomes (17).
We previously noted that not all SeV stocks that contain DI
genomes strongly induce IFN; this ability appears to be re-
stricted to stocks containing relatively small copyback DI ge-
nomes (the smaller the DI genomes, the more moles of ends
are present for a given weight). The commercially available
Cantell strain contains a copyback DI genome of only 546
nucleotides in length, the smallest SeV DI genome described
to date (30). SeV copyback DI-H4 genomes (1,410 nucleo-
tides) have the same strong replicative advantage as their VSV
counterparts because they also contain strong replication pro-
moters at both their genome and antigenome 3 ends. Thus,
SeV copyback DI infections presumably synthesize consider-
ably more pppRNAs than standard virus infections. We also
previously noted that when cytoplasmic extracts of DI-H4-
infected cells are centrifuged on CsCl density gradients, small
amounts of DI genome RNA are found in the pellet fraction
(30). This indicates that this RNA is not encapsidated with the
N protein and therefore forms dsRNA panhandles in a con-
centration-independent manner. Thus, copyback DI-H4 infec-
tions apparently produce considerably more of both known
PAMPs of RNA virus infection than do standard virus infec-
tions. Coupled with their strongly reduced accumulation of the
viral C and V proteins, it is easy to see why these copyback DI
infections are such potent inducers of IFN-.
All paramyxoviruses express either C or V proteins, and
many viruses express both. In viruses that express only C or V,
we presume that either viral protein alone counteracts the
innate immune response of the host to aid virus replication.
The C and V proteins, which bear no sequence similarity, likely
target different key elements of the host response. Viruses that
express both C and V presumably have more diverse ways of
countering innate immunity. In support of this notion, SeV
infections that cannot specifically express either the C or V
protein contain increased levels of IFN- and interleukin-8
mRNAs relative to wt SeV infections (31), and the indepen-
dent expression of the C or V protein will inhibit poly(I-C)- or
Newcastle disease virus-dependent activation of IRF-3 (15).
Previous work has identified mda-5 as being a key target of
paramyxovirus V proteins in countering the innate immune
response (1). This paper provides evidence that for SeV infec-
tion of MEFs, it is the C protein (and not V) that is primarily
responsible for this effect and that C acts by countering RIG-
I-dependent signaling to IFN-. For example, the independent
expression of either C or V inhibited IFN- activation due to
RIG-I overexpression (Fig. 2B). Also, both proteins inhibited
IFN- activation due to DI-H4 infection, although C was al-
ways more effective here than V (Fig. 3). However, only C
expression effectively inhibited IFN- activation due to
GFP(/) infection (Fig. 3) or transfected poly(I-C) or pp-
pRNAs (Fig. 5). Perhaps the strongest indication that the C
proteins are primarily responsible for countering the innate
immune response comes from experiments with SeV that can-
not specifically express the C or V proteins. SeV-Cminus infec-
tion not only cannot prevent the effects of transfected
poly(I-C) or pppRNAs on IFN- activation but also synergis-
tically enhances these effects. SeV-Vminus infection, in contrast,
behaves mostly like wt SeV infection and counteracts the ef-
fects of transfected poly(I-C) or pppRNAs (Fig. 6).
Finally, we note that poly(I-C) (made with polynucleotide
phosphorylase that generates 5 diphosphate ends and which is
transfected into cells) and the presumed GFP dsRNA (that is
directly generated in the cytoplasm via the viral transcriptase
and which contains capped 5 ends) both activate IFN- via
RIG-I in MEFs. Thus, the ability of dsRNA to induce RIG-I
signaling does not depend on the manner in which it is intro-
duced into this cell compartment, nor is it peculiar to the
presence of 5-diphosphorylated ends that are not normally
found in cells and could theoretically act as PAMPs. Moreover,
in either case, the activation of IFN- by these dsRNAs is
inhibited by the SeV C protein and not V, presumably because
this signaling passes through RIG-I and not mda-5. It appears
that our MEFs contain insufficient amounts of mda-5 to sense
SeV infection, as these MEFs respond well to the expression of
plasmid-derived mda-5 (Fig. 2B). This conclusion is also con-
sistent with our finding that three different rubulavirus V pro-
teins that are known to counteract poly(I-C)-induced mda-5
signaling were unable to inhibit IFN- activation in response to
SeV-DI-H4 infection (data not shown). We expect that the
SeV V protein will be more important in countering the innate
immune response in other cells in which mda-5 functions as a
PAMP recognition receptor.
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